data_1bkt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bkt _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.01 158.71 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -102.27 125.71 49.06 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 125.432 1.707 . . . . 0.0 107.635 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.7 p -114.14 167.56 10.58 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.773 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -119.5 -40.04 2.82 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 110.402 -3.09 . . . . 0.0 105.847 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.416 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.7 m-70 -129.84 176.82 7.73 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.645 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.1 m -87.46 25.52 1.42 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.815 -1.538 . . . . 0.0 109.301 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.01 -50.75 0.28 Allowed Glycine 0 N--CA 1.495 2.6 1 N-CA-C 102.48 -4.248 . . . . 0.0 102.48 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.39 -24.74 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.861 -1.669 . . . . 0.0 109.577 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 29.5 t -98.67 -37.41 9.52 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 112.551 -2.113 . . . . 0.0 111.527 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.415 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.8 tt -58.23 -43.57 87.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.432 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 48.0 mmtm -60.24 -56.12 38.6 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-O 117.898 -1.049 . . . . 0.0 112.059 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 88.5 Cg_endo -67.23 -34.25 28.29 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.248 1.965 . . . . 0.0 111.24 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 10.6 m -59.79 -59.96 4.6 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -52.17 -55.11 23.09 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.936 -1.483 . . . . 0.0 108.178 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.22 -23.36 55.53 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 127.089 2.743 . . . . 0.0 112.307 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 -1.4 42.79 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 123.915 0.759 . . . . 0.0 110.927 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.68 39.93 1.81 Allowed Glycine 0 N--CA 1.483 1.793 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.0 mmm -127.24 -165.74 1.51 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -111.29 -65.98 1.12 Allowed 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -123.88 -179.94 4.59 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.399 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.11 154.63 18.94 Favored Glycine 0 C--O 1.216 -1.031 0 CA-C-N 113.041 -1.89 . . . . 0.0 114.494 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -150.0 136.17 18.8 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.48 139.74 34.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -112.17 -80.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.41 34.53 3.88 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.982 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.34 -23.34 33.45 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 107.073 -2.411 . . . . 0.0 107.073 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -99.42 165.05 11.84 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.5 t -88.06 153.99 20.83 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.529 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 33.9 t70 -139.92 143.8 36.8 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.4 m -113.91 167.18 10.87 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 119.446 1.021 . . . . 0.0 112.812 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.6 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.195 179.79 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -125.88 162.28 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -99.63 135.47 41.0 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.821 1.326 . . . . 0.0 109.122 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 p -119.47 167.93 11.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.607 -2.088 . . . . 0.0 112.384 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -120.89 -43.59 2.45 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 110.023 -3.262 . . . . 0.0 105.404 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -124.13 177.34 5.87 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.678 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.4 p -89.38 26.84 1.57 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.875 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.92 -50.87 0.26 Allowed Glycine 0 N--CA 1.493 2.496 1 N-CA-C 102.544 -4.222 . . . . 0.0 102.544 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -24.06 1.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 112.803 -1.698 . . . . 0.0 109.628 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 39.6 t -98.97 -43.04 6.85 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.757 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.0 tt -55.09 -46.15 75.46 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.832 0.853 . . . . 0.0 112.104 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -56.38 -60.84 7.91 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 124.12 0.888 . . . . 0.0 111.521 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -66.11 -33.37 40.88 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.412 1.408 . . . . 0.0 109.965 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 13.2 m -58.67 -63.66 1.21 Allowed 'General case' 0 C--N 1.31 -1.15 0 O-C-N 123.599 0.562 . . . . 0.0 109.756 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -58.81 -47.28 85.32 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.284 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.11 -22.89 61.57 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 125.708 1.88 . . . . 0.0 111.695 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.27 -3.25 37.73 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 123.889 0.743 . . . . 0.0 110.594 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.67 38.1 1.11 Allowed Glycine 0 N--CA 1.482 1.727 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.414 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 25.4 mmt -126.41 -163.48 1.23 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -115.05 -63.09 1.51 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -128.16 -179.91 5.25 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.059 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.451 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -137.65 151.99 21.46 Favored Glycine 0 N--CA 1.472 1.043 0 CA-C-N 112.633 -2.076 . . . . 0.0 115.074 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -149.57 147.76 28.54 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -99.85 140.83 33.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.54 -80.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -110.33 33.67 4.36 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.141 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.47 -22.06 38.86 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -99.91 164.42 12.02 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.1 t -89.43 147.82 23.81 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.546 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 68.5 t0 -132.17 141.78 49.22 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.8 m -113.37 171.35 7.61 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 119.112 0.869 . . . . 0.0 111.916 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.0 m . . . . . 0 N--CA 1.484 1.259 0 O-C-N 125.068 1.48 . . . . 0.0 107.496 179.708 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.29 164.4 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -99.84 138.2 37.25 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 124.7 1.25 . . . . 0.0 108.517 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 p -123.92 167.16 14.49 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.377 -1.738 . . . . 0.0 112.563 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -119.25 -41.26 2.74 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 110.522 -3.035 . . . . 0.0 105.359 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.409 ' C ' ' H ' ' A' ' 11' ' ' GLY . 87.2 m-70 -130.03 177.79 7.02 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.58 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 m -87.09 25.89 1.27 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 113.6 -1.636 . . . . 0.0 108.982 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -119.69 -50.26 0.3 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 103.205 -3.958 . . . . 0.0 103.205 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -24.87 3.21 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 113.012 -1.594 . . . . 0.0 109.763 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 27.3 t -97.92 -38.22 9.5 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.438 -2.165 . . . . 0.0 111.439 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.433 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.6 tt -58.06 -44.21 87.36 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.526 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -59.24 -56.85 31.85 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-O 117.877 -1.059 . . . . 0.0 112.079 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -67.55 -36.1 20.77 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.214 1.942 . . . . 0.0 111.418 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.64 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 12.5 m -58.96 -59.59 5.22 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -52.37 -55.33 22.36 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.658 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -57.38 -24.49 55.67 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 127.165 2.791 . . . . 0.0 112.086 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.21 -1.28 42.42 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.596 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.76 39.62 1.56 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 116.343 1.297 . . . . 0.0 116.343 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 13.5 mmm -127.51 -165.83 1.53 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -111.32 -66.21 1.1 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -123.84 -178.23 3.99 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.488 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.6 154.4 20.39 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 113.352 -1.749 . . . . 0.0 114.214 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -149.56 137.97 20.74 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -99.44 138.51 36.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.9 mm -112.82 -78.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -110.17 34.45 3.89 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.381 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.94 -26.21 23.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -99.77 165.06 11.76 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.375 0.691 . . . . 0.0 109.395 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.64 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 38.6 t -84.89 150.78 24.74 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.53 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.0 t70 -135.69 141.69 44.99 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.4 m -110.6 170.38 8.13 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 119.462 1.028 . . . . 0.0 112.819 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 N--CA 1.49 1.533 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.208 179.674 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.77 162.1 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -99.83 137.08 38.8 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.225 0.953 . . . . 0.0 110.77 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 p -123.06 167.58 13.46 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.834 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -119.71 -40.36 2.77 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 110.472 -3.058 . . . . 0.0 105.756 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.427 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.9 m80 -128.34 177.69 6.78 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.902 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.9 t -84.2 19.26 1.88 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.961 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.29 -49.17 0.37 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 103.639 -3.784 . . . . 0.0 103.639 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -24.16 4.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.905 -1.647 . . . . 0.0 109.882 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 25.4 t -98.96 -38.5 8.97 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 112.888 -1.96 . . . . 0.0 111.013 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.409 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.8 tt -57.34 -43.93 83.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.688 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -60.05 -55.62 43.62 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-O 118.137 -0.935 . . . . 0.0 112.942 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -67.38 -35.63 23.12 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.739 1.626 . . . . 0.0 109.97 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.695 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 19.2 m -56.73 -64.76 0.77 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -47.59 81.72 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.017 0.823 . . . . 0.0 109.665 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.0 -23.19 53.04 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 126.098 2.124 . . . . 0.0 112.022 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.14 -5.32 33.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.057 0.848 . . . . 0.0 110.758 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.79 38.87 1.02 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.401 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 11.1 mmm -127.13 -162.36 1.15 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -116.67 -64.67 1.28 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.85 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -124.66 179.4 4.99 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.499 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.409 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -127.75 160.74 21.75 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 112.701 -2.045 . . . . 0.0 113.56 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.408 ' HE3' ' H ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -156.24 135.84 12.45 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.408 ' H ' ' HE3' ' A' ' 26' ' ' LYS . 11.0 t -99.28 141.24 32.31 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 105.518 -2.031 . . . . 0.0 105.518 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.2 mt -115.21 -79.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.35 35.69 3.34 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 124.486 1.116 . . . . 0.0 111.343 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.63 -22.15 39.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -100.71 166.82 10.69 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.695 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.4 t -88.28 147.68 24.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.419 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 37.3 t70 -131.02 132.35 44.92 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.9 m -109.48 166.16 11.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.62 1.1 . . . . 0.0 113.675 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.9 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.646 179.823 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.6 t30 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.18 164.96 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.62 145.97 26.98 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 124.875 1.359 . . . . 0.0 108.535 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 p -126.15 168.38 14.11 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.193 -1.821 . . . . 0.0 113.846 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -121.31 -43.07 2.43 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 110.047 -3.251 . . . . 0.0 105.554 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.421 ' C ' ' H ' ' A' ' 11' ' ' GLY . 82.8 m-70 -131.72 179.2 6.21 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.545 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.3 m -89.44 34.61 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.977 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -125.77 -51.28 0.18 Allowed Glycine 0 N--CA 1.494 2.545 1 N-CA-C 102.998 -4.041 . . . . 0.0 102.998 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -23.04 1.9 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 112.668 -1.766 . . . . 0.0 109.934 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 39.4 t -98.7 -44.2 6.51 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.399 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.6 tt -54.3 -45.09 72.48 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.585 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.04 -56.86 31.31 Favored Pre-proline 0 C--N 1.306 -1.324 0 O-C-N 124.294 0.997 . . . . 0.0 113.032 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -67.62 -33.33 28.59 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.973 1.782 . . . . 0.0 110.418 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 16.9 m -59.58 -64.05 1.08 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -56.95 -47.78 79.87 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.238 0.961 . . . . 0.0 108.975 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -58.1 -24.53 59.02 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 126.119 2.137 . . . . 0.0 111.944 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.3 -2.36 39.65 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 124.039 0.837 . . . . 0.0 110.842 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.2 40.32 1.17 Allowed Glycine 0 N--CA 1.483 1.794 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.414 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 14.8 mmm -128.44 -163.02 1.24 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -114.56 -66.1 1.12 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.452 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -125.79 177.74 6.11 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.613 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.467 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -142.38 145.01 14.85 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 112.634 -2.076 . . . . 0.0 114.624 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -138.51 153.47 48.77 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.5 t -99.97 132.41 45.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.24 -73.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -110.15 34.1 4.08 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.046 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.88 -25.16 29.36 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -100.92 168.11 9.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 21.3 t -86.77 145.58 26.58 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.465 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 36.6 t70 -131.59 136.46 47.81 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.3 m -108.56 166.94 10.4 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.872 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.486 1.335 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.831 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.88 165.37 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -99.86 140.58 33.86 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 124.556 1.16 . . . . 0.0 109.471 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 p -124.7 168.26 13.43 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.023 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -120.24 -43.92 2.51 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 109.977 -3.283 . . . . 0.0 104.96 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.426 ' C ' ' H ' ' A' ' 11' ' ' GLY . 43.1 m170 -128.06 177.26 7.01 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 124.968 1.417 . . . . 0.0 111.476 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.4 t -84.74 23.07 1.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.295 -1.775 . . . . 0.0 108.81 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.15 -49.89 0.29 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 103.475 -3.85 . . . . 0.0 103.475 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 -24.96 3.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 112.869 -1.666 . . . . 0.0 109.835 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 21.7 t -98.07 -38.79 9.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 112.578 -2.101 . . . . 0.0 111.748 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.418 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.7 tt -56.44 -44.55 80.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.78 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -59.76 -56.5 35.12 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 124.102 0.876 . . . . 0.0 112.611 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.61 -34.01 26.67 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.808 1.672 . . . . 0.0 110.32 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 9.9 m -59.01 -63.65 1.23 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.19 -47.67 80.68 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 124.088 0.868 . . . . 0.0 109.16 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.76 -25.32 60.29 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 125.976 2.048 . . . . 0.0 111.33 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.15 -1.94 41.06 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 123.876 0.735 . . . . 0.0 111.422 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.75 38.42 1.18 Allowed Glycine 0 N--CA 1.481 1.682 0 N-CA-C 116.929 1.531 . . . . 0.0 116.929 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.416 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 27.3 mmt -125.98 -164.34 1.31 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -114.29 -62.99 1.52 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -127.25 179.69 5.32 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 123.887 0.742 . . . . 0.0 110.734 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.418 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -128.24 156.75 20.98 Favored Glycine 0 C--O 1.216 -1.013 0 CA-C-N 113.064 -1.88 . . . . 0.0 114.295 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -149.25 138.1 21.19 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -99.43 132.95 44.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.2 mt -112.08 -74.15 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -110.08 35.22 3.48 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.905 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.79 -22.84 38.74 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 107.356 -2.298 . . . . 0.0 107.356 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -99.94 168.35 9.92 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 43.1 t -86.37 146.19 26.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.528 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 36.6 t70 -130.85 141.37 50.32 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 22' ' ' MET . 33.6 m -115.12 162.56 16.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 119.147 0.885 . . . . 0.0 112.076 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.5 m . . . . . 0 N--CA 1.487 1.423 0 CA-C-N 113.967 -1.47 . . . . 0.0 108.128 179.849 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.8 t30 . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.5 165.45 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -99.78 138.51 36.77 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 124.427 1.08 . . . . 0.0 109.906 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 p -121.86 167.45 13.02 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 112.693 -2.049 . . . . 0.0 112.212 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -117.87 -41.61 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.47 -3.059 . . . . 0.0 105.275 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.427 ' C ' ' H ' ' A' ' 11' ' ' GLY . 82.7 m-70 -131.8 177.2 7.71 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.985 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.3 m -86.58 26.63 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.17 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.12 -51.26 0.27 Allowed Glycine 0 N--CA 1.495 2.61 1 N-CA-C 102.636 -4.186 . . . . 0.0 102.636 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -24.07 3.73 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.623 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 14.9 t -98.19 -36.97 9.88 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.442 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 tt -57.62 -44.7 85.73 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.863 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.08 -54.37 54.63 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.245 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -67.01 -35.67 24.93 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.576 1.518 . . . . 0.0 110.335 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.625 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 6.5 m -57.62 -63.18 1.32 Allowed 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.37 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.8 -47.84 81.44 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 124.077 0.86 . . . . 0.0 109.365 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.49 -23.16 57.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 125.925 2.016 . . . . 0.0 112.048 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.33 -4.61 34.63 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 124.023 0.827 . . . . 0.0 110.521 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.25 39.94 1.0 Allowed Glycine 0 N--CA 1.483 1.786 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 19.2 mmm -128.27 -164.01 1.33 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -111.43 -65.87 1.13 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.444 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -127.09 -178.93 4.61 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 123.838 0.711 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.83 157.47 18.25 Favored Glycine 0 C--O 1.216 -1.003 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.846 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -150.7 133.46 15.83 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.1 t -99.43 140.33 33.76 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.55 -82.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -110.24 34.73 3.74 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.192 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.63 -23.41 31.42 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -101.04 165.6 11.23 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.625 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 39.4 t -88.52 150.12 23.26 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.521 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 31.5 t70 -134.46 143.4 47.5 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.7 m -112.91 166.28 11.54 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.682 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.5 m . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.712 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.1 t30 . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.52 162.96 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -99.78 140.06 34.54 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 124.608 1.192 . . . . 0.0 110.549 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.6 p -121.64 167.84 12.45 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.459 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -118.78 -42.66 2.71 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.3 -3.137 . . . . 0.0 104.463 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.44 ' C ' ' H ' ' A' ' 11' ' ' GLY . 26.7 m80 -128.41 176.19 7.91 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.179 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.1 m -87.49 25.75 1.38 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.922 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.82 -49.92 0.33 Allowed Glycine 0 N--CA 1.493 2.488 1 N-CA-C 102.353 -4.299 . . . . 0.0 102.353 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -23.83 4.55 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 113.18 -1.51 . . . . 0.0 109.587 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 26.3 t -97.45 -38.57 9.55 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 112.918 -1.946 . . . . 0.0 111.047 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.418 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.6 tt -59.54 -41.88 91.06 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.123 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -58.21 -58.92 15.32 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-O 117.871 -1.061 . . . . 0.0 111.301 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -68.42 -39.08 10.25 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.185 1.923 . . . . 0.0 111.055 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.712 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 14.4 m -55.39 -58.39 7.93 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -56.36 -52.77 63.35 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.385 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -62.45 -17.88 60.45 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 126.037 2.086 . . . . 0.0 112.303 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.46 -5.67 31.96 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 124.056 0.847 . . . . 0.0 109.659 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.76 37.21 1.31 Allowed Glycine 0 N--CA 1.481 1.665 0 N-CA-C 116.596 1.399 . . . . 0.0 116.596 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 14.3 mmm -127.32 -164.81 1.39 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -112.3 -64.54 1.28 Allowed 'General case' 0 C--N 1.309 -1.169 0 O-C-N 123.993 0.808 . . . . 0.0 110.389 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -124.35 -179.68 4.56 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.088 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.418 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.17 153.99 20.09 Favored Glycine 0 C--O 1.216 -0.98 0 CA-C-N 113.218 -1.81 . . . . 0.0 114.43 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -144.39 135.99 25.76 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -99.69 136.38 39.7 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 103.679 -2.711 . . . . 0.0 103.679 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.2 mm -113.26 -81.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 116.917 2.192 . . . . 0.0 116.917 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.22 34.38 3.93 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.426 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.27 -22.77 33.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -102.25 166.98 10.28 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.629 0.841 . . . . 0.0 109.269 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.712 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 37.3 t -90.09 148.78 22.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.459 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 39.2 t70 -132.63 137.12 46.9 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.0 m -108.74 162.77 13.86 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 119.796 1.18 . . . . 0.0 112.517 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.486 1.34 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.363 179.762 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.4 t30 . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.72 166.51 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -99.96 138.01 37.63 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 124.841 1.338 . . . . 0.0 108.993 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 p -123.22 164.36 18.88 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.497 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -115.61 -41.11 3.28 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 111.168 -2.742 . . . . 0.0 104.108 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -126.1 175.31 7.84 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.308 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.1 p -91.37 24.73 2.84 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.525 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 13' ' ' CYS . . . -121.68 -43.02 0.43 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 105.63 -2.988 . . . . 0.0 105.63 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -74.4 5.4 4.67 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.28 -0.96 . . . . 0.0 109.762 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.466 ' H ' ' C ' ' A' ' 11' ' ' GLY . 14.3 t -114.53 -38.26 4.08 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 113.218 -1.81 . . . . 0.0 106.381 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tt -63.61 -39.36 94.18 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.748 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.461 ' N ' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -55.75 -61.51 6.17 Favored Pre-proline 0 N--CA 1.48 1.053 0 O-C-N 124.028 0.83 . . . . 0.0 109.594 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -66.96 -37.02 20.65 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.982 1.788 . . . . 0.0 110.634 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 7.7 m -55.54 -64.73 0.75 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.319 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -45.63 91.86 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.339 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.41 -22.66 54.89 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 125.504 1.753 . . . . 0.0 111.749 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.08 -6.67 31.23 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 123.994 0.809 . . . . 0.0 110.64 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.3 40.46 0.8 Allowed Glycine 0 N--CA 1.479 1.506 0 N-CA-C 116.466 1.347 . . . . 0.0 116.466 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.0 mmm -127.62 -166.01 1.55 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -111.27 -64.16 1.32 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.825 0.703 . . . . 0.0 109.531 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.34 179.91 4.89 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.934 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -124.57 154.32 17.97 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-N 113.166 -1.834 . . . . 0.0 114.748 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.23 134.46 15.09 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.4 t -99.52 139.63 34.89 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.27 -79.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 116.879 2.178 . . . . 0.0 116.879 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.16 34.61 3.8 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.47 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.97 -22.56 37.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -100.22 165.82 11.3 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 44.2 t -90.15 151.09 21.74 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.479 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.456 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.4 t70 -133.46 146.98 51.64 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.4 m -117.94 162.39 18.22 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.681 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.0 m . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.772 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.66 163.95 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.41 145.61 28.7 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 124.526 1.141 . . . . 0.0 110.266 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.3 p -128.38 167.21 17.31 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.808 -1.996 . . . . 0.0 112.991 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -121.17 -42.74 2.46 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 110.097 -3.228 . . . . 0.0 104.928 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.436 ' C ' ' H ' ' A' ' 11' ' ' GLY . 22.5 m80 -128.55 176.31 7.86 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.667 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.1 m -87.9 28.76 0.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.088 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.94 -50.93 0.26 Allowed Glycine 0 N--CA 1.495 2.567 1 N-CA-C 102.075 -4.41 . . . . 0.0 102.075 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.58 -25.93 1.96 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 113.239 -1.48 . . . . 0.0 109.384 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 31.0 t -96.75 -38.83 9.73 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.469 -2.15 . . . . 0.0 111.094 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.421 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -56.84 -45.64 82.24 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.514 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -57.65 -59.58 12.57 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.42 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.12 -33.39 40.71 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.428 1.419 . . . . 0.0 109.417 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.696 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.8 m -58.18 -64.29 0.97 Allowed 'General case' 0 C--N 1.307 -1.239 0 O-C-N 123.739 0.649 . . . . 0.0 109.932 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -57.97 -45.36 86.84 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.121 0.888 . . . . 0.0 109.553 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.472 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 40.4 m-20 -64.74 -18.53 65.13 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 125.59 1.806 . . . . 0.0 112.092 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.14 -3.89 36.79 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.24 41.08 1.31 Allowed Glycine 0 N--CA 1.483 1.811 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.401 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 13.1 mmm -128.49 -163.51 1.29 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -113.51 -64.12 1.35 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.611 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -125.79 179.15 5.32 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.469 0.652 . . . . 0.0 111.506 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.421 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -130.01 150.86 19.2 Favored Glycine 0 C--O 1.215 -1.076 0 CA-C-N 113.152 -1.84 . . . . 0.0 114.737 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -143.49 138.36 29.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.4 t -99.89 133.5 44.17 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.3 mm -114.33 -77.45 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -110.26 34.94 3.62 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.855 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.05 -19.69 52.04 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -106.41 168.54 9.09 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.696 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 35.0 t -88.28 149.7 23.66 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.507 -1.224 . . . . 0.0 114.186 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -134.94 123.61 23.65 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -99.94 162.18 13.15 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.153 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.488 1.441 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.144 179.893 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -126.92 165.56 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -99.88 147.58 25.38 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 124.595 1.184 . . . . 0.0 110.499 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p -127.67 168.14 15.46 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 112.547 -2.115 . . . . 0.0 113.114 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -119.95 -43.04 2.57 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 110.098 -3.228 . . . . 0.0 105.003 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.439 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.5 m-70 -132.88 176.88 8.09 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.536 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -85.63 28.89 0.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.455 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.37 -50.62 0.28 Allowed Glycine 0 N--CA 1.495 2.61 1 N-CA-C 102.551 -4.219 . . . . 0.0 102.551 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -25.68 3.87 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 112.962 -1.619 . . . . 0.0 109.593 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 25.7 t -97.01 -39.27 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 112.691 -2.05 . . . . 0.0 111.29 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.411 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.2 tt -57.28 -43.65 83.31 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.545 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -58.89 -57.45 26.87 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.605 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -68.09 -34.41 22.65 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.199 1.933 . . . . 0.0 109.985 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 14.8 m -58.06 -63.99 1.07 Allowed 'General case' 0 C--N 1.31 -1.127 0 O-C-N 123.837 0.711 . . . . 0.0 109.398 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -57.78 -47.3 82.93 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.265 0.978 . . . . 0.0 109.231 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -57.82 -24.37 57.05 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 126.02 2.075 . . . . 0.0 111.597 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.25 -3.41 37.46 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.137 0.898 . . . . 0.0 110.929 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.0 38.44 1.15 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.429 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.7 mmt -124.44 -164.71 1.29 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -115.43 -62.0 1.66 Allowed 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -126.92 179.44 5.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 123.883 0.739 . . . . 0.0 111.223 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.411 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.33 154.86 20.53 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-N 113.136 -1.847 . . . . 0.0 114.41 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -144.65 137.2 26.48 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -99.78 130.85 46.02 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.28 -78.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.23 34.53 3.85 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.831 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.46 -19.2 53.64 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 32' ' ' CYS . 18.4 ttpp -107.0 169.55 8.48 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 38.3 t -90.19 148.27 23.05 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.421 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 65.5 t0 -133.84 135.06 43.51 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.1 m -109.87 163.16 13.8 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 119.851 1.205 . . . . 0.0 113.421 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 N--CA 1.488 1.434 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.689 179.79 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.12 165.65 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.8 142.17 31.64 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 124.602 1.189 . . . . 0.0 109.027 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 p -123.59 166.53 15.31 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 112.43 -2.168 . . . . 0.0 112.041 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -121.79 -40.54 2.53 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 110.359 -3.109 . . . . 0.0 106.034 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.434 ' C ' ' H ' ' A' ' 11' ' ' GLY . 85.6 m-70 -134.13 179.82 6.02 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.05 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 t -84.71 29.42 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.167 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -125.93 -50.86 0.18 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 103.768 -3.733 . . . . 0.0 103.768 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.52 -24.87 1.44 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 112.958 -1.621 . . . . 0.0 110.069 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 33' ' ' ASP . 40.9 t -97.01 -42.05 8.08 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.64 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.478 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.6 tt -55.51 -45.89 77.06 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.394 0.677 . . . . 0.0 112.395 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -56.77 -58.92 14.23 Favored Pre-proline 0 C--N 1.309 -1.17 0 O-C-N 123.888 0.743 . . . . 0.0 112.379 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -68.25 -33.03 25.36 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.992 1.794 . . . . 0.0 110.458 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.6 m -59.87 -65.16 0.72 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.71 0.631 . . . . 0.0 109.305 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -56.56 -45.2 81.41 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.425 1.078 . . . . 0.0 108.952 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.453 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 52.8 t0 -60.85 -24.77 66.15 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 125.934 2.021 . . . . 0.0 110.752 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 -0.01 45.54 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.582 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.48 39.32 1.49 Allowed Glycine 0 N--CA 1.484 1.878 0 N-CA-C 116.691 1.436 . . . . 0.0 116.691 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.428 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.6 mmt -124.49 -163.74 1.19 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -118.49 -60.96 1.72 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.16 176.54 6.98 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.37 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.478 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -139.37 145.16 16.2 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.818 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -139.65 149.21 43.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.5 t -99.83 137.82 37.76 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.3 mt -115.12 -78.49 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -110.29 35.0 3.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.368 1.043 . . . . 0.0 111.282 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.3 -23.21 35.08 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -103.97 163.21 12.52 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 124.397 0.704 . . . . 0.0 109.151 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 25.3 t -82.14 148.46 28.49 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.346 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.416 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 36.8 t70 -131.94 129.22 39.95 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.4 m -106.84 164.15 12.35 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.977 1.262 . . . . 0.0 113.493 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.488 1.454 0 CA-C-N 113.329 -1.759 . . . . 0.0 108.942 179.827 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.8 t30 . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.57 164.83 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -99.76 144.04 29.29 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 124.515 1.135 . . . . 0.0 109.783 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.4 p -125.09 167.41 14.82 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.613 -2.085 . . . . 0.0 112.898 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -119.43 -41.95 2.68 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 110.163 -3.199 . . . . 0.0 105.21 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.1 m-70 -132.23 176.2 8.6 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.521 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.7 p -85.37 26.42 0.91 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.564 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -119.39 -51.27 0.29 Allowed Glycine 0 N--CA 1.494 2.556 1 N-CA-C 102.832 -4.107 . . . . 0.0 102.832 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.66 -27.84 2.11 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.234 -1.483 . . . . 0.0 109.479 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 23.6 t -96.04 -35.84 11.24 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.116 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tt -59.24 -44.99 92.33 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.431 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 5.7 mptp? -56.1 -57.57 21.57 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.146 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 94.6 Cg_endo -68.35 -37.48 13.54 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.353 2.035 . . . . 0.0 111.845 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 7.4 m -57.78 -59.11 5.72 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -53.37 -54.65 33.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.585 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.18 -23.19 54.59 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 126.701 2.5 . . . . 0.0 112.402 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.38 -2.51 39.04 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 124.159 0.912 . . . . 0.0 111.282 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.84 38.31 1.44 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.426 ' HG3' ' SG ' ' A' ' 34' ' ' CYS . 29.1 mmt -123.82 -165.74 1.39 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -112.88 -62.86 1.52 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.45 -179.87 4.97 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.036 0.835 . . . . 0.0 110.433 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.13 157.04 16.14 Favored Glycine 0 C--O 1.216 -1.011 0 CA-C-N 113.147 -1.842 . . . . 0.0 113.53 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -149.46 132.77 16.5 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.2 t -99.5 132.28 44.93 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.0 mt -112.59 -78.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.37 34.91 3.66 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.364 1.04 . . . . 0.0 111.708 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.77 -17.05 58.85 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -105.01 168.22 9.2 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 43.2 t -90.75 147.62 23.11 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.535 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 13.3 t70 -132.29 144.01 50.29 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 22' ' ' MET . 29.8 m -114.5 160.39 19.28 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.449 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.0 m . . . . . 0 N--CA 1.488 1.446 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.172 179.792 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.73 165.5 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.93 143.31 30.3 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.256 1.027 . . . . 0.0 110.276 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 p -126.71 166.46 17.34 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 112.37 -2.196 . . . . 0.0 112.705 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -120.08 -40.68 2.7 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 110.44 -3.073 . . . . 0.0 105.847 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.421 ' C ' ' H ' ' A' ' 11' ' ' GLY . 84.2 m-70 -131.87 178.5 6.72 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.386 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.4 m -85.1 23.14 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.329 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.34 -50.32 0.34 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 103.272 -3.931 . . . . 0.0 103.272 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -25.79 2.02 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.3 -1.45 . . . . 0.0 109.595 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 34.6 t -97.28 -37.44 10.06 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 112.335 -2.211 . . . . 0.0 111.551 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.41 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -58.67 -43.98 90.06 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.063 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -56.95 -58.2 19.3 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-O 118.24 -0.886 . . . . 0.0 112.036 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -67.83 -36.61 17.89 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.396 2.064 . . . . 0.0 111.376 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 19.1 m -58.3 -60.54 3.62 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -52.26 -54.69 28.01 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.055 -1.43 . . . . 0.0 108.63 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.34 -23.11 55.73 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 126.954 2.659 . . . . 0.0 112.665 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.21 -2.37 39.88 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.131 0.894 . . . . 0.0 110.82 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.34 39.87 1.58 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 116.005 1.162 . . . . 0.0 116.005 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 12.4 mmm -126.73 -165.24 1.43 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -111.65 -67.42 1.0 Allowed 'General case' 0 C--N 1.31 -1.143 0 O-C-N 123.98 0.8 . . . . 0.0 109.474 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -123.47 179.53 4.71 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.739 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.41 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.77 156.27 20.02 Favored Glycine 0 C--O 1.215 -1.079 0 CA-C-N 112.918 -1.947 . . . . 0.0 114.099 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -151.4 138.32 19.02 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.3 t -99.6 138.71 36.3 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.2 mt -116.12 -79.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -110.38 35.34 3.48 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.413 1.07 . . . . 0.0 111.859 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.39 -22.08 38.9 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -103.93 166.36 10.46 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.594 0.82 . . . . 0.0 108.831 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 32.4 t -85.79 149.13 25.48 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.479 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 37.1 t70 -132.34 134.8 45.63 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.3 m -108.45 163.61 13.06 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 119.726 1.148 . . . . 0.0 112.537 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.838 179.856 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.2 t30 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.06 163.14 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -102.27 141.19 35.5 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 124.517 1.135 . . . . 0.0 109.711 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 p -118.52 168.73 10.4 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.064 -1.88 . . . . 0.0 112.938 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -118.17 -42.52 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 110.001 -3.272 . . . . 0.0 104.896 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.448 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.6 m-70 -132.9 175.7 9.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.627 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.0 m -85.6 28.9 0.73 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.255 -1.338 . . . . 0.0 109.296 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -121.28 -49.95 0.26 Allowed Glycine 0 N--CA 1.495 2.597 1 N-CA-C 102.916 -4.074 . . . . 0.0 102.916 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -23.07 4.88 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.109 -1.545 . . . . 0.0 109.753 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 33.8 t -97.72 -37.69 9.79 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 112.997 -1.911 . . . . 0.0 110.863 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.464 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.3 tt -59.21 -42.56 91.25 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.23 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -58.67 -57.17 28.65 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.251 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.9 -37.12 11.9 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.567 2.178 . . . . 0.0 111.855 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.692 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 12.8 m -58.82 -58.6 7.91 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -53.28 -54.81 30.88 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.242 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -57.81 -23.77 54.14 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 126.809 2.568 . . . . 0.0 112.34 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.38 -1.3 41.89 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 124.078 0.861 . . . . 0.0 111.301 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.12 38.61 1.65 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.404 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.6 mmt -124.25 -165.44 1.37 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -113.44 -62.7 1.55 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -126.25 178.57 5.74 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.045 0.84 . . . . 0.0 110.84 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.464 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -127.98 145.28 15.86 Favored Glycine 0 C--O 1.215 -1.083 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.571 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.22 136.58 45.69 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.8 t -99.6 132.29 45.04 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.1 mm -109.72 -83.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.35 33.94 4.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.439 1.087 . . . . 0.0 111.436 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.36 -19.08 46.65 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.015 -2.434 . . . . 0.0 107.015 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -103.01 165.42 11.03 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.757 0.916 . . . . 0.0 109.708 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.692 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 36.7 t -92.74 145.76 24.17 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.454 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 38.5 t70 -131.57 141.41 49.68 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.6 m -110.48 159.91 17.09 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 119.822 1.192 . . . . 0.0 112.553 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.2 m . . . . . 0 N--CA 1.489 1.495 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.476 179.88 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -126.87 158.26 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -102.89 133.85 47.28 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 124.503 1.127 . . . . 0.0 110.764 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 p -126.57 166.66 16.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.613 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -117.98 -35.63 3.82 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 111.659 -2.519 . . . . 0.0 105.705 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -123.56 173.32 8.13 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.07 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.6 p -91.26 35.22 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.059 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.57 -47.92 0.24 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 105.405 -3.078 . . . . 0.0 105.405 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -61.94 -8.41 5.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.618 1.567 . . . . 0.0 111.116 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 37.4 t -106.51 -41.76 5.19 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.671 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.458 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.8 tt -58.28 -41.09 83.61 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.995 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -62.81 -57.09 23.54 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-O 118.128 -0.939 . . . . 0.0 112.138 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -67.68 -32.59 30.1 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.467 2.111 . . . . 0.0 110.99 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.5 m -61.4 -60.71 3.31 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -51.28 -54.97 20.89 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.792 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -58.3 -23.75 57.36 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 127.09 2.744 . . . . 0.0 112.769 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.22 0.11 45.17 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 124.011 0.819 . . . . 0.0 110.833 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.53 40.57 2.02 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 12.6 mmm -127.15 -165.5 1.48 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -112.96 -65.51 1.18 Allowed 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.982 0.801 . . . . 0.0 109.16 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -123.83 -179.77 4.51 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.662 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.458 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -134.54 152.39 20.65 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-N 113.246 -1.797 . . . . 0.0 114.377 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -148.47 140.26 23.76 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -99.62 142.19 31.44 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 105.15 -2.166 . . . . 0.0 105.15 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.1 mm -115.11 -78.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.27 35.27 3.49 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.45 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.53 -24.51 29.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.223 -2.351 . . . . 0.0 107.223 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -99.95 167.92 10.19 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 124.761 0.918 . . . . 0.0 109.294 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 32.0 t -89.69 151.09 22.04 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -136.75 124.87 22.97 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.8 m -99.8 164.9 11.83 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 118.981 0.81 . . . . 0.0 112.367 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.7 m . . . . . 0 N--CA 1.487 1.418 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.075 179.874 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.5 t30 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.57 164.54 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -99.74 137.94 37.51 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 124.583 1.177 . . . . 0.0 110.432 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 p -121.7 167.88 12.44 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 112.387 -2.188 . . . . 0.0 111.778 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -120.18 -40.35 2.72 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 110.387 -3.097 . . . . 0.0 105.643 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.429 ' C ' ' H ' ' A' ' 11' ' ' GLY . 20.3 m80 -128.89 177.9 6.77 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.946 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.5 t -85.8 21.99 1.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 113.24 -1.8 . . . . 0.0 108.758 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.91 -49.07 0.29 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 103.571 -3.812 . . . . 0.0 103.571 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.13 -21.99 3.8 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 113.004 -1.598 . . . . 0.0 110.067 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 32.8 t -99.95 -38.9 8.41 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 112.98 -1.918 . . . . 0.0 110.939 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.462 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.9 tt -58.98 -38.42 79.1 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.776 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.97 -56.67 22.91 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.997 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.14 -31.8 35.51 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.137 1.891 . . . . 0.0 110.824 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.5 m -62.26 -58.22 8.55 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -48.89 -57.51 6.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.617 1.198 . . . . 0.0 108.171 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -55.62 -27.17 48.11 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 128.186 3.429 . . . . 0.0 112.455 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 1.97 48.45 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 124.264 0.978 . . . . 0.0 111.458 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.86 43.72 2.05 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 115.241 0.856 . . . . 0.0 115.241 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 mmt -124.85 -166.57 1.54 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 116.972 0.386 . . . . 0.0 109.974 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -113.87 -62.94 1.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.19 177.27 6.79 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.971 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.462 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -132.01 150.91 19.68 Favored Glycine 0 C--O 1.216 -0.986 0 CA-C-N 112.504 -2.135 . . . . 0.0 112.98 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -146.98 140.93 25.94 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.64 141.08 32.91 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.96 -81.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -110.32 34.41 3.93 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.226 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.56 -24.15 29.48 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.401 -2.279 . . . . 0.0 107.401 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -100.7 165.65 11.28 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.694 0.879 . . . . 0.0 109.157 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 25.7 t -89.48 149.6 22.85 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.44 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.6 t70 -133.11 134.75 44.66 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.4 m -110.46 163.82 13.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 119.079 0.854 . . . . 0.0 111.489 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.49 1.541 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.639 179.812 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.4 t30 . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.21 166.06 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -100.47 140.71 34.33 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 124.906 1.379 . . . . 0.0 108.638 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.3 p -125.27 166.83 15.81 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 113.266 -1.788 . . . . 0.0 112.532 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -120.97 -40.95 2.57 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 110.635 -2.984 . . . . 0.0 104.973 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -124.11 175.02 7.26 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.546 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.1 p -94.67 34.14 1.37 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.552 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 13' ' ' CYS . . . -126.7 -44.69 0.24 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -73.17 7.51 2.12 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.95 1.3 . . . . 0.0 110.604 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 37.6 t -114.19 -41.04 3.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.117 -1.856 . . . . 0.0 106.204 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.471 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 7.6 tt -61.94 -35.45 78.47 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.794 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -66.82 -56.23 14.87 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.815 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.13 -31.96 44.15 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.047 1.831 . . . . 0.0 111.327 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.6 m -63.51 -56.3 17.14 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -48.67 -58.69 4.37 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -56.09 -25.84 47.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 128.245 3.466 . . . . 0.0 113.241 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.12 1.67 47.79 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 124.522 1.139 . . . . 0.0 111.133 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.96 43.08 2.3 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 115.166 0.826 . . . . 0.0 115.166 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 21.5 mmm -128.57 -167.32 1.75 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -112.85 -66.46 1.08 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.066 0.854 . . . . 0.0 109.442 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -121.27 179.26 4.47 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.987 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.471 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -137.59 148.12 19.64 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-N 112.81 -1.995 . . . . 0.0 114.676 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.405 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -147.36 148.79 31.72 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -99.58 140.12 34.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.22 -77.65 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.37 33.72 4.33 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.656 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.57 -21.88 40.87 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -102.62 165.41 11.09 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 15.6 t -90.16 148.36 23.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.511 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 29.0 t70 -131.18 146.41 52.32 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 103.366 -2.828 . . . . 0.0 103.366 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.5 m -111.6 173.75 6.2 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.685 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.8 m . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.827 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.52 165.71 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -103.6 140.86 36.98 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 125.016 1.448 . . . . 0.0 108.956 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 p -122.98 166.4 15.14 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.485 -1.689 . . . . 0.0 112.511 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -40.5 2.91 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 110.764 -2.925 . . . . 0.0 105.775 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.423 ' C ' ' H ' ' A' ' 11' ' ' GLY . 84.3 m-70 -131.87 179.59 5.99 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.67 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.0 t -86.69 28.91 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.188 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -124.87 -51.16 0.19 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 103.294 -3.922 . . . . 0.0 103.294 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -22.6 2.03 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.506 -1.847 . . . . 0.0 110.077 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 44.3 t -99.24 -43.23 6.69 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.937 -1.938 . . . . 0.0 111.478 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.47 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.3 tt -53.73 -43.97 69.5 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.859 0.863 . . . . 0.0 112.329 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -61.46 -56.51 32.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 124.189 0.931 . . . . 0.0 112.707 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -67.57 -31.3 33.75 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.837 1.691 . . . . 0.0 110.323 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 9.2 m -61.44 -63.52 1.25 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -56.52 -47.82 78.53 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -59.03 -23.77 62.25 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 126.126 2.142 . . . . 0.0 111.486 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.91 -1.19 43.49 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 123.703 0.627 . . . . 0.0 110.391 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.67 40.8 1.54 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 116.112 1.205 . . . . 0.0 116.112 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 14.8 mmm -128.22 -164.04 1.34 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.3 mtm180 -111.57 -66.53 1.07 Allowed 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.14 178.86 5.33 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.234 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.47 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -140.6 149.0 20.63 Favored Glycine 0 C--O 1.215 -1.087 0 CA-C-N 113.101 -1.863 . . . . 0.0 114.502 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 21.5 ptmt -144.73 152.15 39.96 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -99.61 143.38 29.92 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.122 -1.431 . . . . 0.0 107.359 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.8 mm -114.68 -81.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.45 33.6 4.41 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.453 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.76 -22.57 35.13 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.103 -2.399 . . . . 0.0 107.103 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -99.97 163.81 12.28 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 11.4 t -90.44 150.78 21.69 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.557 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 32.5 t70 -135.01 144.23 47.24 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.9 m -112.37 167.48 10.4 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 119.317 0.962 . . . . 0.0 113.34 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.487 1.421 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.072 179.825 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.83 163.27 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.26 143.61 31.12 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 122.111 0.958 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.6 p -128.85 167.49 17.28 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 112.52 -2.127 . . . . 0.0 113.159 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -121.93 -42.64 2.38 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 110.216 -3.175 . . . . 0.0 105.272 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.418 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.0 m80 -127.13 177.37 6.7 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.293 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.2 m -88.64 28.16 1.18 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.902 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -121.22 -50.54 0.26 Allowed Glycine 0 N--CA 1.494 2.53 1 N-CA-C 102.504 -4.239 . . . . 0.0 102.504 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -24.96 2.05 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 113.053 -1.574 . . . . 0.0 109.523 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 35.6 t -97.58 -39.33 9.17 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 112.559 -2.109 . . . . 0.0 110.77 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.436 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -56.17 -45.3 79.77 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.198 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 2.1 mptm? -58.05 -58.96 14.96 Favored Pre-proline 0 C--N 1.308 -1.196 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.829 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 84.1 Cg_endo -66.97 -31.62 37.12 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.335 2.023 . . . . 0.0 110.888 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.748 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 32.8 m -61.38 -62.3 1.93 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -50.47 -54.42 22.28 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 113.82 -1.537 . . . . 0.0 107.997 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.19 -26.6 60.91 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 127.196 2.81 . . . . 0.0 112.072 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.08 2.19 48.43 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 124.004 0.815 . . . . 0.0 111.529 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.98 39.65 2.11 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.6 mmt -125.15 -164.27 1.27 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -117.43 -62.04 1.62 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.19 178.82 5.36 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.167 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.436 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -131.9 150.74 19.63 Favored Glycine 0 C--O 1.216 -1.023 0 CA-C-N 113.15 -1.841 . . . . 0.0 113.792 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -145.15 140.72 28.17 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t -99.89 139.38 35.64 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 mt -116.91 -78.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 117.171 2.285 . . . . 0.0 117.171 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.38 35.36 3.47 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.353 1.033 . . . . 0.0 111.945 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.05 -21.38 41.97 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -105.11 166.37 10.44 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.748 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 37.9 t -84.97 149.54 25.54 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.877 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -134.71 120.91 20.06 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.8 m -99.66 166.06 11.3 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.646 1.112 . . . . 0.0 113.044 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.6 m . . . . . 0 N--CA 1.488 1.469 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.495 179.86 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.65 164.0 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -99.96 139.38 35.71 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 124.732 1.27 . . . . 0.0 109.059 -179.723 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 p -123.36 166.75 14.8 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 112.616 -2.084 . . . . 0.0 111.525 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -42.79 2.21 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 110.513 -3.04 . . . . 0.0 103.953 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.418 ' C ' ' H ' ' A' ' 11' ' ' GLY . 18.7 m80 -124.32 179.0 5.08 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.081 0.944 . . . . 0.0 111.745 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.4 t -89.04 28.62 1.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.211 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -124.63 -50.59 0.2 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 103.301 -3.92 . . . . 0.0 103.301 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.95 -22.84 1.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.718 -1.741 . . . . 0.0 109.788 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 43.0 t -99.4 -43.89 6.39 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.493 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.463 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.4 tt -54.8 -44.09 73.49 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.616 0.766 . . . . 0.0 112.499 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -60.85 -56.44 35.02 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.877 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.53 -32.93 23.75 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.336 2.024 . . . . 0.0 111.287 178.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.728 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.1 m -61.07 -61.07 2.84 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -52.72 -52.79 54.77 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.888 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.82 -24.66 62.29 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 126.431 2.332 . . . . 0.0 111.817 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.28 1.71 47.45 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.077 0.861 . . . . 0.0 111.073 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.69 38.31 2.07 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 116.592 1.397 . . . . 0.0 116.592 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.7 mmt -125.64 -164.85 1.34 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -113.27 -63.78 1.4 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.75 178.37 5.73 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 123.954 0.784 . . . . 0.0 111.036 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.463 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -143.91 150.93 22.94 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-N 113.154 -1.839 . . . . 0.0 114.145 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.72 153.14 41.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.84 141.96 31.96 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.08 -78.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 116.509 2.041 . . . . 0.0 116.509 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -110.28 34.84 3.68 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 124.526 1.141 . . . . 0.0 111.223 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.6 -24.2 31.59 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -103.58 163.07 12.54 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.443 0.731 . . . . 0.0 109.138 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.728 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 12.7 t -84.13 146.97 27.59 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.9 t70 -129.8 130.48 45.38 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.4 m -103.8 161.22 14.13 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 119.745 1.157 . . . . 0.0 112.439 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.2 m . . . . . 0 N--CA 1.488 1.442 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.831 179.807 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.25 155.01 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -99.96 133.22 44.66 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 125.06 1.475 . . . . 0.0 111.226 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -123.61 167.13 14.35 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 112.458 -2.156 . . . . 0.0 111.959 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -117.79 -38.26 3.29 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 111.081 -2.781 . . . . 0.0 105.206 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -126.31 174.22 8.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.604 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -88.59 35.54 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.758 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.46 -50.63 0.21 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 104.531 -3.428 . . . . 0.0 104.531 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -56.15 -16.59 5.44 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 113.593 -1.304 . . . . 0.0 110.526 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.461 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 39.4 t -100.83 -41.31 6.91 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.255 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.407 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.9 tt -55.91 -46.13 78.51 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.023 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -57.93 -60.19 10.79 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.651 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -66.43 -32.75 39.65 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.102 1.868 . . . . 0.0 110.314 -177.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 33.5 m -59.84 -58.96 6.32 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -52.09 -56.0 17.19 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 124.888 1.367 . . . . 0.0 108.417 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -20.18 61.07 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 126.891 2.619 . . . . 0.0 113.268 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.3 -1.96 40.57 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 124.037 0.836 . . . . 0.0 109.841 179.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.93 38.19 2.06 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 115.735 1.054 . . . . 0.0 115.735 179.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.1 mmt -125.15 -165.71 1.44 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.21 -61.37 1.76 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.82 -178.21 4.2 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.195 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.407 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -131.05 154.17 20.68 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 112.267 -2.242 . . . . 0.0 113.361 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -151.83 136.13 16.75 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 t -99.74 143.06 30.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.6 -82.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.34 34.61 3.82 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.409 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.66 -20.99 40.09 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.082 -2.407 . . . . 0.0 107.082 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -100.02 166.61 10.96 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 36.4 t -91.6 150.95 20.93 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -137.01 124.04 21.54 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 28.5 m -99.75 176.5 5.43 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.466 1.03 . . . . 0.0 112.444 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.7 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-N 112.917 -1.947 . . . . 0.0 106.877 179.771 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.48 158.53 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -100.82 138.47 37.83 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.305 1.003 . . . . 0.0 111.131 -179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 p -126.85 167.28 16.02 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.595 -2.093 . . . . 0.0 112.328 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -118.35 -39.0 3.08 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 110.955 -2.839 . . . . 0.0 105.645 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -126.32 175.09 8.08 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.956 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.4 m -89.5 34.16 0.82 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.511 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.9 -48.38 0.25 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 104.959 -3.256 . . . . 0.0 104.959 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.86 -11.88 6.38 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 113.536 -1.332 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 38.7 t -103.24 -41.6 6.01 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.775 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.477 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.4 tt -57.31 -43.04 82.92 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.353 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -60.85 -57.23 27.97 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.203 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.29 -32.22 26.91 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.531 2.154 . . . . 0.0 111.065 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 22.4 m -61.54 -60.92 2.97 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.36 -54.51 30.91 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -57.75 -23.81 53.93 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 126.577 2.423 . . . . 0.0 112.601 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.25 0.76 46.32 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 124.098 0.874 . . . . 0.0 111.013 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.7 39.07 2.26 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.7 mmt -124.82 -165.95 1.46 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -112.36 -64.93 1.23 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -124.87 179.08 5.16 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.692 0.758 . . . . 0.0 110.62 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.477 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -132.92 149.56 19.6 Favored Glycine 0 C--O 1.216 -0.992 0 CA-C-N 112.802 -1.999 . . . . 0.0 113.252 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -144.25 141.63 29.96 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 104.47 -2.418 . . . . 0.0 104.47 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.3 t -99.65 141.03 32.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.6 mt -117.13 -78.45 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.26 35.58 3.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.57 1.169 . . . . 0.0 111.465 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.23 -23.35 34.69 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -101.93 167.82 9.81 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.75 0.912 . . . . 0.0 109.055 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.1 t -88.38 148.84 24.04 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.667 -1.151 . . . . 0.0 113.946 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -132.97 124.14 27.2 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.0 m -99.83 162.45 12.99 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 119.605 1.093 . . . . 0.0 111.946 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.489 1.496 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.536 179.891 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.2 t30 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.25 163.22 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -99.98 136.87 39.23 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 124.457 1.098 . . . . 0.0 111.609 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 p -122.0 167.12 13.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.73 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -118.8 -41.12 2.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 110.598 -3.001 . . . . 0.0 105.405 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.41 ' C ' ' H ' ' A' ' 11' ' ' GLY . 20.7 m80 -126.21 177.22 6.53 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.607 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.5 p -87.33 21.05 2.56 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.904 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -117.58 -48.93 0.4 Allowed Glycine 0 N--CA 1.495 2.567 1 N-CA-C 103.088 -4.005 . . . . 0.0 103.088 179.699 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -23.91 4.37 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 113.071 -1.565 . . . . 0.0 109.522 179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 23.1 t -98.42 -36.01 10.1 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.827 -1.988 . . . . 0.0 111.035 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.409 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.0 tt -59.14 -42.3 90.34 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.288 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -60.17 -55.84 41.34 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-O 117.796 -1.097 . . . . 0.0 112.538 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -68.49 -36.81 14.36 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.289 1.992 . . . . 0.0 111.374 178.156 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 15.6 m -58.45 -59.43 5.36 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -52.85 -54.77 29.66 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.37 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.47 -24.74 57.53 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 126.764 2.54 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.41 -0.72 43.07 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 124.167 0.917 . . . . 0.0 111.541 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.38 38.78 1.58 Allowed Glycine 0 N--CA 1.483 1.809 0 N-CA-C 116.831 1.493 . . . . 0.0 116.831 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.408 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.8 mmt -124.18 -165.62 1.39 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -114.09 -62.41 1.6 Allowed 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -126.28 179.59 5.2 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.048 0.842 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.409 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.57 158.1 20.54 Favored Glycine 0 C--O 1.217 -0.913 0 CA-C-N 113.001 -1.909 . . . . 0.0 113.247 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.38 137.03 15.17 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 102.138 -3.282 . . . . 0.0 102.138 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t -99.62 142.39 31.17 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 117.928 -1.509 . . . . 0.0 107.601 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 33' ' ' ASP . 33.0 mt -109.63 -85.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -179.361 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -110.38 35.35 3.48 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.272 0.982 . . . . 0.0 111.329 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.22 -22.06 33.94 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 106.382 -2.687 . . . . 0.0 106.382 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -99.68 166.4 11.13 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 39.1 t -89.9 146.3 24.51 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -179.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.483 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 37.6 t70 -129.64 137.35 50.62 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 m -110.66 160.17 16.93 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.276 -0.969 . . . . 0.0 112.39 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 N--CA 1.488 1.434 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.409 179.791 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.92 161.27 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -99.98 139.0 36.28 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 122.213 1.006 . . . . 0.0 111.244 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.0 p -125.44 167.37 15.08 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.709 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -117.51 -38.76 3.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 110.884 -2.871 . . . . 0.0 105.342 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -129.61 175.48 8.77 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.653 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.5 t -85.46 34.52 0.58 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 13' ' ' CYS . . . -126.08 -48.47 0.19 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 106.598 -2.601 . . . . 0.0 106.598 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -62.65 -7.59 5.07 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.753 -1.224 . . . . 0.0 110.864 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 35.4 t -105.85 -40.6 5.66 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.301 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.428 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.0 tt -57.46 -45.11 85.13 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.341 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -60.36 -56.15 38.18 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-O 117.995 -1.002 . . . . 0.0 112.846 -179.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -67.23 -34.7 26.91 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.694 1.596 . . . . 0.0 110.928 178.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 11.9 m -60.39 -63.97 1.11 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -56.3 -45.08 80.37 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.122 0.889 . . . . 0.0 109.347 -179.73 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.447 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 10.7 t70 -61.3 -25.19 66.95 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 125.832 1.958 . . . . 0.0 111.091 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.99 0.57 46.59 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 123.929 0.768 . . . . 0.0 110.858 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.35 39.43 1.36 Allowed Glycine 0 N--CA 1.483 1.81 0 N-CA-C 117.008 1.563 . . . . 0.0 117.008 179.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.422 ' HG3' ' SG ' ' A' ' 34' ' ' CYS . 26.1 mmt -126.14 -164.56 1.33 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.9 mtm180 -114.01 -64.59 1.29 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -126.07 179.95 4.99 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.384 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -128.27 153.47 19.51 Favored Glycine 0 C--O 1.216 -1.013 0 CA-C-N 113.05 -1.886 . . . . 0.0 113.576 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -145.52 137.69 25.59 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -99.31 138.83 35.86 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 179.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.3 mt -116.45 -79.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 117.667 2.469 . . . . 0.0 117.667 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.31 35.29 3.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.468 1.105 . . . . 0.0 111.36 -179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.36 -22.82 36.33 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 106.922 -2.471 . . . . 0.0 106.922 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -102.46 168.26 9.42 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.815 0.95 . . . . 0.0 109.064 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 35.2 t -90.43 147.57 23.34 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 12.1 t70 -131.04 141.55 50.22 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.422 ' SG ' ' HG3' ' A' ' 22' ' ' MET . 29.8 m -112.33 164.24 13.47 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 119.088 0.858 . . . . 0.0 112.315 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.3 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.781 179.82 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.815 0.34 . . . . 1.0 110.895 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -21.54 148.15 0.0 OUTLIER Glycine 0 N--CA 1.503 3.133 0 N-CA-C 119.478 2.551 . . . . 0.0 119.478 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.579 HG22 ' SG ' ' A' ' 34' ' ' CYS . 14.6 pt -115.06 -103.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.519 ' H ' HG13 ' A' ' 3' ' ' ILE . 15.3 t-20 -173.26 38.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.01 158.71 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -102.27 125.71 49.06 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 125.432 1.707 . . . . 0.0 107.635 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.7 p -114.14 167.56 10.58 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.773 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -119.5 -40.04 2.82 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 110.402 -3.09 . . . . 0.0 105.847 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.416 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.7 m-70 -129.84 176.82 7.73 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.645 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.1 m -87.46 25.52 1.42 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.815 -1.538 . . . . 0.0 109.301 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.01 -50.75 0.28 Allowed Glycine 0 N--CA 1.495 2.6 1 N-CA-C 102.48 -4.248 . . . . 0.0 102.48 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.39 -24.74 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.861 -1.669 . . . . 0.0 109.577 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 29.5 t -98.67 -37.41 9.52 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 112.551 -2.113 . . . . 0.0 111.527 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.415 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.8 tt -58.23 -43.57 87.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.432 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 48.0 mmtm -60.24 -56.12 38.6 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-O 117.898 -1.049 . . . . 0.0 112.059 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 88.5 Cg_endo -67.23 -34.25 28.29 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.248 1.965 . . . . 0.0 111.24 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 10.6 m -59.79 -59.96 4.6 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -52.17 -55.11 23.09 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.936 -1.483 . . . . 0.0 108.178 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.22 -23.36 55.53 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 127.089 2.743 . . . . 0.0 112.307 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 -1.4 42.79 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 123.915 0.759 . . . . 0.0 110.927 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.68 39.93 1.81 Allowed Glycine 0 N--CA 1.483 1.793 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.0 mmm -127.24 -165.74 1.51 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -111.29 -65.98 1.12 Allowed 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -123.88 -179.94 4.59 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.399 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.11 154.63 18.94 Favored Glycine 0 C--O 1.216 -1.031 0 CA-C-N 113.041 -1.89 . . . . 0.0 114.494 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -150.0 136.17 18.8 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.48 139.74 34.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -112.17 -80.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.41 34.53 3.88 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.982 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.34 -23.34 33.45 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 107.073 -2.411 . . . . 0.0 107.073 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -99.42 165.05 11.84 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.5 t -88.06 153.99 20.83 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.529 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 33.9 t70 -139.92 143.8 36.8 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.579 ' SG ' HG22 ' A' ' 3' ' ' ILE . 38.4 m -113.91 167.18 10.87 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 119.446 1.021 . . . . 0.0 112.812 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.6 m -121.38 58.75 8.28 Favored Pre-proline 0 N--CA 1.489 1.486 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.195 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.05 174.26 8.17 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.25 2.633 . . . . 0.0 111.508 -168.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -29.39 -50.53 0.1 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 125.701 1.876 . . . . 0.0 115.2 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 119.002 -2.311 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 123.355 1.55 . . . . 1.0 111.343 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.55 ' N ' ' H ' ' A' ' 34' ' ' CYS . . . 124.69 176.0 14.47 Favored Glycine 0 C--N 1.301 -1.399 0 CA-C-N 112.175 -2.284 . . . . 0.0 113.258 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.509 HG12 ' SG ' ' A' ' 32' ' ' CYS . 11.0 pt -121.61 -106.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.495 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.7 t30 -176.01 37.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 125.409 1.484 . . . . 0.0 107.812 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.2 t -125.88 162.28 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -99.63 135.47 41.0 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.821 1.326 . . . . 0.0 109.122 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 p -119.47 167.93 11.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.607 -2.088 . . . . 0.0 112.384 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -120.89 -43.59 2.45 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 110.023 -3.262 . . . . 0.0 105.404 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -124.13 177.34 5.87 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.678 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.4 p -89.38 26.84 1.57 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.875 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.92 -50.87 0.26 Allowed Glycine 0 N--CA 1.493 2.496 1 N-CA-C 102.544 -4.222 . . . . 0.0 102.544 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -24.06 1.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 112.803 -1.698 . . . . 0.0 109.628 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 39.6 t -98.97 -43.04 6.85 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.757 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.0 tt -55.09 -46.15 75.46 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.832 0.853 . . . . 0.0 112.104 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -56.38 -60.84 7.91 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 124.12 0.888 . . . . 0.0 111.521 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -66.11 -33.37 40.88 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.412 1.408 . . . . 0.0 109.965 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 13.2 m -58.67 -63.66 1.21 Allowed 'General case' 0 C--N 1.31 -1.15 0 O-C-N 123.599 0.562 . . . . 0.0 109.756 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -58.81 -47.28 85.32 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.284 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.11 -22.89 61.57 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 125.708 1.88 . . . . 0.0 111.695 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.27 -3.25 37.73 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 123.889 0.743 . . . . 0.0 110.594 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.67 38.1 1.11 Allowed Glycine 0 N--CA 1.482 1.727 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.414 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 25.4 mmt -126.41 -163.48 1.23 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -115.05 -63.09 1.51 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -128.16 -179.91 5.25 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.059 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.451 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -137.65 151.99 21.46 Favored Glycine 0 N--CA 1.472 1.043 0 CA-C-N 112.633 -2.076 . . . . 0.0 115.074 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -149.57 147.76 28.54 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -99.85 140.83 33.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.54 -80.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -110.33 33.67 4.36 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.141 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.47 -22.06 38.86 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -99.91 164.42 12.02 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.1 t -89.43 147.82 23.81 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.546 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 68.5 t0 -132.17 141.78 49.22 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.55 ' H ' ' N ' ' A' ' 2' ' ' GLY . 33.8 m -113.37 171.35 7.61 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 119.112 0.869 . . . . 0.0 111.916 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.0 m -118.72 64.42 6.2 Favored Pre-proline 0 N--CA 1.484 1.259 0 O-C-N 125.068 1.48 . . . . 0.0 107.496 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 73.8 Cg_endo -59.18 176.79 0.45 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 123.484 2.79 . . . . 0.0 112.677 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.18 60.29 0.6 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.918 -1.946 . . . . 0.0 107.338 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.325 0 O-C-N 119.278 -2.139 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.4 m . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.747 0.784 . . . . 1.0 110.849 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.12 -163.35 28.89 Favored Glycine 0 C--N 1.306 -1.102 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.696 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.511 HG12 ' SG ' ' A' ' 32' ' ' CYS . 11.8 pt -116.35 -107.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.503 ' H ' HG13 ' A' ' 3' ' ' ILE . 15.8 t-20 -176.45 40.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.29 164.4 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -99.84 138.2 37.25 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 124.7 1.25 . . . . 0.0 108.517 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 p -123.92 167.16 14.49 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.377 -1.738 . . . . 0.0 112.563 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -119.25 -41.26 2.74 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 110.522 -3.035 . . . . 0.0 105.359 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.409 ' C ' ' H ' ' A' ' 11' ' ' GLY . 87.2 m-70 -130.03 177.79 7.02 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.58 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 m -87.09 25.89 1.27 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 113.6 -1.636 . . . . 0.0 108.982 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -119.69 -50.26 0.3 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 103.205 -3.958 . . . . 0.0 103.205 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -24.87 3.21 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 113.012 -1.594 . . . . 0.0 109.763 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 27.3 t -97.92 -38.22 9.5 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.438 -2.165 . . . . 0.0 111.439 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.433 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.6 tt -58.06 -44.21 87.36 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.526 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -59.24 -56.85 31.85 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-O 117.877 -1.059 . . . . 0.0 112.079 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -67.55 -36.1 20.77 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.214 1.942 . . . . 0.0 111.418 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.64 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 12.5 m -58.96 -59.59 5.22 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -52.37 -55.33 22.36 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.658 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -57.38 -24.49 55.67 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 127.165 2.791 . . . . 0.0 112.086 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.21 -1.28 42.42 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.596 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.76 39.62 1.56 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 116.343 1.297 . . . . 0.0 116.343 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 13.5 mmm -127.51 -165.83 1.53 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -111.32 -66.21 1.1 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -123.84 -178.23 3.99 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.488 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.6 154.4 20.39 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 113.352 -1.749 . . . . 0.0 114.214 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -149.56 137.97 20.74 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -99.44 138.51 36.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.9 mm -112.82 -78.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -110.17 34.45 3.89 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.381 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.94 -26.21 23.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -99.77 165.06 11.76 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.375 0.691 . . . . 0.0 109.395 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.64 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 38.6 t -84.89 150.78 24.74 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.53 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.0 t70 -135.69 141.69 44.99 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.496 ' SG ' HG22 ' A' ' 3' ' ' ILE . 38.4 m -110.6 170.38 8.13 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 119.462 1.028 . . . . 0.0 112.819 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.1 m -121.51 56.83 6.61 Favored Pre-proline 0 N--CA 1.49 1.533 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.208 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 98.1 Cg_endo -64.93 178.29 1.93 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.609 2.873 . . . . 0.0 113.233 -165.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' NZ ' ' HN1' ' A' ' 38' ' ' NH2 . 0.5 OUTLIER -94.31 173.02 7.85 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.067 -1.879 . . . . 0.0 107.3 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . 0.452 ' HN1' ' NZ ' ' A' ' 37' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.363 0 O-C-N 118.38 -2.7 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -33.99 172.04 0.01 OUTLIER Glycine 0 N--CA 1.499 2.862 0 N-CA-C 120.674 3.03 . . . . 0.0 120.674 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.606 HG22 ' SG ' ' A' ' 34' ' ' CYS . 12.1 pt -113.99 -104.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 112.11 -2.045 . . . . 0.0 106.893 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.503 ' H ' HG13 ' A' ' 3' ' ' ILE . 13.3 t-20 -174.48 34.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 124.511 1.132 . . . . 0.0 108.213 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.77 162.1 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -99.83 137.08 38.8 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.225 0.953 . . . . 0.0 110.77 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 p -123.06 167.58 13.46 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.834 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -119.71 -40.36 2.77 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 110.472 -3.058 . . . . 0.0 105.756 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.427 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.9 m80 -128.34 177.69 6.78 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.902 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.9 t -84.2 19.26 1.88 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.961 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.29 -49.17 0.37 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 103.639 -3.784 . . . . 0.0 103.639 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -24.16 4.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.905 -1.647 . . . . 0.0 109.882 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 25.4 t -98.96 -38.5 8.97 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 112.888 -1.96 . . . . 0.0 111.013 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.409 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.8 tt -57.34 -43.93 83.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.688 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -60.05 -55.62 43.62 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-O 118.137 -0.935 . . . . 0.0 112.942 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -67.38 -35.63 23.12 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.739 1.626 . . . . 0.0 109.97 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.695 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 19.2 m -56.73 -64.76 0.77 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -47.59 81.72 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.017 0.823 . . . . 0.0 109.665 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.0 -23.19 53.04 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 126.098 2.124 . . . . 0.0 112.022 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.14 -5.32 33.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.057 0.848 . . . . 0.0 110.758 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.79 38.87 1.02 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.493 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 11.1 mmm -127.13 -162.36 1.15 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -116.67 -64.67 1.28 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.85 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -124.66 179.4 4.99 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.499 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.409 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -127.75 160.74 21.75 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 112.701 -2.045 . . . . 0.0 113.56 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.408 ' HE3' ' H ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -156.24 135.84 12.45 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.408 ' H ' ' HE3' ' A' ' 26' ' ' LYS . 11.0 t -99.28 141.24 32.31 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 105.518 -2.031 . . . . 0.0 105.518 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.2 mt -115.21 -79.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.35 35.69 3.34 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 124.486 1.116 . . . . 0.0 111.343 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.63 -22.15 39.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -100.71 166.82 10.69 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.695 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.4 t -88.28 147.68 24.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.539 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 37.3 t70 -131.02 132.35 44.92 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.606 ' SG ' HG22 ' A' ' 3' ' ' ILE . 27.9 m -109.48 166.16 11.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.62 1.1 . . . . 0.0 113.675 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.9 m -121.24 60.82 9.98 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.646 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.493 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 76.7 Cg_endo -66.44 177.59 3.18 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 123.529 2.819 . . . . 0.0 113.442 -166.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -29.81 156.35 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 126.131 2.145 . . . . 0.0 116.123 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.343 0 O-C-N 119.046 -2.284 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.941 0.877 . . . . 1.0 111.084 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.662 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 54.11 -179.46 0.18 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 113.093 -1.867 . . . . 0.0 115.214 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.517 HG22 ' SG ' ' A' ' 34' ' ' CYS . 12.4 pt -121.58 -107.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.491 ' H ' ' CG1' ' A' ' 3' ' ' ILE . 48.6 t30 -175.63 38.29 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 O-C-N 124.959 1.412 . . . . 0.0 107.868 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.415 ' H ' HG13 ' A' ' 3' ' ' ILE . 44.8 t -125.18 164.96 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.62 145.97 26.98 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 124.875 1.359 . . . . 0.0 108.535 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 p -126.15 168.38 14.11 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.193 -1.821 . . . . 0.0 113.846 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -121.31 -43.07 2.43 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 110.047 -3.251 . . . . 0.0 105.554 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.421 ' C ' ' H ' ' A' ' 11' ' ' GLY . 82.8 m-70 -131.72 179.2 6.21 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.545 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.3 m -89.44 34.61 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.977 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -125.77 -51.28 0.18 Allowed Glycine 0 N--CA 1.494 2.545 1 N-CA-C 102.998 -4.041 . . . . 0.0 102.998 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -23.04 1.9 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 112.668 -1.766 . . . . 0.0 109.934 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 39.4 t -98.7 -44.2 6.51 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.399 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.6 tt -54.3 -45.09 72.48 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.585 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.04 -56.86 31.31 Favored Pre-proline 0 C--N 1.306 -1.324 0 O-C-N 124.294 0.997 . . . . 0.0 113.032 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -67.62 -33.33 28.59 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.973 1.782 . . . . 0.0 110.418 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 16.9 m -59.58 -64.05 1.08 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -56.95 -47.78 79.87 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.238 0.961 . . . . 0.0 108.975 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -58.1 -24.53 59.02 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 126.119 2.137 . . . . 0.0 111.944 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.3 -2.36 39.65 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 124.039 0.837 . . . . 0.0 110.842 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.2 40.32 1.17 Allowed Glycine 0 N--CA 1.483 1.794 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.414 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 14.8 mmm -128.44 -163.02 1.24 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.486 ' HE ' ' C ' ' A' ' 36' ' ' PRO . 49.0 mtm180 -114.56 -66.1 1.12 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.452 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -125.79 177.74 6.11 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.613 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.467 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -142.38 145.01 14.85 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 112.634 -2.076 . . . . 0.0 114.624 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -138.51 153.47 48.77 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.5 t -99.97 132.41 45.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.24 -73.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -110.15 34.1 4.08 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.046 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.88 -25.16 29.36 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -100.92 168.11 9.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 21.3 t -86.77 145.58 26.58 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.465 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 36.6 t70 -131.59 136.46 47.81 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.662 ' H ' ' H ' ' A' ' 2' ' ' GLY . 29.3 m -108.56 166.94 10.4 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.872 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.3 m -120.36 66.31 12.13 Favored Pre-proline 0 N--CA 1.486 1.335 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.831 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' C ' ' HE ' ' A' ' 23' ' ' ARG . 70.2 Cg_endo -68.4 174.96 7.49 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 123.243 2.629 . . . . 0.0 111.457 -175.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -29.57 -58.57 0.16 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 113.163 -1.835 . . . . 0.0 114.003 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.348 0 O-C-N 119.422 -2.049 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.845 0.831 . . . . 1.0 111.169 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.607 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 63.73 177.16 4.39 Favored Glycine 0 C--N 1.306 -1.118 0 CA-C-N 113.46 -1.7 . . . . 0.0 114.115 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.518 HG22 ' SG ' ' A' ' 34' ' ' CYS . 11.8 pt -121.32 -107.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.499 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.7 t30 -175.71 38.47 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 124.972 1.42 . . . . 0.0 108.085 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.88 165.37 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -99.86 140.58 33.86 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 124.556 1.16 . . . . 0.0 109.471 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 p -124.7 168.26 13.43 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.023 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -120.24 -43.92 2.51 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 109.977 -3.283 . . . . 0.0 104.96 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.426 ' C ' ' H ' ' A' ' 11' ' ' GLY . 43.1 m170 -128.06 177.26 7.01 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 124.968 1.417 . . . . 0.0 111.476 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.4 t -84.74 23.07 1.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.295 -1.775 . . . . 0.0 108.81 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.15 -49.89 0.29 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 103.475 -3.85 . . . . 0.0 103.475 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 -24.96 3.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 112.869 -1.666 . . . . 0.0 109.835 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 21.7 t -98.07 -38.79 9.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 112.578 -2.101 . . . . 0.0 111.748 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.418 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.7 tt -56.44 -44.55 80.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.78 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -59.76 -56.5 35.12 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 124.102 0.876 . . . . 0.0 112.611 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.61 -34.01 26.67 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.808 1.672 . . . . 0.0 110.32 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 9.9 m -59.01 -63.65 1.23 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.19 -47.67 80.68 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 124.088 0.868 . . . . 0.0 109.16 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.76 -25.32 60.29 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 125.976 2.048 . . . . 0.0 111.33 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.15 -1.94 41.06 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 123.876 0.735 . . . . 0.0 111.422 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.75 38.42 1.18 Allowed Glycine 0 N--CA 1.481 1.682 0 N-CA-C 116.929 1.531 . . . . 0.0 116.929 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 27.3 mmt -125.98 -164.34 1.31 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -114.29 -62.99 1.52 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -127.25 179.69 5.32 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 123.887 0.742 . . . . 0.0 110.734 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -128.24 156.75 20.98 Favored Glycine 0 C--O 1.216 -1.013 0 CA-C-N 113.064 -1.88 . . . . 0.0 114.295 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -149.25 138.1 21.19 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -99.43 132.95 44.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.2 mt -112.08 -74.15 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -110.08 35.22 3.48 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.905 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.79 -22.84 38.74 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 107.356 -2.298 . . . . 0.0 107.356 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -99.94 168.35 9.92 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 43.1 t -86.37 146.19 26.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.528 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 36.6 t70 -130.85 141.37 50.32 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.607 ' H ' ' H ' ' A' ' 2' ' ' GLY . 33.6 m -115.12 162.56 16.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 119.147 0.885 . . . . 0.0 112.076 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.5 m -122.27 60.61 13.24 Favored Pre-proline 0 N--CA 1.487 1.423 0 CA-C-N 113.967 -1.47 . . . . 0.0 108.128 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 78.3 Cg_endo -67.15 175.61 5.52 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 123.236 2.624 . . . . 0.0 111.58 -172.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -29.37 -53.59 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 125.762 1.914 . . . . 0.0 113.444 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.37 0 O-C-N 119.346 -2.096 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.516 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 53.4 -174.75 0.33 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-N 115.27 -0.877 . . . . 0.0 114.544 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.508 ' CG1' ' HB3' ' A' ' 32' ' ' CYS . 12.4 pt -122.48 -107.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.496 ' H ' HG13 ' A' ' 3' ' ' ILE . 49.8 t30 -176.65 37.5 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 125.439 1.496 . . . . 0.0 108.171 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.411 ' H ' HG13 ' A' ' 3' ' ' ILE . 45.1 t -124.5 165.45 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -99.78 138.51 36.77 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 124.427 1.08 . . . . 0.0 109.906 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 p -121.86 167.45 13.02 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 112.693 -2.049 . . . . 0.0 112.212 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -117.87 -41.61 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.47 -3.059 . . . . 0.0 105.275 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.427 ' C ' ' H ' ' A' ' 11' ' ' GLY . 82.7 m-70 -131.8 177.2 7.71 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.985 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.3 m -86.58 26.63 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.17 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.12 -51.26 0.27 Allowed Glycine 0 N--CA 1.495 2.61 1 N-CA-C 102.636 -4.186 . . . . 0.0 102.636 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -24.07 3.73 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.623 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 14.9 t -98.19 -36.97 9.88 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.442 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 tt -57.62 -44.7 85.73 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.863 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.08 -54.37 54.63 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.245 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -67.01 -35.67 24.93 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.576 1.518 . . . . 0.0 110.335 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.625 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 6.5 m -57.62 -63.18 1.32 Allowed 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.37 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.8 -47.84 81.44 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 124.077 0.86 . . . . 0.0 109.365 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.49 -23.16 57.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 125.925 2.016 . . . . 0.0 112.048 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.33 -4.61 34.63 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 124.023 0.827 . . . . 0.0 110.521 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.25 39.94 1.0 Allowed Glycine 0 N--CA 1.483 1.786 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 19.2 mmm -128.27 -164.01 1.33 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.434 ' NH2' ' HN1' ' A' ' 38' ' ' NH2 . 19.4 mtm180 -111.43 -65.87 1.13 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.444 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -127.09 -178.93 4.61 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 123.838 0.711 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.83 157.47 18.25 Favored Glycine 0 C--O 1.216 -1.003 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.846 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -150.7 133.46 15.83 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.1 t -99.43 140.33 33.76 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.55 -82.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -110.24 34.73 3.74 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.192 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.63 -23.41 31.42 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -101.04 165.6 11.23 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.625 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 39.4 t -88.52 150.12 23.26 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.521 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 31.5 t70 -134.46 143.4 47.5 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.516 ' H ' ' H ' ' A' ' 2' ' ' GLY . 55.7 m -112.91 166.28 11.54 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.682 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.5 m -123.3 60.67 17.79 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -74.83 173.4 14.5 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 123.348 2.699 . . . . 0.0 111.688 -168.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -29.6 83.6 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 125.898 1.999 . . . . 0.0 115.277 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . 0.434 ' HN1' ' NH2' ' A' ' 23' ' ' ARG . . . . . . . . 0 C--N 1.304 -1.401 0 O-C-N 118.656 -2.528 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.872 0.367 . . . . 1.0 110.933 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -30.69 170.61 0.0 OUTLIER Glycine 0 N--CA 1.501 2.993 0 N-CA-C 121.093 3.197 . . . . 0.0 121.093 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.539 HG22 ' SG ' ' A' ' 34' ' ' CYS . 12.9 pt -114.27 -105.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 111.721 -2.24 . . . . 0.0 105.682 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.502 ' H ' HG13 ' A' ' 3' ' ' ILE . 50.1 t30 -175.22 34.92 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 124.792 1.237 . . . . 0.0 108.635 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.52 162.96 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -99.78 140.06 34.54 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 124.608 1.192 . . . . 0.0 110.549 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.6 p -121.64 167.84 12.45 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.459 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -118.78 -42.66 2.71 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.3 -3.137 . . . . 0.0 104.463 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.44 ' C ' ' H ' ' A' ' 11' ' ' GLY . 26.7 m80 -128.41 176.19 7.91 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.179 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.1 m -87.49 25.75 1.38 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.922 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.82 -49.92 0.33 Allowed Glycine 0 N--CA 1.493 2.488 1 N-CA-C 102.353 -4.299 . . . . 0.0 102.353 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -23.83 4.55 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 113.18 -1.51 . . . . 0.0 109.587 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 26.3 t -97.45 -38.57 9.55 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 112.918 -1.946 . . . . 0.0 111.047 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.418 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.6 tt -59.54 -41.88 91.06 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.123 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -58.21 -58.92 15.32 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-O 117.871 -1.061 . . . . 0.0 111.301 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -68.42 -39.08 10.25 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.185 1.923 . . . . 0.0 111.055 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.712 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 14.4 m -55.39 -58.39 7.93 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -56.36 -52.77 63.35 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.385 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -62.45 -17.88 60.45 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 126.037 2.086 . . . . 0.0 112.303 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.46 -5.67 31.96 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 124.056 0.847 . . . . 0.0 109.659 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.76 37.21 1.31 Allowed Glycine 0 N--CA 1.481 1.665 0 N-CA-C 116.596 1.399 . . . . 0.0 116.596 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 14.3 mmm -127.32 -164.81 1.39 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HE ' ' C ' ' A' ' 36' ' ' PRO . 42.0 mtm180 -112.3 -64.54 1.28 Allowed 'General case' 0 C--N 1.309 -1.169 0 O-C-N 123.993 0.808 . . . . 0.0 110.389 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -124.35 -179.68 4.56 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.088 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.17 153.99 20.09 Favored Glycine 0 C--O 1.216 -0.98 0 CA-C-N 113.218 -1.81 . . . . 0.0 114.43 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -144.39 135.99 25.76 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -99.69 136.38 39.7 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 103.679 -2.711 . . . . 0.0 103.679 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.2 mm -113.26 -81.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 116.917 2.192 . . . . 0.0 116.917 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.22 34.38 3.93 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.426 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.27 -22.77 33.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -102.25 166.98 10.28 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.629 0.841 . . . . 0.0 109.269 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.712 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 37.3 t -90.09 148.78 22.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.531 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 39.2 t70 -132.63 137.12 46.9 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.539 ' SG ' HG22 ' A' ' 3' ' ' ILE . 17.0 m -108.74 162.77 13.86 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 119.796 1.18 . . . . 0.0 112.517 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.1 m -121.62 65.93 18.48 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.363 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.461 ' C ' ' HE ' ' A' ' 23' ' ' ARG . 92.3 Cg_endo -65.2 178.26 2.09 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 123.486 2.791 . . . . 0.0 112.384 -174.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -29.12 83.75 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 O-C-N 125.829 1.956 . . . . 0.0 114.415 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.332 0 O-C-N 119.107 -2.246 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.62 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 41.87 -175.38 0.01 OUTLIER Glycine 0 N--CA 1.499 2.878 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.515 ' CG1' ' HB3' ' A' ' 32' ' ' CYS . 12.4 pt -124.26 -106.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.493 ' H ' ' CG1' ' A' ' 3' ' ' ILE . 48.4 t30 -176.69 36.49 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 125.444 1.498 . . . . 0.0 108.132 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.72 166.51 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -99.96 138.01 37.63 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 124.841 1.338 . . . . 0.0 108.993 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 p -123.22 164.36 18.88 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.497 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -115.61 -41.11 3.28 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 111.168 -2.742 . . . . 0.0 104.108 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -126.1 175.31 7.84 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.308 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.1 p -91.37 24.73 2.84 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.525 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 13' ' ' CYS . . . -121.68 -43.02 0.43 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 105.63 -2.988 . . . . 0.0 105.63 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -74.4 5.4 4.67 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.28 -0.96 . . . . 0.0 109.762 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.466 ' H ' ' C ' ' A' ' 11' ' ' GLY . 14.3 t -114.53 -38.26 4.08 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 113.218 -1.81 . . . . 0.0 106.381 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tt -63.61 -39.36 94.18 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.748 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.461 ' N ' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -55.75 -61.51 6.17 Favored Pre-proline 0 N--CA 1.48 1.053 0 O-C-N 124.028 0.83 . . . . 0.0 109.594 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -66.96 -37.02 20.65 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.982 1.788 . . . . 0.0 110.634 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 7.7 m -55.54 -64.73 0.75 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.319 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -45.63 91.86 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.339 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.41 -22.66 54.89 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 125.504 1.753 . . . . 0.0 111.749 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.08 -6.67 31.23 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 123.994 0.809 . . . . 0.0 110.64 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.3 40.46 0.8 Allowed Glycine 0 N--CA 1.479 1.506 0 N-CA-C 116.466 1.347 . . . . 0.0 116.466 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.0 mmm -127.62 -166.01 1.55 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -111.27 -64.16 1.32 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.825 0.703 . . . . 0.0 109.531 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.34 179.91 4.89 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.934 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -124.57 154.32 17.97 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-N 113.166 -1.834 . . . . 0.0 114.748 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.23 134.46 15.09 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.4 t -99.52 139.63 34.89 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.27 -79.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 116.879 2.178 . . . . 0.0 116.879 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.16 34.61 3.8 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.47 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.97 -22.56 37.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -100.22 165.82 11.3 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 44.2 t -90.15 151.09 21.74 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.479 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.456 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.4 t70 -133.46 146.98 51.64 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.62 ' H ' ' H ' ' A' ' 2' ' ' GLY . 37.4 m -117.94 162.39 18.22 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.0 m -121.4 62.05 11.9 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.7 176.0 6.48 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 C-N-CA 123.393 2.728 . . . . 0.0 111.361 -169.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.425 ' HZ1' ' HN1' ' A' ' 38' ' ' NH2 . 2.4 pptp? -29.45 -46.8 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 125.695 1.872 . . . . 0.0 114.614 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . 0.425 ' HN1' ' HZ1' ' A' ' 37' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.326 0 O-C-N 119.023 -2.298 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 122.134 0.969 . . . . 1.0 110.688 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -131.22 -171.19 12.83 Favored Glycine 0 C--O 1.215 -1.034 0 CA-C-N 113.517 -1.674 . . . . 0.0 112.865 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.57 HG22 ' SG ' ' A' ' 34' ' ' CYS . 15.1 pt -111.69 -105.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.504 ' H ' ' CG1' ' A' ' 3' ' ' ILE . 14.4 t-20 -173.18 35.75 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 124.483 1.115 . . . . 0.0 108.126 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.66 163.95 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.41 145.61 28.7 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 124.526 1.141 . . . . 0.0 110.266 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.3 p -128.38 167.21 17.31 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.808 -1.996 . . . . 0.0 112.991 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -121.17 -42.74 2.46 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 110.097 -3.228 . . . . 0.0 104.928 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.436 ' C ' ' H ' ' A' ' 11' ' ' GLY . 22.5 m80 -128.55 176.31 7.86 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.667 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.1 m -87.9 28.76 0.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.088 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.94 -50.93 0.26 Allowed Glycine 0 N--CA 1.495 2.567 1 N-CA-C 102.075 -4.41 . . . . 0.0 102.075 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.58 -25.93 1.96 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 113.239 -1.48 . . . . 0.0 109.384 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 31.0 t -96.75 -38.83 9.73 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.469 -2.15 . . . . 0.0 111.094 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.421 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -56.84 -45.64 82.24 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.514 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -57.65 -59.58 12.57 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.42 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.12 -33.39 40.71 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.428 1.419 . . . . 0.0 109.417 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.696 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.8 m -58.18 -64.29 0.97 Allowed 'General case' 0 C--N 1.307 -1.239 0 O-C-N 123.739 0.649 . . . . 0.0 109.932 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -57.97 -45.36 86.84 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.121 0.888 . . . . 0.0 109.553 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.472 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 40.4 m-20 -64.74 -18.53 65.13 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 125.59 1.806 . . . . 0.0 112.092 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.14 -3.89 36.79 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.24 41.08 1.31 Allowed Glycine 0 N--CA 1.483 1.811 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.401 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 13.1 mmm -128.49 -163.51 1.29 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -113.51 -64.12 1.35 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.611 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -125.79 179.15 5.32 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.469 0.652 . . . . 0.0 111.506 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.421 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -130.01 150.86 19.2 Favored Glycine 0 C--O 1.215 -1.076 0 CA-C-N 113.152 -1.84 . . . . 0.0 114.737 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -143.49 138.36 29.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.4 t -99.89 133.5 44.17 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.3 mm -114.33 -77.45 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -110.26 34.94 3.62 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.855 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.05 -19.69 52.04 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -106.41 168.54 9.09 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.696 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 35.0 t -88.28 149.7 23.66 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.507 -1.224 . . . . 0.0 114.186 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.423 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 11.3 t70 -134.94 123.61 23.65 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.57 ' SG ' HG22 ' A' ' 3' ' ' ILE . 31.5 m -99.94 162.18 13.15 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.153 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.9 m -121.52 64.75 16.02 Favored Pre-proline 0 N--CA 1.488 1.441 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.144 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.19 176.02 7.66 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 123.343 2.696 . . . . 0.0 111.293 -171.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -29.36 -51.34 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 125.625 1.828 . . . . 0.0 115.148 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.391 0 O-C-N 119.095 -2.253 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.828 0.346 . . . . 1.0 110.778 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -35.46 171.03 0.01 OUTLIER Glycine 0 N--CA 1.501 2.972 0 N-CA-C 119.411 2.524 . . . . 0.0 119.411 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.513 HG22 ' SG ' ' A' ' 34' ' ' CYS . 13.2 pt -114.71 -106.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 112.639 -1.781 . . . . 0.0 106.399 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.5 ' H ' HG13 ' A' ' 3' ' ' ILE . 14.9 t-20 -174.38 36.63 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 124.667 1.229 . . . . 0.0 107.714 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -126.92 165.56 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -99.88 147.58 25.38 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 124.595 1.184 . . . . 0.0 110.499 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p -127.67 168.14 15.46 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 112.547 -2.115 . . . . 0.0 113.114 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -119.95 -43.04 2.57 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 110.098 -3.228 . . . . 0.0 105.003 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.439 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.5 m-70 -132.88 176.88 8.09 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.536 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -85.63 28.89 0.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.455 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.37 -50.62 0.28 Allowed Glycine 0 N--CA 1.495 2.61 1 N-CA-C 102.551 -4.219 . . . . 0.0 102.551 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -25.68 3.87 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 112.962 -1.619 . . . . 0.0 109.593 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 25.7 t -97.01 -39.27 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 112.691 -2.05 . . . . 0.0 111.29 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.411 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.2 tt -57.28 -43.65 83.31 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.545 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -58.89 -57.45 26.87 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.605 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -68.09 -34.41 22.65 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.199 1.933 . . . . 0.0 109.985 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 14.8 m -58.06 -63.99 1.07 Allowed 'General case' 0 C--N 1.31 -1.127 0 O-C-N 123.837 0.711 . . . . 0.0 109.398 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -57.78 -47.3 82.93 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.265 0.978 . . . . 0.0 109.231 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -57.82 -24.37 57.05 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 126.02 2.075 . . . . 0.0 111.597 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.25 -3.41 37.46 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.137 0.898 . . . . 0.0 110.929 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.0 38.44 1.15 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.456 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 29.7 mmt -124.44 -164.71 1.29 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -115.43 -62.0 1.66 Allowed 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -126.92 179.44 5.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 123.883 0.739 . . . . 0.0 111.223 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.33 154.86 20.53 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-N 113.136 -1.847 . . . . 0.0 114.41 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -144.65 137.2 26.48 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -99.78 130.85 46.02 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.28 -78.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.23 34.53 3.85 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.831 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.46 -19.2 53.64 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 32' ' ' CYS . 18.4 ttpp -107.0 169.55 8.48 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 38.3 t -90.19 148.27 23.05 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.523 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 65.5 t0 -133.84 135.06 43.51 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.513 ' SG ' HG22 ' A' ' 3' ' ' ILE . 20.1 m -109.87 163.16 13.8 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 119.851 1.205 . . . . 0.0 113.421 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.6 m -122.29 62.57 16.24 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.689 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 81.4 Cg_endo -67.1 176.36 4.68 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 123.218 2.612 . . . . 0.0 111.551 -174.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HD3' ' HN1' ' A' ' 38' ' ' NH2 . 0.0 OUTLIER -29.3 -41.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . 0.455 ' HN1' ' HD3' ' A' ' 37' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.36 0 O-C-N 118.0 -2.938 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.875 0.369 . . . . 1.0 110.751 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -38.33 173.72 0.01 OUTLIER Glycine 0 N--CA 1.5 2.907 0 N-CA-C 119.228 2.451 . . . . 0.0 119.228 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.618 HG22 ' SG ' ' A' ' 34' ' ' CYS . 11.5 pt -113.62 -104.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 112.759 -1.721 . . . . 0.0 107.149 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.503 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.6 t30 -175.3 35.6 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 O-C-N 124.747 1.279 . . . . 0.0 108.496 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.12 165.65 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.8 142.17 31.64 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 124.602 1.189 . . . . 0.0 109.027 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 p -123.59 166.53 15.31 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 112.43 -2.168 . . . . 0.0 112.041 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -121.79 -40.54 2.53 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 110.359 -3.109 . . . . 0.0 106.034 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.434 ' C ' ' H ' ' A' ' 11' ' ' GLY . 85.6 m-70 -134.13 179.82 6.02 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.05 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 t -84.71 29.42 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.167 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -125.93 -50.86 0.18 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 103.768 -3.733 . . . . 0.0 103.768 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.52 -24.87 1.44 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 112.958 -1.621 . . . . 0.0 110.069 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 33' ' ' ASP . 40.9 t -97.01 -42.05 8.08 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.64 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.478 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.6 tt -55.51 -45.89 77.06 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.394 0.677 . . . . 0.0 112.395 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -56.77 -58.92 14.23 Favored Pre-proline 0 C--N 1.309 -1.17 0 O-C-N 123.888 0.743 . . . . 0.0 112.379 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -68.25 -33.03 25.36 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.992 1.794 . . . . 0.0 110.458 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.6 m -59.87 -65.16 0.72 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.71 0.631 . . . . 0.0 109.305 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -56.56 -45.2 81.41 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.425 1.078 . . . . 0.0 108.952 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.453 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 52.8 t0 -60.85 -24.77 66.15 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 125.934 2.021 . . . . 0.0 110.752 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 -0.01 45.54 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.582 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.48 39.32 1.49 Allowed Glycine 0 N--CA 1.484 1.878 0 N-CA-C 116.691 1.436 . . . . 0.0 116.691 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.467 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 29.6 mmt -124.49 -163.74 1.19 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -118.49 -60.96 1.72 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.16 176.54 6.98 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.37 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.478 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -139.37 145.16 16.2 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.818 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -139.65 149.21 43.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.5 t -99.83 137.82 37.76 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.3 mt -115.12 -78.49 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -110.29 35.0 3.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.368 1.043 . . . . 0.0 111.282 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.3 -23.21 35.08 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -103.97 163.21 12.52 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 124.397 0.704 . . . . 0.0 109.151 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 25.3 t -82.14 148.46 28.49 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.346 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.509 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 36.8 t70 -131.94 129.22 39.95 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.618 ' SG ' HG22 ' A' ' 3' ' ' ILE . 13.4 m -106.84 164.15 12.35 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.977 1.262 . . . . 0.0 113.493 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.4 m -122.15 68.45 27.32 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-N 113.329 -1.759 . . . . 0.0 108.942 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.467 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 17.1 Cg_endo -79.73 177.68 8.15 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 123.554 2.836 . . . . 0.0 112.072 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -110.07 69.92 0.71 Allowed 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.119 -1.855 . . . . 0.0 106.237 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.356 0 O-C-N 119.194 -2.191 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.757 0.789 . . . . 1.0 111.186 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.575 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 71.65 176.3 25.23 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 113.696 -1.593 . . . . 0.0 114.087 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.519 HG13 ' H ' ' A' ' 4' ' ' ASN . 11.6 pt -121.24 -105.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.519 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.8 t30 -175.7 36.6 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 125.242 1.417 . . . . 0.0 108.237 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.57 164.83 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -99.76 144.04 29.29 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 124.515 1.135 . . . . 0.0 109.783 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.4 p -125.09 167.41 14.82 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.613 -2.085 . . . . 0.0 112.898 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -119.43 -41.95 2.68 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 110.163 -3.199 . . . . 0.0 105.21 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.1 m-70 -132.23 176.2 8.6 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.521 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.7 p -85.37 26.42 0.91 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.564 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -119.39 -51.27 0.29 Allowed Glycine 0 N--CA 1.494 2.556 1 N-CA-C 102.832 -4.107 . . . . 0.0 102.832 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.66 -27.84 2.11 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.234 -1.483 . . . . 0.0 109.479 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 23.6 t -96.04 -35.84 11.24 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.116 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tt -59.24 -44.99 92.33 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.431 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 5.7 mptp? -56.1 -57.57 21.57 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.146 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 94.6 Cg_endo -68.35 -37.48 13.54 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.353 2.035 . . . . 0.0 111.845 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 7.4 m -57.78 -59.11 5.72 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -53.37 -54.65 33.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.585 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.18 -23.19 54.59 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 126.701 2.5 . . . . 0.0 112.402 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.38 -2.51 39.04 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 124.159 0.912 . . . . 0.0 111.282 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.84 38.31 1.44 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.426 ' HG3' ' SG ' ' A' ' 34' ' ' CYS . 29.1 mmt -123.82 -165.74 1.39 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -112.88 -62.86 1.52 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.45 -179.87 4.97 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.036 0.835 . . . . 0.0 110.433 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.13 157.04 16.14 Favored Glycine 0 C--O 1.216 -1.011 0 CA-C-N 113.147 -1.842 . . . . 0.0 113.53 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -149.46 132.77 16.5 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.2 t -99.5 132.28 44.93 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.0 mt -112.59 -78.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.37 34.91 3.66 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.364 1.04 . . . . 0.0 111.708 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.77 -17.05 58.85 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -105.01 168.22 9.2 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 43.2 t -90.75 147.62 23.11 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.535 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 13.3 t70 -132.29 144.01 50.29 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.575 ' H ' ' H ' ' A' ' 2' ' ' GLY . 29.8 m -114.5 160.39 19.28 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.449 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.0 m -121.9 61.38 13.0 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.172 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.8 175.81 6.82 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 123.375 2.717 . . . . 0.0 111.553 -172.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -29.32 -59.36 0.15 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 125.741 1.901 . . . . 0.0 113.823 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.327 0 O-C-N 119.377 -2.077 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.535 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -31.98 170.67 0.0 OUTLIER Glycine 0 N--CA 1.501 2.97 0 N-CA-C 120.898 3.119 . . . . 0.0 120.898 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.561 HG22 ' SG ' ' A' ' 34' ' ' CYS . 12.6 pt -113.81 -105.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 111.877 -2.161 . . . . 0.0 106.168 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.511 ' H ' HG13 ' A' ' 3' ' ' ILE . 13.2 t-20 -174.67 36.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 124.641 1.213 . . . . 0.0 108.059 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.73 165.5 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.93 143.31 30.3 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.256 1.027 . . . . 0.0 110.276 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 p -126.71 166.46 17.34 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 112.37 -2.196 . . . . 0.0 112.705 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -120.08 -40.68 2.7 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 110.44 -3.073 . . . . 0.0 105.847 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.421 ' C ' ' H ' ' A' ' 11' ' ' GLY . 84.2 m-70 -131.87 178.5 6.72 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.386 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.4 m -85.1 23.14 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.329 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.34 -50.32 0.34 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 103.272 -3.931 . . . . 0.0 103.272 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -25.79 2.02 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.3 -1.45 . . . . 0.0 109.595 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 34.6 t -97.28 -37.44 10.06 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 112.335 -2.211 . . . . 0.0 111.551 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.41 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -58.67 -43.98 90.06 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.063 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -56.95 -58.2 19.3 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-O 118.24 -0.886 . . . . 0.0 112.036 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -67.83 -36.61 17.89 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.396 2.064 . . . . 0.0 111.376 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 19.1 m -58.3 -60.54 3.62 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -52.26 -54.69 28.01 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.055 -1.43 . . . . 0.0 108.63 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.34 -23.11 55.73 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 126.954 2.659 . . . . 0.0 112.665 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.21 -2.37 39.88 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.131 0.894 . . . . 0.0 110.82 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.34 39.87 1.58 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 116.005 1.162 . . . . 0.0 116.005 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 12.4 mmm -126.73 -165.24 1.43 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.437 ' NH2' ' HN1' ' A' ' 38' ' ' NH2 . 21.7 mtm180 -111.65 -67.42 1.0 Allowed 'General case' 0 C--N 1.31 -1.143 0 O-C-N 123.98 0.8 . . . . 0.0 109.474 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -123.47 179.53 4.71 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.739 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.41 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.77 156.27 20.02 Favored Glycine 0 C--O 1.215 -1.079 0 CA-C-N 112.918 -1.947 . . . . 0.0 114.099 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -151.4 138.32 19.02 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.3 t -99.6 138.71 36.3 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.2 mt -116.12 -79.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -110.38 35.34 3.48 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.413 1.07 . . . . 0.0 111.859 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.39 -22.08 38.9 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -103.93 166.36 10.46 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.594 0.82 . . . . 0.0 108.831 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 32.4 t -85.79 149.13 25.48 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.535 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 37.1 t70 -132.34 134.8 45.63 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.561 ' SG ' HG22 ' A' ' 3' ' ' ILE . 27.3 m -108.45 163.61 13.06 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 119.726 1.148 . . . . 0.0 112.537 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.5 m -121.32 59.66 9.05 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.838 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -74.35 172.41 16.14 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 123.286 2.657 . . . . 0.0 111.866 -167.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -29.61 83.08 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 126.061 2.101 . . . . 0.0 115.217 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . 0.437 ' HN1' ' NH2' ' A' ' 23' ' ' ARG . . . . . . . . 0 C--N 1.303 -1.442 0 O-C-N 118.455 -2.653 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -28.75 168.66 0.0 OUTLIER Glycine 0 N--CA 1.501 3.021 0 N-CA-C 121.023 3.169 . . . . 0.0 121.023 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.517 HG22 ' SG ' ' A' ' 34' ' ' CYS . 13.1 pt -113.81 -104.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 112.092 -2.054 . . . . 0.0 107.077 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.502 ' H ' ' CG1' ' A' ' 3' ' ' ILE . 48.2 t30 -174.67 34.8 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 124.641 1.213 . . . . 0.0 108.2 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.06 163.14 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -102.27 141.19 35.5 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 124.517 1.135 . . . . 0.0 109.711 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 p -118.52 168.73 10.4 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.064 -1.88 . . . . 0.0 112.938 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -118.17 -42.52 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 110.001 -3.272 . . . . 0.0 104.896 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.448 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.6 m-70 -132.9 175.7 9.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.627 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.0 m -85.6 28.9 0.73 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.255 -1.338 . . . . 0.0 109.296 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -121.28 -49.95 0.26 Allowed Glycine 0 N--CA 1.495 2.597 1 N-CA-C 102.916 -4.074 . . . . 0.0 102.916 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -23.07 4.88 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.109 -1.545 . . . . 0.0 109.753 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 33.8 t -97.72 -37.69 9.79 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 112.997 -1.911 . . . . 0.0 110.863 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.464 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.3 tt -59.21 -42.56 91.25 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.23 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -58.67 -57.17 28.65 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.251 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.9 -37.12 11.9 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.567 2.178 . . . . 0.0 111.855 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.692 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 12.8 m -58.82 -58.6 7.91 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -53.28 -54.81 30.88 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.242 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -57.81 -23.77 54.14 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 126.809 2.568 . . . . 0.0 112.34 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.38 -1.3 41.89 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 124.078 0.861 . . . . 0.0 111.301 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.12 38.61 1.65 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.404 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.6 mmt -124.25 -165.44 1.37 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -113.44 -62.7 1.55 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -126.25 178.57 5.74 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.045 0.84 . . . . 0.0 110.84 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.464 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -127.98 145.28 15.86 Favored Glycine 0 C--O 1.215 -1.083 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.571 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.22 136.58 45.69 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.8 t -99.6 132.29 45.04 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.1 mm -109.72 -83.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.35 33.94 4.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.439 1.087 . . . . 0.0 111.436 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.36 -19.08 46.65 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.015 -2.434 . . . . 0.0 107.015 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -103.01 165.42 11.03 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.757 0.916 . . . . 0.0 109.708 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.692 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 36.7 t -92.74 145.76 24.17 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.503 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 38.5 t70 -131.57 141.41 49.68 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.517 ' SG ' HG22 ' A' ' 3' ' ' ILE . 20.6 m -110.48 159.91 17.09 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 119.822 1.192 . . . . 0.0 112.553 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.2 m -121.56 62.02 12.48 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.476 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.22 175.95 6.11 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 123.356 2.704 . . . . 0.0 111.652 -174.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -29.42 -59.31 0.15 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 125.751 1.907 . . . . 0.0 113.83 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.349 0 O-C-N 119.52 -1.988 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.955 0.883 . . . . 1.0 110.477 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.78 -169.76 12.59 Favored Glycine 0 C--N 1.307 -1.044 0 CA-C-N 113.562 -1.654 . . . . 0.0 113.153 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.601 HG22 ' SG ' ' A' ' 34' ' ' CYS . 13.1 pt -110.3 -104.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.504 ' H ' HG13 ' A' ' 3' ' ' ILE . 13.6 t-20 -173.91 35.29 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 O-C-N 124.42 1.075 . . . . 0.0 108.347 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -126.87 158.26 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -102.89 133.85 47.28 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 124.503 1.127 . . . . 0.0 110.764 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 p -126.57 166.66 16.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.613 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -117.98 -35.63 3.82 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 111.659 -2.519 . . . . 0.0 105.705 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -123.56 173.32 8.13 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.07 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.6 p -91.26 35.22 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.059 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.57 -47.92 0.24 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 105.405 -3.078 . . . . 0.0 105.405 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -61.94 -8.41 5.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.618 1.567 . . . . 0.0 111.116 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 37.4 t -106.51 -41.76 5.19 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.671 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.458 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.8 tt -58.28 -41.09 83.61 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.995 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -62.81 -57.09 23.54 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-O 118.128 -0.939 . . . . 0.0 112.138 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -67.68 -32.59 30.1 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.467 2.111 . . . . 0.0 110.99 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.5 m -61.4 -60.71 3.31 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -51.28 -54.97 20.89 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.792 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -58.3 -23.75 57.36 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 127.09 2.744 . . . . 0.0 112.769 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.22 0.11 45.17 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 124.011 0.819 . . . . 0.0 110.833 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.53 40.57 2.02 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.447 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 12.6 mmm -127.15 -165.5 1.48 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -112.96 -65.51 1.18 Allowed 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.982 0.801 . . . . 0.0 109.16 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -123.83 -179.77 4.51 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.662 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.458 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -134.54 152.39 20.65 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-N 113.246 -1.797 . . . . 0.0 114.377 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -148.47 140.26 23.76 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -99.62 142.19 31.44 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 105.15 -2.166 . . . . 0.0 105.15 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.1 mm -115.11 -78.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.27 35.27 3.49 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.45 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.53 -24.51 29.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.223 -2.351 . . . . 0.0 107.223 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -99.95 167.92 10.19 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 124.761 0.918 . . . . 0.0 109.294 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 32.0 t -89.69 151.09 22.04 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -136.75 124.87 22.97 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.601 ' SG ' HG22 ' A' ' 3' ' ' ILE . 23.8 m -99.8 164.9 11.83 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 118.981 0.81 . . . . 0.0 112.367 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.7 m -120.93 61.85 9.92 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.075 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.447 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 58.9 Cg_endo -68.75 176.64 5.73 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 123.103 2.535 . . . . 0.0 111.663 -168.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -29.76 167.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 119.515 3.154 . . . . 0.0 119.515 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.34 0 O-C-N 118.799 -2.438 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.589 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 44.15 -173.39 0.01 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.537 HG22 ' SG ' ' A' ' 34' ' ' CYS . 12.3 pt -122.54 -106.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.486 ' H ' HG13 ' A' ' 3' ' ' ILE . 49.5 t30 -177.24 34.6 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 125.509 1.524 . . . . 0.0 108.375 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.429 ' H ' HG13 ' A' ' 3' ' ' ILE . 42.6 t -124.57 164.54 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -99.74 137.94 37.51 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 124.583 1.177 . . . . 0.0 110.432 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 p -121.7 167.88 12.44 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 112.387 -2.188 . . . . 0.0 111.778 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -120.18 -40.35 2.72 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 110.387 -3.097 . . . . 0.0 105.643 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.429 ' C ' ' H ' ' A' ' 11' ' ' GLY . 20.3 m80 -128.89 177.9 6.77 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.946 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.5 t -85.8 21.99 1.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 113.24 -1.8 . . . . 0.0 108.758 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.91 -49.07 0.29 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 103.571 -3.812 . . . . 0.0 103.571 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.13 -21.99 3.8 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 113.004 -1.598 . . . . 0.0 110.067 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 32.8 t -99.95 -38.9 8.41 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 112.98 -1.918 . . . . 0.0 110.939 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.462 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.9 tt -58.98 -38.42 79.1 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.776 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.97 -56.67 22.91 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.997 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.14 -31.8 35.51 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.137 1.891 . . . . 0.0 110.824 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.5 m -62.26 -58.22 8.55 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -48.89 -57.51 6.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.617 1.198 . . . . 0.0 108.171 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -55.62 -27.17 48.11 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 128.186 3.429 . . . . 0.0 112.455 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 1.97 48.45 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 124.264 0.978 . . . . 0.0 111.458 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.86 43.72 2.05 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 115.241 0.856 . . . . 0.0 115.241 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.463 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 27.0 mmt -124.85 -166.57 1.54 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 116.972 0.386 . . . . 0.0 109.974 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' NH2' ' HN1' ' A' ' 38' ' ' NH2 . 20.4 mtm180 -113.87 -62.94 1.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.19 177.27 6.79 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.971 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.462 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -132.01 150.91 19.68 Favored Glycine 0 C--O 1.216 -0.986 0 CA-C-N 112.504 -2.135 . . . . 0.0 112.98 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -146.98 140.93 25.94 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.64 141.08 32.91 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.96 -81.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -110.32 34.41 3.93 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.226 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.56 -24.15 29.48 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.401 -2.279 . . . . 0.0 107.401 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -100.7 165.65 11.28 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.694 0.879 . . . . 0.0 109.157 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 25.7 t -89.48 149.6 22.85 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.44 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.6 t70 -133.11 134.75 44.66 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' H ' ' H ' ' A' ' 2' ' ' GLY . 33.4 m -110.46 163.82 13.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 119.079 0.854 . . . . 0.0 111.489 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.1 m -122.06 58.78 10.03 Favored Pre-proline 0 N--CA 1.49 1.541 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.639 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.463 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 37.1 Cg_endo -73.33 169.87 21.24 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 122.948 2.432 . . . . 0.0 111.832 -169.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -29.69 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 126.147 2.154 . . . . 0.0 114.987 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . 0.426 ' HN1' ' NH2' ' A' ' 23' ' ' ARG . . . . . . . . 0 C--N 1.305 -1.36 0 O-C-N 118.839 -2.413 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.529 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 53.77 -175.91 0.33 Allowed Glycine 0 N--CA 1.485 1.928 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.545 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.505 ' CG1' ' HB3' ' A' ' 32' ' ' CYS . 15.4 pt -122.5 -107.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.495 ' H ' ' CG1' ' A' ' 3' ' ' ILE . 48.4 t30 -175.63 35.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 125.474 1.51 . . . . 0.0 108.339 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' H ' HG13 ' A' ' 3' ' ' ILE . 42.8 t -126.21 166.06 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -100.47 140.71 34.33 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 124.906 1.379 . . . . 0.0 108.638 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.3 p -125.27 166.83 15.81 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 113.266 -1.788 . . . . 0.0 112.532 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -120.97 -40.95 2.57 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 110.635 -2.984 . . . . 0.0 104.973 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -124.11 175.02 7.26 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.546 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.1 p -94.67 34.14 1.37 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.552 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 13' ' ' CYS . . . -126.7 -44.69 0.24 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -73.17 7.51 2.12 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.95 1.3 . . . . 0.0 110.604 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 37.6 t -114.19 -41.04 3.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.117 -1.856 . . . . 0.0 106.204 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.471 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 7.6 tt -61.94 -35.45 78.47 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.794 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -66.82 -56.23 14.87 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.815 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.13 -31.96 44.15 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.047 1.831 . . . . 0.0 111.327 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.6 m -63.51 -56.3 17.14 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -48.67 -58.69 4.37 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -56.09 -25.84 47.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 128.245 3.466 . . . . 0.0 113.241 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.12 1.67 47.79 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 124.522 1.139 . . . . 0.0 111.133 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.96 43.08 2.3 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 115.166 0.826 . . . . 0.0 115.166 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 21.5 mmm -128.57 -167.32 1.75 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.42 ' HE ' ' C ' ' A' ' 36' ' ' PRO . 45.8 mtm180 -112.85 -66.46 1.08 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.066 0.854 . . . . 0.0 109.442 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -121.27 179.26 4.47 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.987 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.471 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -137.59 148.12 19.64 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-N 112.81 -1.995 . . . . 0.0 114.676 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.405 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -147.36 148.79 31.72 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -99.58 140.12 34.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.22 -77.65 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.37 33.72 4.33 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.656 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.57 -21.88 40.87 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -102.62 165.41 11.09 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.505 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 15.6 t -90.16 148.36 23.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.511 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 29.0 t70 -131.18 146.41 52.32 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 103.366 -2.828 . . . . 0.0 103.366 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.529 ' H ' ' H ' ' A' ' 2' ' ' GLY . 58.5 m -111.6 173.75 6.2 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.685 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.8 m -121.03 64.88 13.07 Favored Pre-proline 0 N--CA 1.486 1.331 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' C ' ' HE ' ' A' ' 23' ' ' ARG . 59.6 Cg_endo -57.5 174.8 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 123.286 2.657 . . . . 0.0 113.397 -173.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -29.26 -60.38 0.14 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 112.995 -1.911 . . . . 0.0 113.667 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.333 0 O-C-N 119.412 -2.055 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.773 0.321 . . . . 1.0 110.953 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -21.12 149.78 0.0 OUTLIER Glycine 0 N--CA 1.503 3.133 0 N-CA-C 119.541 2.576 . . . . 0.0 119.541 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.554 HG22 ' SG ' ' A' ' 34' ' ' CYS . 13.3 pt -114.25 -103.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.513 ' H ' HG13 ' A' ' 3' ' ' ILE . 14.0 t-20 -173.81 31.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' H ' HG13 ' A' ' 3' ' ' ILE . 46.3 t -131.52 165.71 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -103.6 140.86 36.98 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 125.016 1.448 . . . . 0.0 108.956 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 p -122.98 166.4 15.14 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.485 -1.689 . . . . 0.0 112.511 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -40.5 2.91 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 110.764 -2.925 . . . . 0.0 105.775 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.423 ' C ' ' H ' ' A' ' 11' ' ' GLY . 84.3 m-70 -131.87 179.59 5.99 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.67 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.0 t -86.69 28.91 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.188 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -124.87 -51.16 0.19 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 103.294 -3.922 . . . . 0.0 103.294 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -22.6 2.03 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.506 -1.847 . . . . 0.0 110.077 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 44.3 t -99.24 -43.23 6.69 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.937 -1.938 . . . . 0.0 111.478 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.47 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.3 tt -53.73 -43.97 69.5 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.859 0.863 . . . . 0.0 112.329 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -61.46 -56.51 32.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 124.189 0.931 . . . . 0.0 112.707 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -67.57 -31.3 33.75 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.837 1.691 . . . . 0.0 110.323 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 9.2 m -61.44 -63.52 1.25 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -56.52 -47.82 78.53 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -59.03 -23.77 62.25 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 126.126 2.142 . . . . 0.0 111.486 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.91 -1.19 43.49 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 123.703 0.627 . . . . 0.0 110.391 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.67 40.8 1.54 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 116.112 1.205 . . . . 0.0 116.112 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 14.8 mmm -128.22 -164.04 1.34 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.3 mtm180 -111.57 -66.53 1.07 Allowed 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.14 178.86 5.33 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.234 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.47 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -140.6 149.0 20.63 Favored Glycine 0 C--O 1.215 -1.087 0 CA-C-N 113.101 -1.863 . . . . 0.0 114.502 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 21.5 ptmt -144.73 152.15 39.96 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -99.61 143.38 29.92 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.122 -1.431 . . . . 0.0 107.359 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.8 mm -114.68 -81.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.45 33.6 4.41 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.453 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.76 -22.57 35.13 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.103 -2.399 . . . . 0.0 107.103 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -99.97 163.81 12.28 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 11.4 t -90.44 150.78 21.69 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.557 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 32.5 t70 -135.01 144.23 47.24 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.554 ' SG ' HG22 ' A' ' 3' ' ' ILE . 35.9 m -112.37 167.48 10.4 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 119.317 0.962 . . . . 0.0 113.34 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.2 m -122.21 58.85 10.51 Favored Pre-proline 0 N--CA 1.487 1.421 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.072 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -68.41 173.67 9.38 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 123.25 2.634 . . . . 0.0 111.501 -168.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -29.35 -59.2 0.15 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 125.848 1.967 . . . . 0.0 113.761 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.338 0 O-C-N 119.391 -2.068 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 122.087 0.946 . . . . 1.0 110.369 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.78 -170.29 13.0 Favored Glycine 0 C--N 1.306 -1.094 0 CA-C-N 113.391 -1.731 . . . . 0.0 113.67 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.574 HG22 ' SG ' ' A' ' 34' ' ' CYS . 14.7 pt -111.62 -105.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.507 ' H ' HG13 ' A' ' 3' ' ' ILE . 12.9 t-20 -173.8 36.81 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 124.415 1.072 . . . . 0.0 108.326 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.83 163.27 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.26 143.61 31.12 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 122.111 0.958 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.6 p -128.85 167.49 17.28 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 112.52 -2.127 . . . . 0.0 113.159 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -121.93 -42.64 2.38 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 110.216 -3.175 . . . . 0.0 105.272 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.418 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.0 m80 -127.13 177.37 6.7 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.293 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.2 m -88.64 28.16 1.18 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.902 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -121.22 -50.54 0.26 Allowed Glycine 0 N--CA 1.494 2.53 1 N-CA-C 102.504 -4.239 . . . . 0.0 102.504 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -24.96 2.05 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 113.053 -1.574 . . . . 0.0 109.523 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 35.6 t -97.58 -39.33 9.17 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 112.559 -2.109 . . . . 0.0 110.77 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.436 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -56.17 -45.3 79.77 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.198 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 2.1 mptm? -58.05 -58.96 14.96 Favored Pre-proline 0 C--N 1.308 -1.196 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.829 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 84.1 Cg_endo -66.97 -31.62 37.12 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.335 2.023 . . . . 0.0 110.888 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.748 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 32.8 m -61.38 -62.3 1.93 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -50.47 -54.42 22.28 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 113.82 -1.537 . . . . 0.0 107.997 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.19 -26.6 60.91 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 127.196 2.81 . . . . 0.0 112.072 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.08 2.19 48.43 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 124.004 0.815 . . . . 0.0 111.529 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.98 39.65 2.11 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 26.6 mmt -125.15 -164.27 1.27 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -117.43 -62.04 1.62 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.19 178.82 5.36 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.167 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.436 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -131.9 150.74 19.63 Favored Glycine 0 C--O 1.216 -1.023 0 CA-C-N 113.15 -1.841 . . . . 0.0 113.792 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -145.15 140.72 28.17 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t -99.89 139.38 35.64 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 mt -116.91 -78.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 117.171 2.285 . . . . 0.0 117.171 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.38 35.36 3.47 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.353 1.033 . . . . 0.0 111.945 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.05 -21.38 41.97 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -105.11 166.37 10.44 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.748 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 37.9 t -84.97 149.54 25.54 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.877 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -134.71 120.91 20.06 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.574 ' SG ' HG22 ' A' ' 3' ' ' ILE . 21.8 m -99.66 166.06 11.3 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.646 1.112 . . . . 0.0 113.044 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.6 m -120.8 67.36 14.64 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.495 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 13.4 Cg_endo -80.92 176.37 9.02 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 123.175 2.583 . . . . 0.0 111.863 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -110.26 -58.72 2.03 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.278 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.381 0 O-C-N 119.456 -2.028 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.56 -170.94 14.11 Favored Glycine 0 C--O 1.216 -0.979 0 O-C-N 124.15 0.906 . . . . 0.0 111.124 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.625 HG22 ' SG ' ' A' ' 34' ' ' CYS . 12.9 pt -111.82 -104.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.517 ' H ' ' CG1' ' A' ' 3' ' ' ILE . 48.7 t30 -176.01 33.76 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 124.714 1.259 . . . . 0.0 108.79 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.65 164.0 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -99.96 139.38 35.71 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 124.732 1.27 . . . . 0.0 109.059 -179.723 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 p -123.36 166.75 14.8 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 112.616 -2.084 . . . . 0.0 111.525 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -42.79 2.21 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 110.513 -3.04 . . . . 0.0 103.953 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.418 ' C ' ' H ' ' A' ' 11' ' ' GLY . 18.7 m80 -124.32 179.0 5.08 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.081 0.944 . . . . 0.0 111.745 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.4 t -89.04 28.62 1.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.211 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -124.63 -50.59 0.2 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 103.301 -3.92 . . . . 0.0 103.301 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.95 -22.84 1.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.718 -1.741 . . . . 0.0 109.788 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 43.0 t -99.4 -43.89 6.39 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.493 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.463 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.4 tt -54.8 -44.09 73.49 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.616 0.766 . . . . 0.0 112.499 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -60.85 -56.44 35.02 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.877 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.53 -32.93 23.75 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.336 2.024 . . . . 0.0 111.287 178.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.728 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.1 m -61.07 -61.07 2.84 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -52.72 -52.79 54.77 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.888 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.82 -24.66 62.29 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 126.431 2.332 . . . . 0.0 111.817 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.28 1.71 47.45 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.077 0.861 . . . . 0.0 111.073 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.69 38.31 2.07 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 116.592 1.397 . . . . 0.0 116.592 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 25.7 mmt -125.64 -164.85 1.34 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.444 ' NH2' ' HN1' ' A' ' 38' ' ' NH2 . 19.0 mtm180 -113.27 -63.78 1.4 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.75 178.37 5.73 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 123.954 0.784 . . . . 0.0 111.036 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -143.91 150.93 22.94 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-N 113.154 -1.839 . . . . 0.0 114.145 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.72 153.14 41.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.84 141.96 31.96 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.08 -78.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 116.509 2.041 . . . . 0.0 116.509 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -110.28 34.84 3.68 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 124.526 1.141 . . . . 0.0 111.223 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.6 -24.2 31.59 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -103.58 163.07 12.54 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.443 0.731 . . . . 0.0 109.138 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.728 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 12.7 t -84.13 146.97 27.59 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.9 t70 -129.8 130.48 45.38 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.625 ' SG ' HG22 ' A' ' 3' ' ' ILE . 15.4 m -103.8 161.22 14.13 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 119.745 1.157 . . . . 0.0 112.439 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.2 m -123.37 63.09 23.85 Favored Pre-proline 0 N--CA 1.488 1.442 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.831 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.419 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 32.8 Cg_endo -74.6 171.96 17.13 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.955 2.437 . . . . 0.0 111.377 -172.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -29.58 81.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 126.219 2.199 . . . . 0.0 116.128 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . 0.444 ' HN1' ' NH2' ' A' ' 23' ' ' ARG . . . . . . . . 0 C--N 1.304 -1.379 0 O-C-N 118.79 -2.444 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.769 0.795 . . . . 1.0 110.585 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.77 -170.98 12.84 Favored Glycine 0 C--O 1.216 -1.012 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.184 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.617 HG22 ' SG ' ' A' ' 34' ' ' CYS . 14.2 pt -112.06 -104.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.516 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.7 t30 -173.01 33.4 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 O-C-N 124.64 1.213 . . . . 0.0 108.932 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.25 155.01 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -99.96 133.22 44.66 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 125.06 1.475 . . . . 0.0 111.226 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -123.61 167.13 14.35 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 112.458 -2.156 . . . . 0.0 111.959 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -117.79 -38.26 3.29 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 111.081 -2.781 . . . . 0.0 105.206 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -126.31 174.22 8.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.604 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -88.59 35.54 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.758 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.46 -50.63 0.21 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 104.531 -3.428 . . . . 0.0 104.531 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -56.15 -16.59 5.44 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 113.593 -1.304 . . . . 0.0 110.526 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 39.4 t -100.83 -41.31 6.91 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.255 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.407 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.9 tt -55.91 -46.13 78.51 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.023 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -57.93 -60.19 10.79 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.651 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -66.43 -32.75 39.65 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.102 1.868 . . . . 0.0 110.314 -177.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 33.5 m -59.84 -58.96 6.32 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -52.09 -56.0 17.19 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 124.888 1.367 . . . . 0.0 108.417 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -20.18 61.07 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 126.891 2.619 . . . . 0.0 113.268 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.3 -1.96 40.57 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 124.037 0.836 . . . . 0.0 109.841 179.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.93 38.19 2.06 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 115.735 1.054 . . . . 0.0 115.735 179.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.457 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 22.1 mmt -125.15 -165.71 1.44 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.21 -61.37 1.76 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.82 -178.21 4.2 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.195 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.407 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -131.05 154.17 20.68 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 112.267 -2.242 . . . . 0.0 113.361 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -151.83 136.13 16.75 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 t -99.74 143.06 30.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.6 -82.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.34 34.61 3.82 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.409 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.66 -20.99 40.09 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.082 -2.407 . . . . 0.0 107.082 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -100.02 166.61 10.96 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 36.4 t -91.6 150.95 20.93 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -137.01 124.04 21.54 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.617 ' SG ' HG22 ' A' ' 3' ' ' ILE . 28.5 m -99.75 176.5 5.43 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.466 1.03 . . . . 0.0 112.444 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.7 m -116.76 66.28 3.64 Favored Pre-proline 0 N--CA 1.486 1.327 0 CA-C-N 112.917 -1.947 . . . . 0.0 106.877 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.457 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 97.5 Cg_endo -63.04 179.05 0.86 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 123.962 3.108 . . . . 0.0 113.076 -176.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.75 179.28 4.31 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 112.844 -1.98 . . . . 0.0 111.671 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.3 0 O-C-N 119.208 -2.182 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 122.096 0.951 . . . . 1.0 110.508 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.78 -170.38 12.67 Favored Glycine 0 C--N 1.308 -1.026 0 CA-C-N 113.513 -1.676 . . . . 0.0 113.022 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.608 HG22 ' SG ' ' A' ' 34' ' ' CYS . 13.7 pt -110.47 -104.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.508 ' H ' HG13 ' A' ' 3' ' ' ILE . 12.7 t-20 -173.95 33.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 O-C-N 124.416 1.073 . . . . 0.0 108.585 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.48 158.53 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -100.82 138.47 37.83 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.305 1.003 . . . . 0.0 111.131 -179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 p -126.85 167.28 16.02 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.595 -2.093 . . . . 0.0 112.328 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -118.35 -39.0 3.08 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 110.955 -2.839 . . . . 0.0 105.645 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -126.32 175.09 8.08 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.956 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.4 m -89.5 34.16 0.82 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.511 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.9 -48.38 0.25 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 104.959 -3.256 . . . . 0.0 104.959 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.86 -11.88 6.38 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 113.536 -1.332 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 38.7 t -103.24 -41.6 6.01 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.775 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.477 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.4 tt -57.31 -43.04 82.92 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.353 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -60.85 -57.23 27.97 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.203 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.29 -32.22 26.91 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.531 2.154 . . . . 0.0 111.065 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 22.4 m -61.54 -60.92 2.97 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.36 -54.51 30.91 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -57.75 -23.81 53.93 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 126.577 2.423 . . . . 0.0 112.601 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.25 0.76 46.32 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 124.098 0.874 . . . . 0.0 111.013 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.7 39.07 2.26 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.503 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 25.7 mmt -124.82 -165.95 1.46 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -112.36 -64.93 1.23 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -124.87 179.08 5.16 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.692 0.758 . . . . 0.0 110.62 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.477 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -132.92 149.56 19.6 Favored Glycine 0 C--O 1.216 -0.992 0 CA-C-N 112.802 -1.999 . . . . 0.0 113.252 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -144.25 141.63 29.96 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 104.47 -2.418 . . . . 0.0 104.47 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.3 t -99.65 141.03 32.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.6 mt -117.13 -78.45 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.26 35.58 3.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.57 1.169 . . . . 0.0 111.465 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.23 -23.35 34.69 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -101.93 167.82 9.81 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.75 0.912 . . . . 0.0 109.055 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.1 t -88.38 148.84 24.04 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.667 -1.151 . . . . 0.0 113.946 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -132.97 124.14 27.2 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.608 ' SG ' HG22 ' A' ' 3' ' ' ILE . 22.0 m -99.83 162.45 12.99 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 119.605 1.093 . . . . 0.0 111.946 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.3 m -121.79 61.12 12.27 Favored Pre-proline 0 N--CA 1.489 1.496 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.536 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.503 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 66.7 Cg_endo -68.2 175.24 6.94 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 C-N-CA 123.172 2.581 . . . . 0.0 111.659 -172.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -29.38 -59.21 0.15 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 125.775 1.922 . . . . 0.0 113.894 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.337 0 O-C-N 119.425 -2.047 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -32.53 171.01 0.0 OUTLIER Glycine 0 N--CA 1.5 2.948 0 N-CA-C 120.304 2.882 . . . . 0.0 120.304 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.555 HG22 ' SG ' ' A' ' 34' ' ' CYS . 13.5 pt -114.55 -105.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 112.434 -1.883 . . . . 0.0 106.705 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.512 ' H ' HG13 ' A' ' 3' ' ' ILE . 49.2 t30 -175.15 33.58 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 124.71 1.257 . . . . 0.0 108.951 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.407 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.3 t -124.25 163.22 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -99.98 136.87 39.23 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 124.457 1.098 . . . . 0.0 111.609 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 p -122.0 167.12 13.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.73 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -118.8 -41.12 2.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 110.598 -3.001 . . . . 0.0 105.405 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.41 ' C ' ' H ' ' A' ' 11' ' ' GLY . 20.7 m80 -126.21 177.22 6.53 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.607 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.5 p -87.33 21.05 2.56 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.904 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -117.58 -48.93 0.4 Allowed Glycine 0 N--CA 1.495 2.567 1 N-CA-C 103.088 -4.005 . . . . 0.0 103.088 179.699 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -23.91 4.37 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 113.071 -1.565 . . . . 0.0 109.522 179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 23.1 t -98.42 -36.01 10.1 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.827 -1.988 . . . . 0.0 111.035 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.409 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.0 tt -59.14 -42.3 90.34 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.288 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -60.17 -55.84 41.34 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-O 117.796 -1.097 . . . . 0.0 112.538 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -68.49 -36.81 14.36 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.289 1.992 . . . . 0.0 111.374 178.156 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 15.6 m -58.45 -59.43 5.36 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -52.85 -54.77 29.66 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.37 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.47 -24.74 57.53 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 126.764 2.54 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.41 -0.72 43.07 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 124.167 0.917 . . . . 0.0 111.541 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.38 38.78 1.58 Allowed Glycine 0 N--CA 1.483 1.809 0 N-CA-C 116.831 1.493 . . . . 0.0 116.831 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 29.8 mmt -124.18 -165.62 1.39 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -114.09 -62.41 1.6 Allowed 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -126.28 179.59 5.2 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.048 0.842 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.409 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.57 158.1 20.54 Favored Glycine 0 C--O 1.217 -0.913 0 CA-C-N 113.001 -1.909 . . . . 0.0 113.247 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.38 137.03 15.17 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 102.138 -3.282 . . . . 0.0 102.138 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t -99.62 142.39 31.17 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 117.928 -1.509 . . . . 0.0 107.601 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 33' ' ' ASP . 33.0 mt -109.63 -85.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -179.361 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -110.38 35.35 3.48 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.272 0.982 . . . . 0.0 111.329 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.22 -22.06 33.94 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 106.382 -2.687 . . . . 0.0 106.382 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -99.68 166.4 11.13 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 39.1 t -89.9 146.3 24.51 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -179.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.515 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 37.6 t70 -129.64 137.35 50.62 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.555 ' SG ' HG22 ' A' ' 3' ' ' ILE . 17.1 m -110.66 160.17 16.93 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.276 -0.969 . . . . 0.0 112.39 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.5 m -122.42 62.65 16.92 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.409 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 66.6 Cg_endo -68.33 176.36 5.72 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 123.525 2.817 . . . . 0.0 111.665 -173.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 38' ' ' NH2 . 0.0 OUTLIER -29.43 -37.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.929 2.196 . . . . 0.0 116.929 179.993 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . 0.477 ' N ' ' HD3' ' A' ' 37' ' ' LYS . . . . . . . . 0 C--N 1.304 -1.38 0 O-C-N 118.555 -2.591 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.746 0.784 . . . . 1.0 111.231 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.565 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 74.63 177.24 38.1 Favored Glycine 0 C--N 1.307 -1.075 0 CA-C-N 113.853 -1.522 . . . . 0.0 113.927 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.51 ' CG1' ' HB3' ' A' ' 32' ' ' CYS . 12.4 pt -120.92 -106.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.499 ' H ' HG13 ' A' ' 3' ' ' ILE . 13.2 t-20 -175.76 35.43 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 124.979 1.312 . . . . 0.0 108.022 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.413 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.3 t -123.92 161.27 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -99.98 139.0 36.28 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 122.213 1.006 . . . . 0.0 111.244 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.0 p -125.44 167.37 15.08 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.709 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -117.51 -38.76 3.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 110.884 -2.871 . . . . 0.0 105.342 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -129.61 175.48 8.77 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.653 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.5 t -85.46 34.52 0.58 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 13' ' ' CYS . . . -126.08 -48.47 0.19 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 106.598 -2.601 . . . . 0.0 106.598 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -62.65 -7.59 5.07 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.753 -1.224 . . . . 0.0 110.864 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 35.4 t -105.85 -40.6 5.66 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.301 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.428 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.0 tt -57.46 -45.11 85.13 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.341 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -60.36 -56.15 38.18 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-O 117.995 -1.002 . . . . 0.0 112.846 -179.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -67.23 -34.7 26.91 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.694 1.596 . . . . 0.0 110.928 178.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 11.9 m -60.39 -63.97 1.11 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -56.3 -45.08 80.37 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.122 0.889 . . . . 0.0 109.347 -179.73 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.447 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 10.7 t70 -61.3 -25.19 66.95 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 125.832 1.958 . . . . 0.0 111.091 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.99 0.57 46.59 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 123.929 0.768 . . . . 0.0 110.858 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.35 39.43 1.36 Allowed Glycine 0 N--CA 1.483 1.81 0 N-CA-C 117.008 1.563 . . . . 0.0 117.008 179.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.472 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 26.1 mmt -126.14 -164.56 1.33 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.447 ' NH2' ' HN1' ' A' ' 38' ' ' NH2 . 19.9 mtm180 -114.01 -64.59 1.29 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.364 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -126.07 179.95 4.99 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.384 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -128.27 153.47 19.51 Favored Glycine 0 C--O 1.216 -1.013 0 CA-C-N 113.05 -1.886 . . . . 0.0 113.576 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -145.52 137.69 25.59 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -99.31 138.83 35.86 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 179.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.3 mt -116.45 -79.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 117.667 2.469 . . . . 0.0 117.667 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.31 35.29 3.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.468 1.105 . . . . 0.0 111.36 -179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.36 -22.82 36.33 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 106.922 -2.471 . . . . 0.0 106.922 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -102.46 168.26 9.42 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.815 0.95 . . . . 0.0 109.064 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 35.2 t -90.43 147.57 23.34 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 12.1 t70 -131.04 141.55 50.22 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.565 ' H ' ' H ' ' A' ' 2' ' ' GLY . 29.8 m -112.33 164.24 13.47 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 119.088 0.858 . . . . 0.0 112.315 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.3 m -121.5 58.12 7.94 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.781 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.472 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 36.7 Cg_endo -73.61 168.67 24.2 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.927 2.418 . . . . 0.0 111.51 -169.256 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -29.39 81.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 126.33 2.269 . . . . 0.0 115.69 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' NH2 . . . . . 0.447 ' HN1' ' NH2' ' A' ' 23' ' ' ARG . . . . . . . . 0 C--N 1.304 -1.401 0 O-C-N 118.711 -2.493 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.01 158.71 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -102.27 125.71 49.06 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 125.432 1.707 . . . . 0.0 107.635 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.7 p -114.14 167.56 10.58 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.773 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -119.5 -40.04 2.82 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 110.402 -3.09 . . . . 0.0 105.847 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.4 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.7 m-70 -129.84 176.82 7.73 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.645 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.1 m -87.46 25.52 1.42 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.815 -1.538 . . . . 0.0 109.301 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.01 -50.75 0.28 Allowed Glycine 0 N--CA 1.495 2.6 1 N-CA-C 102.48 -4.248 . . . . 0.0 102.48 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.39 -24.74 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.861 -1.669 . . . . 0.0 109.577 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 29.5 t -98.67 -37.41 9.52 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 112.551 -2.113 . . . . 0.0 111.527 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.434 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.8 tt -58.23 -43.57 87.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.432 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -60.24 -56.12 38.6 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-O 117.898 -1.049 . . . . 0.0 112.059 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.23 -34.25 28.29 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.248 1.965 . . . . 0.0 111.24 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 10.6 m -59.79 -59.96 4.6 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -52.17 -55.11 23.09 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.936 -1.483 . . . . 0.0 108.178 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.22 -23.36 55.53 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 127.089 2.743 . . . . 0.0 112.307 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 -1.4 42.79 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 123.915 0.759 . . . . 0.0 110.927 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.68 39.93 1.81 Allowed Glycine 0 N--CA 1.483 1.793 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.0 mmm -127.24 -165.74 1.51 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -111.29 -65.98 1.12 Allowed 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -123.88 -179.94 4.59 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.399 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.434 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.11 154.63 18.94 Favored Glycine 0 C--O 1.216 -1.031 0 CA-C-N 113.041 -1.89 . . . . 0.0 114.494 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -150.0 136.17 18.8 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.48 139.74 34.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -112.17 -80.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.41 34.53 3.88 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.982 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.34 -23.34 33.45 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 107.073 -2.411 . . . . 0.0 107.073 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -99.42 165.05 11.84 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.5 t -88.06 153.99 20.83 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.529 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 33.9 t70 -139.92 143.8 36.8 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.4 m -113.91 167.18 10.87 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 119.446 1.021 . . . . 0.0 112.812 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.6 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.195 179.79 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -125.88 162.28 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -99.63 135.47 41.0 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.821 1.326 . . . . 0.0 109.122 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 p -119.47 167.93 11.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.607 -2.088 . . . . 0.0 112.384 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -120.89 -43.59 2.45 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 110.023 -3.262 . . . . 0.0 105.404 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -124.13 177.34 5.87 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.678 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.4 p -89.38 26.84 1.57 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.875 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.92 -50.87 0.26 Allowed Glycine 0 N--CA 1.493 2.496 1 N-CA-C 102.544 -4.222 . . . . 0.0 102.544 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -24.06 1.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 112.803 -1.698 . . . . 0.0 109.628 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 39.6 t -98.97 -43.04 6.85 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.757 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.478 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.0 tt -55.09 -46.15 75.46 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.832 0.853 . . . . 0.0 112.104 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -56.38 -60.84 7.91 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 124.12 0.888 . . . . 0.0 111.521 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -66.11 -33.37 40.88 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.412 1.408 . . . . 0.0 109.965 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 13.2 m -58.67 -63.66 1.21 Allowed 'General case' 0 C--N 1.31 -1.15 0 O-C-N 123.599 0.562 . . . . 0.0 109.756 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -58.81 -47.28 85.32 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.284 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.11 -22.89 61.57 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 125.708 1.88 . . . . 0.0 111.695 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.27 -3.25 37.73 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 123.889 0.743 . . . . 0.0 110.594 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.67 38.1 1.11 Allowed Glycine 0 N--CA 1.482 1.727 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.449 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 25.4 mmt -126.41 -163.48 1.23 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -115.05 -63.09 1.51 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -128.16 -179.91 5.25 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.059 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.478 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -137.65 151.99 21.46 Favored Glycine 0 N--CA 1.472 1.043 0 CA-C-N 112.633 -2.076 . . . . 0.0 115.074 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -149.57 147.76 28.54 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -99.85 140.83 33.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.54 -80.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -110.33 33.67 4.36 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.141 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.47 -22.06 38.86 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -99.91 164.42 12.02 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.1 t -89.43 147.82 23.81 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.546 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 68.5 t0 -132.17 141.78 49.22 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.8 m -113.37 171.35 7.61 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 119.112 0.869 . . . . 0.0 111.916 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.0 m . . . . . 0 N--CA 1.484 1.259 0 O-C-N 125.068 1.48 . . . . 0.0 107.496 179.708 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.29 164.4 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -99.84 138.2 37.25 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 124.7 1.25 . . . . 0.0 108.517 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 p -123.92 167.16 14.49 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.377 -1.738 . . . . 0.0 112.563 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -119.25 -41.26 2.74 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 110.522 -3.035 . . . . 0.0 105.359 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 11' ' ' GLY . 87.2 m-70 -130.03 177.79 7.02 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.58 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 m -87.09 25.89 1.27 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 113.6 -1.636 . . . . 0.0 108.982 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -119.69 -50.26 0.3 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 103.205 -3.958 . . . . 0.0 103.205 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -24.87 3.21 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 113.012 -1.594 . . . . 0.0 109.763 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 27.3 t -97.92 -38.22 9.5 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.438 -2.165 . . . . 0.0 111.439 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.453 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.6 tt -58.06 -44.21 87.36 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.526 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -59.24 -56.85 31.85 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-O 117.877 -1.059 . . . . 0.0 112.079 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -67.55 -36.1 20.77 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.214 1.942 . . . . 0.0 111.418 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.64 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 12.5 m -58.96 -59.59 5.22 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -52.37 -55.33 22.36 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.658 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -57.38 -24.49 55.67 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 127.165 2.791 . . . . 0.0 112.086 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.21 -1.28 42.42 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.596 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.76 39.62 1.56 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 116.343 1.297 . . . . 0.0 116.343 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 13.5 mmm -127.51 -165.83 1.53 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -111.32 -66.21 1.1 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -123.84 -178.23 3.99 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.488 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.453 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.6 154.4 20.39 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 113.352 -1.749 . . . . 0.0 114.214 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -149.56 137.97 20.74 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -99.44 138.51 36.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.9 mm -112.82 -78.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -110.17 34.45 3.89 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.381 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.94 -26.21 23.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -99.77 165.06 11.76 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.375 0.691 . . . . 0.0 109.395 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.64 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 38.6 t -84.89 150.78 24.74 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.53 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.0 t70 -135.69 141.69 44.99 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.4 m -110.6 170.38 8.13 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 119.462 1.028 . . . . 0.0 112.819 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 N--CA 1.49 1.533 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.208 179.674 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.77 162.1 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -99.83 137.08 38.8 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.225 0.953 . . . . 0.0 110.77 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 p -123.06 167.58 13.46 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.834 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -119.71 -40.36 2.77 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 110.472 -3.058 . . . . 0.0 105.756 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.428 ' H ' ' HB2' ' A' ' 12' ' ' GLN . 21.9 m80 -128.34 177.69 6.78 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.902 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.9 t -84.2 19.26 1.88 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.961 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.29 -49.17 0.37 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 103.639 -3.784 . . . . 0.0 103.639 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.428 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -51.35 -24.16 4.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.905 -1.647 . . . . 0.0 109.882 179.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 25.4 t -98.96 -38.5 8.97 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 112.888 -1.96 . . . . 0.0 111.013 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.428 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.8 tt -57.34 -43.93 83.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.688 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -60.05 -55.62 43.62 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-O 118.137 -0.935 . . . . 0.0 112.942 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -67.38 -35.63 23.12 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.739 1.626 . . . . 0.0 109.97 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.695 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 19.2 m -56.73 -64.76 0.77 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -47.59 81.72 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.017 0.823 . . . . 0.0 109.665 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.0 -23.19 53.04 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 126.098 2.124 . . . . 0.0 112.022 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.14 -5.32 33.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.057 0.848 . . . . 0.0 110.758 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.79 38.87 1.02 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.422 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 11.1 mmm -127.13 -162.36 1.15 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -116.67 -64.67 1.28 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.85 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -124.66 179.4 4.99 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.499 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -127.75 160.74 21.75 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 112.701 -2.045 . . . . 0.0 113.56 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.444 ' HE3' ' H ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -156.24 135.84 12.45 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.444 ' H ' ' HE3' ' A' ' 26' ' ' LYS . 11.0 t -99.28 141.24 32.31 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 105.518 -2.031 . . . . 0.0 105.518 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.2 mt -115.21 -79.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.35 35.69 3.34 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 124.486 1.116 . . . . 0.0 111.343 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.63 -22.15 39.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -100.71 166.82 10.69 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.695 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.4 t -88.28 147.68 24.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.419 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 37.3 t70 -131.02 132.35 44.92 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.9 m -109.48 166.16 11.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.62 1.1 . . . . 0.0 113.675 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.9 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.646 179.823 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.6 t30 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.18 164.96 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HZ3' ' HB2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -99.62 145.97 26.98 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 124.875 1.359 . . . . 0.0 108.535 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 p -126.15 168.38 14.11 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.193 -1.821 . . . . 0.0 113.846 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -121.31 -43.07 2.43 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 110.047 -3.251 . . . . 0.0 105.554 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -131.72 179.2 6.21 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.545 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.3 m -89.44 34.61 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.977 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.77 -51.28 0.18 Allowed Glycine 0 N--CA 1.494 2.545 1 N-CA-C 102.998 -4.041 . . . . 0.0 102.998 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -23.04 1.9 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 112.668 -1.766 . . . . 0.0 109.934 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 39.4 t -98.7 -44.2 6.51 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.399 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.512 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.6 tt -54.3 -45.09 72.48 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.585 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.04 -56.86 31.31 Favored Pre-proline 0 C--N 1.306 -1.324 0 O-C-N 124.294 0.997 . . . . 0.0 113.032 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -67.62 -33.33 28.59 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.973 1.782 . . . . 0.0 110.418 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 16.9 m -59.58 -64.05 1.08 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -56.95 -47.78 79.87 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.238 0.961 . . . . 0.0 108.975 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -58.1 -24.53 59.02 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 126.119 2.137 . . . . 0.0 111.944 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.3 -2.36 39.65 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 124.039 0.837 . . . . 0.0 110.842 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.2 40.32 1.17 Allowed Glycine 0 N--CA 1.483 1.794 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.439 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 14.8 mmm -128.44 -163.02 1.24 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -114.56 -66.1 1.12 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.452 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -125.79 177.74 6.11 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.613 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.512 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -142.38 145.01 14.85 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 112.634 -2.076 . . . . 0.0 114.624 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 25' ' ' GLY . 12.6 mptt -138.51 153.47 48.77 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.5 t -99.97 132.41 45.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.24 -73.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -110.15 34.1 4.08 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.046 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.88 -25.16 29.36 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -100.92 168.11 9.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 21.3 t -86.77 145.58 26.58 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.465 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 36.6 t70 -131.59 136.46 47.81 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.3 m -108.56 166.94 10.4 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.872 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.486 1.335 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.831 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.88 165.37 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -99.86 140.58 33.86 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 124.556 1.16 . . . . 0.0 109.471 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 p -124.7 168.26 13.43 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.023 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -120.24 -43.92 2.51 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 109.977 -3.283 . . . . 0.0 104.96 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.412 ' C ' ' H ' ' A' ' 11' ' ' GLY . 43.1 m170 -128.06 177.26 7.01 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 124.968 1.417 . . . . 0.0 111.476 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.4 t -84.74 23.07 1.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.295 -1.775 . . . . 0.0 108.81 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.15 -49.89 0.29 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 103.475 -3.85 . . . . 0.0 103.475 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 -24.96 3.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 112.869 -1.666 . . . . 0.0 109.835 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 21.7 t -98.07 -38.79 9.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 112.578 -2.101 . . . . 0.0 111.748 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.438 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.7 tt -56.44 -44.55 80.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.78 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -59.76 -56.5 35.12 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 124.102 0.876 . . . . 0.0 112.611 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.61 -34.01 26.67 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.808 1.672 . . . . 0.0 110.32 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 9.9 m -59.01 -63.65 1.23 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.19 -47.67 80.68 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 124.088 0.868 . . . . 0.0 109.16 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.76 -25.32 60.29 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 125.976 2.048 . . . . 0.0 111.33 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.15 -1.94 41.06 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 123.876 0.735 . . . . 0.0 111.422 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.75 38.42 1.18 Allowed Glycine 0 N--CA 1.481 1.682 0 N-CA-C 116.929 1.531 . . . . 0.0 116.929 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.45 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 27.3 mmt -125.98 -164.34 1.31 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -114.29 -62.99 1.52 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -127.25 179.69 5.32 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 123.887 0.742 . . . . 0.0 110.734 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.438 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -128.24 156.75 20.98 Favored Glycine 0 C--O 1.216 -1.013 0 CA-C-N 113.064 -1.88 . . . . 0.0 114.295 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -149.25 138.1 21.19 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -99.43 132.95 44.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.2 mt -112.08 -74.15 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -110.08 35.22 3.48 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.905 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.79 -22.84 38.74 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 107.356 -2.298 . . . . 0.0 107.356 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 32' ' ' CYS . 19.8 ttpp -99.94 168.35 9.92 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 43.1 t -86.37 146.19 26.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.528 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 36.6 t70 -130.85 141.37 50.32 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 22' ' ' MET . 33.6 m -115.12 162.56 16.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 119.147 0.885 . . . . 0.0 112.076 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.5 m . . . . . 0 N--CA 1.487 1.423 0 CA-C-N 113.967 -1.47 . . . . 0.0 108.128 179.849 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.8 t30 . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.5 165.45 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -99.78 138.51 36.77 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 124.427 1.08 . . . . 0.0 109.906 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 p -121.86 167.45 13.02 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 112.693 -2.049 . . . . 0.0 112.212 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -117.87 -41.61 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.47 -3.059 . . . . 0.0 105.275 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' ' 11' ' ' GLY . 82.7 m-70 -131.8 177.2 7.71 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.985 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.3 m -86.58 26.63 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.17 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.12 -51.26 0.27 Allowed Glycine 0 N--CA 1.495 2.61 1 N-CA-C 102.636 -4.186 . . . . 0.0 102.636 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -24.07 3.73 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.623 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 14.9 t -98.19 -36.97 9.88 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.442 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.41 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.5 tt -57.62 -44.7 85.73 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.863 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.08 -54.37 54.63 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.245 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -67.01 -35.67 24.93 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.576 1.518 . . . . 0.0 110.335 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.625 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 6.5 m -57.62 -63.18 1.32 Allowed 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.37 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.8 -47.84 81.44 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 124.077 0.86 . . . . 0.0 109.365 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.49 -23.16 57.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 125.925 2.016 . . . . 0.0 112.048 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.33 -4.61 34.63 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 124.023 0.827 . . . . 0.0 110.521 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.25 39.94 1.0 Allowed Glycine 0 N--CA 1.483 1.786 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.422 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 19.2 mmm -128.27 -164.01 1.33 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -111.43 -65.87 1.13 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.444 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -127.09 -178.93 4.61 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 123.838 0.711 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.41 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -123.83 157.47 18.25 Favored Glycine 0 C--O 1.216 -1.003 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.846 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -150.7 133.46 15.83 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.1 t -99.43 140.33 33.76 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.55 -82.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -110.24 34.73 3.74 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.192 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.63 -23.41 31.42 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -101.04 165.6 11.23 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.625 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 39.4 t -88.52 150.12 23.26 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.521 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 31.5 t70 -134.46 143.4 47.5 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.7 m -112.91 166.28 11.54 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.682 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.5 m . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.712 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.1 t30 . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.52 162.96 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -99.78 140.06 34.54 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 124.608 1.192 . . . . 0.0 110.549 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.6 p -121.64 167.84 12.45 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.459 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.494 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 7.2 mmpt? -118.78 -42.66 2.71 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.3 -3.137 . . . . 0.0 104.463 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.407 ' C ' ' H ' ' A' ' 11' ' ' GLY . 26.7 m80 -128.41 176.19 7.91 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.179 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.1 m -87.49 25.75 1.38 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.922 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.82 -49.92 0.33 Allowed Glycine 0 N--CA 1.493 2.488 1 N-CA-C 102.353 -4.299 . . . . 0.0 102.353 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -23.83 4.55 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 113.18 -1.51 . . . . 0.0 109.587 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 26.3 t -97.45 -38.57 9.55 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 112.918 -1.946 . . . . 0.0 111.047 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.44 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.6 tt -59.54 -41.88 91.06 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.123 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -58.21 -58.92 15.32 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-O 117.871 -1.061 . . . . 0.0 111.301 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -68.42 -39.08 10.25 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.185 1.923 . . . . 0.0 111.055 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.712 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 14.4 m -55.39 -58.39 7.93 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -56.36 -52.77 63.35 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.385 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -62.45 -17.88 60.45 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 126.037 2.086 . . . . 0.0 112.303 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.46 -5.67 31.96 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 124.056 0.847 . . . . 0.0 109.659 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.76 37.21 1.31 Allowed Glycine 0 N--CA 1.481 1.665 0 N-CA-C 116.596 1.399 . . . . 0.0 116.596 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 14.3 mmm -127.32 -164.81 1.39 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -112.3 -64.54 1.28 Allowed 'General case' 0 C--N 1.309 -1.169 0 O-C-N 123.993 0.808 . . . . 0.0 110.389 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -124.35 -179.68 4.56 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.088 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.17 153.99 20.09 Favored Glycine 0 C--O 1.216 -0.98 0 CA-C-N 113.218 -1.81 . . . . 0.0 114.43 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -144.39 135.99 25.76 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -99.69 136.38 39.7 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 103.679 -2.711 . . . . 0.0 103.679 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.2 mm -113.26 -81.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 116.917 2.192 . . . . 0.0 116.917 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.22 34.38 3.93 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.426 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.27 -22.77 33.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -102.25 166.98 10.28 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.629 0.841 . . . . 0.0 109.269 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.712 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 37.3 t -90.09 148.78 22.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.459 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 39.2 t70 -132.63 137.12 46.9 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.0 m -108.74 162.77 13.86 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 119.796 1.18 . . . . 0.0 112.517 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.486 1.34 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.363 179.762 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.4 t30 . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 6' ' ' LYS . 44.2 t -126.72 166.51 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' N ' HG12 ' A' ' 5' ' ' VAL . 35.3 ttmt -99.96 138.01 37.63 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 124.841 1.338 . . . . 0.0 108.993 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 p -123.22 164.36 18.88 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.497 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 10.2 mmpt? -115.61 -41.11 3.28 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 111.168 -2.742 . . . . 0.0 104.108 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -126.1 175.31 7.84 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.308 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.1 p -91.37 24.73 2.84 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.525 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 13' ' ' CYS . . . -121.68 -43.02 0.43 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 105.63 -2.988 . . . . 0.0 105.63 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -74.4 5.4 4.67 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.28 -0.96 . . . . 0.0 109.762 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 14.3 t -114.53 -38.26 4.08 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 113.218 -1.81 . . . . 0.0 106.381 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tt -63.61 -39.36 94.18 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.748 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.493 ' N ' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -55.75 -61.51 6.17 Favored Pre-proline 0 N--CA 1.48 1.053 0 O-C-N 124.028 0.83 . . . . 0.0 109.594 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -66.96 -37.02 20.65 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.982 1.788 . . . . 0.0 110.634 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 7.7 m -55.54 -64.73 0.75 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.319 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -45.63 91.86 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.339 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.41 -22.66 54.89 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 125.504 1.753 . . . . 0.0 111.749 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.08 -6.67 31.23 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 123.994 0.809 . . . . 0.0 110.64 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.3 40.46 0.8 Allowed Glycine 0 N--CA 1.479 1.506 0 N-CA-C 116.466 1.347 . . . . 0.0 116.466 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.415 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 15.0 mmm -127.62 -166.01 1.55 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -111.27 -64.16 1.32 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.825 0.703 . . . . 0.0 109.531 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.34 179.91 4.89 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.934 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -124.57 154.32 17.97 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-N 113.166 -1.834 . . . . 0.0 114.748 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.23 134.46 15.09 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.4 t -99.52 139.63 34.89 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.27 -79.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 116.879 2.178 . . . . 0.0 116.879 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.16 34.61 3.8 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.47 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.97 -22.56 37.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -100.22 165.82 11.3 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 44.2 t -90.15 151.09 21.74 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.479 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.456 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.4 t70 -133.46 146.98 51.64 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.4 m -117.94 162.39 18.22 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.681 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.0 m . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.772 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.66 163.95 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.41 145.61 28.7 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 124.526 1.141 . . . . 0.0 110.266 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.3 p -128.38 167.21 17.31 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.808 -1.996 . . . . 0.0 112.991 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -121.17 -42.74 2.46 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 110.097 -3.228 . . . . 0.0 104.928 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.423 ' C ' ' H ' ' A' ' 11' ' ' GLY . 22.5 m80 -128.55 176.31 7.86 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.667 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.1 m -87.9 28.76 0.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.088 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.94 -50.93 0.26 Allowed Glycine 0 N--CA 1.495 2.567 1 N-CA-C 102.075 -4.41 . . . . 0.0 102.075 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.58 -25.93 1.96 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 113.239 -1.48 . . . . 0.0 109.384 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 31.0 t -96.75 -38.83 9.73 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.469 -2.15 . . . . 0.0 111.094 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.441 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -56.84 -45.64 82.24 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.514 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -57.65 -59.58 12.57 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.42 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.12 -33.39 40.71 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.428 1.419 . . . . 0.0 109.417 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.696 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.8 m -58.18 -64.29 0.97 Allowed 'General case' 0 C--N 1.307 -1.239 0 O-C-N 123.739 0.649 . . . . 0.0 109.932 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.515 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -57.97 -45.36 86.84 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.121 0.888 . . . . 0.0 109.553 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.515 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 40.4 m-20 -64.74 -18.53 65.13 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 125.59 1.806 . . . . 0.0 112.092 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.14 -3.89 36.79 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.24 41.08 1.31 Allowed Glycine 0 N--CA 1.483 1.811 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.423 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 13.1 mmm -128.49 -163.51 1.29 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -113.51 -64.12 1.35 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.611 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -125.79 179.15 5.32 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.469 0.652 . . . . 0.0 111.506 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.441 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -130.01 150.86 19.2 Favored Glycine 0 C--O 1.215 -1.076 0 CA-C-N 113.152 -1.84 . . . . 0.0 114.737 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -143.49 138.36 29.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.4 t -99.89 133.5 44.17 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.3 mm -114.33 -77.45 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -110.26 34.94 3.62 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.855 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.05 -19.69 52.04 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 32' ' ' CYS . 19.2 ttpp -106.41 168.54 9.09 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.696 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 35.0 t -88.28 149.7 23.66 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.507 -1.224 . . . . 0.0 114.186 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -134.94 123.61 23.65 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -99.94 162.18 13.15 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.153 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.488 1.441 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.144 179.893 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -126.92 165.56 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -99.88 147.58 25.38 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 124.595 1.184 . . . . 0.0 110.499 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p -127.67 168.14 15.46 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 112.547 -2.115 . . . . 0.0 113.114 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -119.95 -43.04 2.57 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 110.098 -3.228 . . . . 0.0 105.003 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.431 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.5 m-70 -132.88 176.88 8.09 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.536 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -85.63 28.89 0.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.455 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.37 -50.62 0.28 Allowed Glycine 0 N--CA 1.495 2.61 1 N-CA-C 102.551 -4.219 . . . . 0.0 102.551 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -25.68 3.87 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 112.962 -1.619 . . . . 0.0 109.593 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 25.7 t -97.01 -39.27 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 112.691 -2.05 . . . . 0.0 111.29 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.433 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.2 tt -57.28 -43.65 83.31 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.545 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -58.89 -57.45 26.87 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.605 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -68.09 -34.41 22.65 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.199 1.933 . . . . 0.0 109.985 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 14.8 m -58.06 -63.99 1.07 Allowed 'General case' 0 C--N 1.31 -1.127 0 O-C-N 123.837 0.711 . . . . 0.0 109.398 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -57.78 -47.3 82.93 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.265 0.978 . . . . 0.0 109.231 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -57.82 -24.37 57.05 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 126.02 2.075 . . . . 0.0 111.597 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.25 -3.41 37.46 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.137 0.898 . . . . 0.0 110.929 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.0 38.44 1.15 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.474 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.7 mmt -124.44 -164.71 1.29 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -115.43 -62.0 1.66 Allowed 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -126.92 179.44 5.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 123.883 0.739 . . . . 0.0 111.223 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.33 154.86 20.53 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-N 113.136 -1.847 . . . . 0.0 114.41 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -144.65 137.2 26.48 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -99.78 130.85 46.02 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.28 -78.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.23 34.53 3.85 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.831 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.46 -19.2 53.64 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 32' ' ' CYS . 18.4 ttpp -107.0 169.55 8.48 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 38.3 t -90.19 148.27 23.05 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.421 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 65.5 t0 -133.84 135.06 43.51 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.1 m -109.87 163.16 13.8 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 119.851 1.205 . . . . 0.0 113.421 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 N--CA 1.488 1.434 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.689 179.79 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.12 165.65 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -99.8 142.17 31.64 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 124.602 1.189 . . . . 0.0 109.027 -179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 p -123.59 166.53 15.31 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 112.43 -2.168 . . . . 0.0 112.041 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -121.79 -40.54 2.53 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 110.359 -3.109 . . . . 0.0 106.034 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.417 ' C ' ' H ' ' A' ' 11' ' ' GLY . 85.6 m-70 -134.13 179.82 6.02 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.05 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 t -84.71 29.42 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.167 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -125.93 -50.86 0.18 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 103.768 -3.733 . . . . 0.0 103.768 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -48.52 -24.87 1.44 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 112.958 -1.621 . . . . 0.0 110.069 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 33' ' ' ASP . 40.9 t -97.01 -42.05 8.08 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.64 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.51 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.6 tt -55.51 -45.89 77.06 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.394 0.677 . . . . 0.0 112.395 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -56.77 -58.92 14.23 Favored Pre-proline 0 C--N 1.309 -1.17 0 O-C-N 123.888 0.743 . . . . 0.0 112.379 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -68.25 -33.03 25.36 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.992 1.794 . . . . 0.0 110.458 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.6 m -59.87 -65.16 0.72 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.71 0.631 . . . . 0.0 109.305 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.499 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -56.56 -45.2 81.41 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.425 1.078 . . . . 0.0 108.952 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.499 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 52.8 t0 -60.85 -24.77 66.15 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 125.934 2.021 . . . . 0.0 110.752 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 -0.01 45.54 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.582 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.48 39.32 1.49 Allowed Glycine 0 N--CA 1.484 1.878 0 N-CA-C 116.691 1.436 . . . . 0.0 116.691 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.467 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.6 mmt -124.49 -163.74 1.19 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -118.49 -60.96 1.72 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.16 176.54 6.98 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.37 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -139.37 145.16 16.2 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.818 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HD2' ' C ' ' A' ' 25' ' ' GLY . 12.7 mptt -139.65 149.21 43.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.5 t -99.83 137.82 37.76 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.3 mt -115.12 -78.49 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -110.29 35.0 3.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.368 1.043 . . . . 0.0 111.282 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.3 -23.21 35.08 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -103.97 163.21 12.52 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 124.397 0.704 . . . . 0.0 109.151 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 25.3 t -82.14 148.46 28.49 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.346 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.416 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 36.8 t70 -131.94 129.22 39.95 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.4 m -106.84 164.15 12.35 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.977 1.262 . . . . 0.0 113.493 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.488 1.454 0 CA-C-N 113.329 -1.759 . . . . 0.0 108.942 179.827 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.8 t30 . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.57 164.83 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.441 ' C ' ' HD3' ' A' ' 6' ' ' LYS . 1.6 tmtm? -99.76 144.04 29.29 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 124.515 1.135 . . . . 0.0 109.783 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.4 p -125.09 167.41 14.82 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.613 -2.085 . . . . 0.0 112.898 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -119.43 -41.95 2.68 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 110.163 -3.199 . . . . 0.0 105.21 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.422 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.1 m-70 -132.23 176.2 8.6 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.521 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.7 p -85.37 26.42 0.91 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.564 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -119.39 -51.27 0.29 Allowed Glycine 0 N--CA 1.494 2.556 1 N-CA-C 102.832 -4.107 . . . . 0.0 102.832 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.66 -27.84 2.11 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.234 -1.483 . . . . 0.0 109.479 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 23.6 t -96.04 -35.84 11.24 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.116 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tt -59.24 -44.99 92.33 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.431 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 5.7 mptp? -56.1 -57.57 21.57 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.146 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 94.6 Cg_endo -68.35 -37.48 13.54 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.353 2.035 . . . . 0.0 111.845 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 7.4 m -57.78 -59.11 5.72 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -53.37 -54.65 33.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.585 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.18 -23.19 54.59 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 126.701 2.5 . . . . 0.0 112.402 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.38 -2.51 39.04 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 124.159 0.912 . . . . 0.0 111.282 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.84 38.31 1.44 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.442 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.1 mmt -123.82 -165.74 1.39 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -112.88 -62.86 1.52 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.45 -179.87 4.97 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.036 0.835 . . . . 0.0 110.433 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.13 157.04 16.14 Favored Glycine 0 C--O 1.216 -1.011 0 CA-C-N 113.147 -1.842 . . . . 0.0 113.53 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -149.46 132.77 16.5 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.2 t -99.5 132.28 44.93 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.0 mt -112.59 -78.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.37 34.91 3.66 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.364 1.04 . . . . 0.0 111.708 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.77 -17.05 58.85 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -105.01 168.22 9.2 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 43.2 t -90.75 147.62 23.11 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.535 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 13.3 t70 -132.29 144.01 50.29 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 22' ' ' MET . 29.8 m -114.5 160.39 19.28 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.449 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.0 m . . . . . 0 N--CA 1.488 1.446 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.172 179.792 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.73 165.5 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.93 143.31 30.3 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.256 1.027 . . . . 0.0 110.276 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 p -126.71 166.46 17.34 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 112.37 -2.196 . . . . 0.0 112.705 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -120.08 -40.68 2.7 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 110.44 -3.073 . . . . 0.0 105.847 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 11' ' ' GLY . 84.2 m-70 -131.87 178.5 6.72 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.386 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.4 m -85.1 23.14 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.329 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.34 -50.32 0.34 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 103.272 -3.931 . . . . 0.0 103.272 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.411 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -48.76 -25.79 2.02 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.3 -1.45 . . . . 0.0 109.595 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 34.6 t -97.28 -37.44 10.06 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 112.335 -2.211 . . . . 0.0 111.551 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.43 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -58.67 -43.98 90.06 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.063 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.403 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 2.1 mptm? -56.95 -58.2 19.3 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-O 118.24 -0.886 . . . . 0.0 112.036 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 91.2 Cg_endo -67.83 -36.61 17.89 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.396 2.064 . . . . 0.0 111.376 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 19.1 m -58.3 -60.54 3.62 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -52.26 -54.69 28.01 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.055 -1.43 . . . . 0.0 108.63 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.34 -23.11 55.73 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 126.954 2.659 . . . . 0.0 112.665 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.21 -2.37 39.88 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.131 0.894 . . . . 0.0 110.82 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.34 39.87 1.58 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 116.005 1.162 . . . . 0.0 116.005 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.4 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 12.4 mmm -126.73 -165.24 1.43 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -111.65 -67.42 1.0 Allowed 'General case' 0 C--N 1.31 -1.143 0 O-C-N 123.98 0.8 . . . . 0.0 109.474 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -123.47 179.53 4.71 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.739 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.43 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.77 156.27 20.02 Favored Glycine 0 C--O 1.215 -1.079 0 CA-C-N 112.918 -1.947 . . . . 0.0 114.099 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -151.4 138.32 19.02 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.3 t -99.6 138.71 36.3 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.2 mt -116.12 -79.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -110.38 35.34 3.48 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.413 1.07 . . . . 0.0 111.859 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.39 -22.08 38.9 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -103.93 166.36 10.46 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.594 0.82 . . . . 0.0 108.831 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 32.4 t -85.79 149.13 25.48 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.479 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 37.1 t70 -132.34 134.8 45.63 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.3 m -108.45 163.61 13.06 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 119.726 1.148 . . . . 0.0 112.537 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.838 179.856 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.2 t30 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.06 163.14 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -102.27 141.19 35.5 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 124.517 1.135 . . . . 0.0 109.711 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 p -118.52 168.73 10.4 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.064 -1.88 . . . . 0.0 112.938 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -118.17 -42.52 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 110.001 -3.272 . . . . 0.0 104.896 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.438 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.6 m-70 -132.9 175.7 9.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.627 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.0 m -85.6 28.9 0.73 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.255 -1.338 . . . . 0.0 109.296 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -121.28 -49.95 0.26 Allowed Glycine 0 N--CA 1.495 2.597 1 N-CA-C 102.916 -4.074 . . . . 0.0 102.916 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -23.07 4.88 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.109 -1.545 . . . . 0.0 109.753 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 33.8 t -97.72 -37.69 9.79 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 112.997 -1.911 . . . . 0.0 110.863 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.485 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.3 tt -59.21 -42.56 91.25 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.23 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -58.67 -57.17 28.65 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.251 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.9 -37.12 11.9 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.567 2.178 . . . . 0.0 111.855 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.692 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 12.8 m -58.82 -58.6 7.91 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -53.28 -54.81 30.88 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.242 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -57.81 -23.77 54.14 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 126.809 2.568 . . . . 0.0 112.34 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.38 -1.3 41.89 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 124.078 0.861 . . . . 0.0 111.301 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.12 38.61 1.65 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.447 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.6 mmt -124.25 -165.44 1.37 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -113.44 -62.7 1.55 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -126.25 178.57 5.74 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.045 0.84 . . . . 0.0 110.84 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.485 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -127.98 145.28 15.86 Favored Glycine 0 C--O 1.215 -1.083 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.571 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.22 136.58 45.69 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.8 t -99.6 132.29 45.04 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.1 mm -109.72 -83.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.35 33.94 4.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.439 1.087 . . . . 0.0 111.436 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.36 -19.08 46.65 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.015 -2.434 . . . . 0.0 107.015 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -103.01 165.42 11.03 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.757 0.916 . . . . 0.0 109.708 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.692 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 36.7 t -92.74 145.76 24.17 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.454 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 38.5 t70 -131.57 141.41 49.68 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.6 m -110.48 159.91 17.09 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 119.822 1.192 . . . . 0.0 112.553 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.2 m . . . . . 0 N--CA 1.489 1.495 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.476 179.88 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -126.87 158.26 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 8.0 mtpm? -102.89 133.85 47.28 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 124.503 1.127 . . . . 0.0 110.764 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 p -126.57 166.66 16.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.613 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -117.98 -35.63 3.82 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 111.659 -2.519 . . . . 0.0 105.705 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -123.56 173.32 8.13 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.07 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.6 p -91.26 35.22 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.059 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.57 -47.92 0.24 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 105.405 -3.078 . . . . 0.0 105.405 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -61.94 -8.41 5.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.618 1.567 . . . . 0.0 111.116 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 37.4 t -106.51 -41.76 5.19 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.671 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.48 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.8 tt -58.28 -41.09 83.61 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.995 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -62.81 -57.09 23.54 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-O 118.128 -0.939 . . . . 0.0 112.138 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -67.68 -32.59 30.1 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.467 2.111 . . . . 0.0 110.99 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.5 m -61.4 -60.71 3.31 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -51.28 -54.97 20.89 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.792 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -58.3 -23.75 57.36 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 127.09 2.744 . . . . 0.0 112.769 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.22 0.11 45.17 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 124.011 0.819 . . . . 0.0 110.833 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.53 40.57 2.02 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.401 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 12.6 mmm -127.15 -165.5 1.48 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -112.96 -65.51 1.18 Allowed 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.982 0.801 . . . . 0.0 109.16 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -123.83 -179.77 4.51 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.662 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.48 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -134.54 152.39 20.65 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-N 113.246 -1.797 . . . . 0.0 114.377 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -148.47 140.26 23.76 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -99.62 142.19 31.44 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 105.15 -2.166 . . . . 0.0 105.15 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.1 mm -115.11 -78.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.27 35.27 3.49 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.45 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.53 -24.51 29.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.223 -2.351 . . . . 0.0 107.223 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -99.95 167.92 10.19 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 124.761 0.918 . . . . 0.0 109.294 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 32.0 t -89.69 151.09 22.04 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -136.75 124.87 22.97 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.8 m -99.8 164.9 11.83 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 118.981 0.81 . . . . 0.0 112.367 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.7 m . . . . . 0 N--CA 1.487 1.418 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.075 179.874 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.5 t30 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.57 164.54 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -99.74 137.94 37.51 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 124.583 1.177 . . . . 0.0 110.432 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 p -121.7 167.88 12.44 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 112.387 -2.188 . . . . 0.0 111.778 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -120.18 -40.35 2.72 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 110.387 -3.097 . . . . 0.0 105.643 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.421 ' H ' ' HB2' ' A' ' 12' ' ' GLN . 20.3 m80 -128.89 177.9 6.77 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.946 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.5 t -85.8 21.99 1.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 113.24 -1.8 . . . . 0.0 108.758 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.91 -49.07 0.29 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 103.571 -3.812 . . . . 0.0 103.571 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.421 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -52.13 -21.99 3.8 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 113.004 -1.598 . . . . 0.0 110.067 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 32.8 t -99.95 -38.9 8.41 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 112.98 -1.918 . . . . 0.0 110.939 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.484 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.9 tt -58.98 -38.42 79.1 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.776 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.97 -56.67 22.91 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.997 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.14 -31.8 35.51 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.137 1.891 . . . . 0.0 110.824 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.5 m -62.26 -58.22 8.55 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HZ2' ' HB3' ' A' ' 18' ' ' LYS . 2.3 mmmp? -48.89 -57.51 6.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.617 1.198 . . . . 0.0 108.171 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -55.62 -27.17 48.11 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 128.186 3.429 . . . . 0.0 112.455 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 1.97 48.45 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 124.264 0.978 . . . . 0.0 111.458 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.86 43.72 2.05 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 115.241 0.856 . . . . 0.0 115.241 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.425 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 27.0 mmt -124.85 -166.57 1.54 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 116.972 0.386 . . . . 0.0 109.974 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -113.87 -62.94 1.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.19 177.27 6.79 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.971 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -132.01 150.91 19.68 Favored Glycine 0 C--O 1.216 -0.986 0 CA-C-N 112.504 -2.135 . . . . 0.0 112.98 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -146.98 140.93 25.94 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.64 141.08 32.91 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.96 -81.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -110.32 34.41 3.93 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.226 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.56 -24.15 29.48 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.401 -2.279 . . . . 0.0 107.401 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -100.7 165.65 11.28 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.694 0.879 . . . . 0.0 109.157 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 25.7 t -89.48 149.6 22.85 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.44 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.6 t70 -133.11 134.75 44.66 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.4 m -110.46 163.82 13.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 119.079 0.854 . . . . 0.0 111.489 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.49 1.541 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.639 179.812 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.4 t30 . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.21 166.06 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -100.47 140.71 34.33 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 124.906 1.379 . . . . 0.0 108.638 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.3 p -125.27 166.83 15.81 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 113.266 -1.788 . . . . 0.0 112.532 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -120.97 -40.95 2.57 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 110.635 -2.984 . . . . 0.0 104.973 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -124.11 175.02 7.26 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.546 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.1 p -94.67 34.14 1.37 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.552 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 13' ' ' CYS . . . -126.7 -44.69 0.24 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -73.17 7.51 2.12 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.95 1.3 . . . . 0.0 110.604 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 37.6 t -114.19 -41.04 3.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.117 -1.856 . . . . 0.0 106.204 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.493 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 7.6 tt -61.94 -35.45 78.47 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.794 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -66.82 -56.23 14.87 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.815 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.13 -31.96 44.15 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.047 1.831 . . . . 0.0 111.327 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.6 m -63.51 -56.3 17.14 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -48.67 -58.69 4.37 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -56.09 -25.84 47.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 128.245 3.466 . . . . 0.0 113.241 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.12 1.67 47.79 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 124.522 1.139 . . . . 0.0 111.133 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.96 43.08 2.3 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 115.166 0.826 . . . . 0.0 115.166 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.403 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 21.5 mmm -128.57 -167.32 1.75 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -112.85 -66.46 1.08 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.066 0.854 . . . . 0.0 109.442 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -121.27 179.26 4.47 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.987 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.493 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -137.59 148.12 19.64 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-N 112.81 -1.995 . . . . 0.0 114.676 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.405 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -147.36 148.79 31.72 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -99.58 140.12 34.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.22 -77.65 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.37 33.72 4.33 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.656 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.57 -21.88 40.87 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -102.62 165.41 11.09 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 15.6 t -90.16 148.36 23.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.511 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 29.0 t70 -131.18 146.41 52.32 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 103.366 -2.828 . . . . 0.0 103.366 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.5 m -111.6 173.75 6.2 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.685 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.8 m . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.827 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 6' ' ' LYS . 46.3 t -131.52 165.71 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' N ' HG12 ' A' ' 5' ' ' VAL . 38.3 mtpt -103.6 140.86 36.98 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 125.016 1.448 . . . . 0.0 108.956 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 p -122.98 166.4 15.14 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.485 -1.689 . . . . 0.0 112.511 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -40.5 2.91 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 110.764 -2.925 . . . . 0.0 105.775 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -131.87 179.59 5.99 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.67 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.0 t -86.69 28.91 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.188 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.87 -51.16 0.19 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 103.294 -3.922 . . . . 0.0 103.294 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -22.6 2.03 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.506 -1.847 . . . . 0.0 110.077 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 44.3 t -99.24 -43.23 6.69 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.937 -1.938 . . . . 0.0 111.478 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.508 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.3 tt -53.73 -43.97 69.5 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.859 0.863 . . . . 0.0 112.329 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -61.46 -56.51 32.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 124.189 0.931 . . . . 0.0 112.707 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -67.57 -31.3 33.75 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.837 1.691 . . . . 0.0 110.323 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 9.2 m -61.44 -63.52 1.25 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -56.52 -47.82 78.53 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -59.03 -23.77 62.25 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 126.126 2.142 . . . . 0.0 111.486 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.91 -1.19 43.49 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 123.703 0.627 . . . . 0.0 110.391 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.67 40.8 1.54 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 116.112 1.205 . . . . 0.0 116.112 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.409 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 14.8 mmm -128.22 -164.04 1.34 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.3 mtm180 -111.57 -66.53 1.07 Allowed 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.14 178.86 5.33 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.234 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -140.6 149.0 20.63 Favored Glycine 0 C--O 1.215 -1.087 0 CA-C-N 113.101 -1.863 . . . . 0.0 114.502 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 21.5 ptmt -144.73 152.15 39.96 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -99.61 143.38 29.92 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.122 -1.431 . . . . 0.0 107.359 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.8 mm -114.68 -81.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.45 33.6 4.41 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.453 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.76 -22.57 35.13 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.103 -2.399 . . . . 0.0 107.103 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -99.97 163.81 12.28 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 11.4 t -90.44 150.78 21.69 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.557 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 32.5 t70 -135.01 144.23 47.24 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.9 m -112.37 167.48 10.4 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 119.317 0.962 . . . . 0.0 113.34 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.487 1.421 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.072 179.825 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.83 163.27 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.26 143.61 31.12 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 122.111 0.958 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.6 p -128.85 167.49 17.28 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 112.52 -2.127 . . . . 0.0 113.159 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -121.93 -42.64 2.38 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 110.216 -3.175 . . . . 0.0 105.272 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.0 m80 -127.13 177.37 6.7 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.293 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.2 m -88.64 28.16 1.18 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.902 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -121.22 -50.54 0.26 Allowed Glycine 0 N--CA 1.494 2.53 1 N-CA-C 102.504 -4.239 . . . . 0.0 102.504 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -24.96 2.05 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 113.053 -1.574 . . . . 0.0 109.523 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 35.6 t -97.58 -39.33 9.17 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 112.559 -2.109 . . . . 0.0 110.77 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.457 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -56.17 -45.3 79.77 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.198 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -58.05 -58.96 14.96 Favored Pre-proline 0 C--N 1.308 -1.196 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.829 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -66.97 -31.62 37.12 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.335 2.023 . . . . 0.0 110.888 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.748 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 32.8 m -61.38 -62.3 1.93 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -50.47 -54.42 22.28 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 113.82 -1.537 . . . . 0.0 107.997 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.19 -26.6 60.91 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 127.196 2.81 . . . . 0.0 112.072 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.08 2.19 48.43 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 124.004 0.815 . . . . 0.0 111.529 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.98 39.65 2.11 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.426 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 26.6 mmt -125.15 -164.27 1.27 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -117.43 -62.04 1.62 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.19 178.82 5.36 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.167 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.457 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -131.9 150.74 19.63 Favored Glycine 0 C--O 1.216 -1.023 0 CA-C-N 113.15 -1.841 . . . . 0.0 113.792 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -145.15 140.72 28.17 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t -99.89 139.38 35.64 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 mt -116.91 -78.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 117.171 2.285 . . . . 0.0 117.171 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.38 35.36 3.47 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.353 1.033 . . . . 0.0 111.945 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.05 -21.38 41.97 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -105.11 166.37 10.44 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.748 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 37.9 t -84.97 149.54 25.54 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.877 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -134.71 120.91 20.06 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.8 m -99.66 166.06 11.3 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.646 1.112 . . . . 0.0 113.044 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.6 m . . . . . 0 N--CA 1.488 1.469 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.495 179.86 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.65 164.0 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.471 ' C ' ' HD2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -99.96 139.38 35.71 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 124.732 1.27 . . . . 0.0 109.059 -179.723 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 p -123.36 166.75 14.8 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 112.616 -2.084 . . . . 0.0 111.525 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -42.79 2.21 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 110.513 -3.04 . . . . 0.0 103.953 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.405 ' C ' ' H ' ' A' ' 11' ' ' GLY . 18.7 m80 -124.32 179.0 5.08 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.081 0.944 . . . . 0.0 111.745 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.4 t -89.04 28.62 1.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.211 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -124.63 -50.59 0.2 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 103.301 -3.92 . . . . 0.0 103.301 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.95 -22.84 1.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.718 -1.741 . . . . 0.0 109.788 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 43.0 t -99.4 -43.89 6.39 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.493 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.5 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.4 tt -54.8 -44.09 73.49 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.616 0.766 . . . . 0.0 112.499 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -60.85 -56.44 35.02 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.877 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.53 -32.93 23.75 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.336 2.024 . . . . 0.0 111.287 178.535 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.728 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.1 m -61.07 -61.07 2.84 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -52.72 -52.79 54.77 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.888 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.82 -24.66 62.29 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 126.431 2.332 . . . . 0.0 111.817 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.28 1.71 47.45 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.077 0.861 . . . . 0.0 111.073 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.69 38.31 2.07 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 116.592 1.397 . . . . 0.0 116.592 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.421 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 25.7 mmt -125.64 -164.85 1.34 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -113.27 -63.78 1.4 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.75 178.37 5.73 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 123.954 0.784 . . . . 0.0 111.036 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.5 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -143.91 150.93 22.94 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-N 113.154 -1.839 . . . . 0.0 114.145 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.72 153.14 41.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.84 141.96 31.96 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.08 -78.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 116.509 2.041 . . . . 0.0 116.509 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -110.28 34.84 3.68 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 124.526 1.141 . . . . 0.0 111.223 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.6 -24.2 31.59 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -103.58 163.07 12.54 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.443 0.731 . . . . 0.0 109.138 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.728 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 12.7 t -84.13 146.97 27.59 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.9 t70 -129.8 130.48 45.38 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.4 m -103.8 161.22 14.13 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 119.745 1.157 . . . . 0.0 112.439 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.2 m . . . . . 0 N--CA 1.488 1.442 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.831 179.807 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.25 155.01 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -99.96 133.22 44.66 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 125.06 1.475 . . . . 0.0 111.226 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -123.61 167.13 14.35 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 112.458 -2.156 . . . . 0.0 111.959 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.466 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 6.9 mmpt? -117.79 -38.26 3.29 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 111.081 -2.781 . . . . 0.0 105.206 179.436 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -126.31 174.22 8.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.604 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -88.59 35.54 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.758 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.46 -50.63 0.21 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 104.531 -3.428 . . . . 0.0 104.531 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -56.15 -16.59 5.44 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 113.593 -1.304 . . . . 0.0 110.526 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.461 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 39.4 t -100.83 -41.31 6.91 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.255 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.428 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.9 tt -55.91 -46.13 78.51 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.023 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -57.93 -60.19 10.79 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.651 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -66.43 -32.75 39.65 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.102 1.868 . . . . 0.0 110.314 -177.664 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 33.5 m -59.84 -58.96 6.32 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -52.09 -56.0 17.19 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 124.888 1.367 . . . . 0.0 108.417 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -20.18 61.07 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 126.891 2.619 . . . . 0.0 113.268 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.3 -1.96 40.57 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 124.037 0.836 . . . . 0.0 109.841 179.557 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.93 38.19 2.06 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 115.735 1.054 . . . . 0.0 115.735 179.337 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.403 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 22.1 mmt -125.15 -165.71 1.44 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.21 -61.37 1.76 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.82 -178.21 4.2 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.195 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -131.05 154.17 20.68 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 112.267 -2.242 . . . . 0.0 113.361 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -151.83 136.13 16.75 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 t -99.74 143.06 30.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.6 -82.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.34 34.61 3.82 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.409 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.66 -20.99 40.09 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.082 -2.407 . . . . 0.0 107.082 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -100.02 166.61 10.96 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 36.4 t -91.6 150.95 20.93 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -137.01 124.04 21.54 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 28.5 m -99.75 176.5 5.43 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.466 1.03 . . . . 0.0 112.444 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.7 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-N 112.917 -1.947 . . . . 0.0 106.877 179.771 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.48 158.53 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -100.82 138.47 37.83 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.305 1.003 . . . . 0.0 111.131 -179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 p -126.85 167.28 16.02 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.595 -2.093 . . . . 0.0 112.328 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -118.35 -39.0 3.08 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 110.955 -2.839 . . . . 0.0 105.645 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -126.32 175.09 8.08 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.956 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.4 m -89.5 34.16 0.82 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.511 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.9 -48.38 0.25 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 104.959 -3.256 . . . . 0.0 104.959 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.86 -11.88 6.38 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 113.536 -1.332 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 38.7 t -103.24 -41.6 6.01 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.775 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.501 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.4 tt -57.31 -43.04 82.92 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.353 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -60.85 -57.23 27.97 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.203 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.29 -32.22 26.91 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.531 2.154 . . . . 0.0 111.065 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 22.4 m -61.54 -60.92 2.97 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.36 -54.51 30.91 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -57.75 -23.81 53.93 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 126.577 2.423 . . . . 0.0 112.601 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.25 0.76 46.32 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 124.098 0.874 . . . . 0.0 111.013 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.7 39.07 2.26 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.415 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 25.7 mmt -124.82 -165.95 1.46 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -112.36 -64.93 1.23 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -124.87 179.08 5.16 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.692 0.758 . . . . 0.0 110.62 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.501 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -132.92 149.56 19.6 Favored Glycine 0 C--O 1.216 -0.992 0 CA-C-N 112.802 -1.999 . . . . 0.0 113.252 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -144.25 141.63 29.96 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 104.47 -2.418 . . . . 0.0 104.47 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.3 t -99.65 141.03 32.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.6 mt -117.13 -78.45 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.26 35.58 3.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.57 1.169 . . . . 0.0 111.465 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.23 -23.35 34.69 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -101.93 167.82 9.81 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.75 0.912 . . . . 0.0 109.055 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.1 t -88.38 148.84 24.04 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.667 -1.151 . . . . 0.0 113.946 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -132.97 124.14 27.2 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.0 m -99.83 162.45 12.99 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 119.605 1.093 . . . . 0.0 111.946 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.489 1.496 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.536 179.891 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.2 t30 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.25 163.22 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -99.98 136.87 39.23 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 124.457 1.098 . . . . 0.0 111.609 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 p -122.0 167.12 13.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.73 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -118.8 -41.12 2.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 110.598 -3.001 . . . . 0.0 105.405 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -126.21 177.22 6.53 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.607 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.5 p -87.33 21.05 2.56 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.904 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.58 -48.93 0.4 Allowed Glycine 0 N--CA 1.495 2.567 1 N-CA-C 103.088 -4.005 . . . . 0.0 103.088 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -23.91 4.37 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 113.071 -1.565 . . . . 0.0 109.522 179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 23.1 t -98.42 -36.01 10.1 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.827 -1.988 . . . . 0.0 111.035 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.428 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.0 tt -59.14 -42.3 90.34 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.288 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -60.17 -55.84 41.34 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-O 117.796 -1.097 . . . . 0.0 112.538 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -68.49 -36.81 14.36 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.289 1.992 . . . . 0.0 111.374 178.156 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 15.6 m -58.45 -59.43 5.36 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -52.85 -54.77 29.66 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.37 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.47 -24.74 57.53 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 126.764 2.54 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.41 -0.72 43.07 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 124.167 0.917 . . . . 0.0 111.541 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.38 38.78 1.58 Allowed Glycine 0 N--CA 1.483 1.809 0 N-CA-C 116.831 1.493 . . . . 0.0 116.831 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.445 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.8 mmt -124.18 -165.62 1.39 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -114.09 -62.41 1.6 Allowed 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -126.28 179.59 5.2 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.048 0.842 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.57 158.1 20.54 Favored Glycine 0 C--O 1.217 -0.913 0 CA-C-N 113.001 -1.909 . . . . 0.0 113.247 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.38 137.03 15.17 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 102.138 -3.282 . . . . 0.0 102.138 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t -99.62 142.39 31.17 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 117.928 -1.509 . . . . 0.0 107.601 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 33' ' ' ASP . 33.0 mt -109.63 -85.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -179.361 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 28' ' ' ILE . 22.9 p30 -110.38 35.35 3.48 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.272 0.982 . . . . 0.0 111.329 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.22 -22.06 33.94 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 106.382 -2.687 . . . . 0.0 106.382 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -99.68 166.4 11.13 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 39.1 t -89.9 146.3 24.51 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -179.477 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.49 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 37.6 t70 -129.64 137.35 50.62 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 m -110.66 160.17 16.93 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.276 -0.969 . . . . 0.0 112.39 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 N--CA 1.488 1.434 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.409 179.791 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.92 161.27 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 8.7 mtpm? -99.98 139.0 36.28 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 122.213 1.006 . . . . 0.0 111.244 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.0 p -125.44 167.37 15.08 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.709 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -117.51 -38.76 3.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 110.884 -2.871 . . . . 0.0 105.342 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -129.61 175.48 8.77 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.653 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.5 t -85.46 34.52 0.58 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.08 -48.47 0.19 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 106.598 -2.601 . . . . 0.0 106.598 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -62.65 -7.59 5.07 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.753 -1.224 . . . . 0.0 110.864 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 35.4 t -105.85 -40.6 5.66 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.301 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.448 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.0 tt -57.46 -45.11 85.13 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.341 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -60.36 -56.15 38.18 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-O 117.995 -1.002 . . . . 0.0 112.846 -179.688 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -67.23 -34.7 26.91 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.694 1.596 . . . . 0.0 110.928 178.578 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 11.9 m -60.39 -63.97 1.11 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -56.3 -45.08 80.37 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.122 0.889 . . . . 0.0 109.347 -179.73 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 10.7 t70 -61.3 -25.19 66.95 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 125.832 1.958 . . . . 0.0 111.091 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.99 0.57 46.59 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 123.929 0.768 . . . . 0.0 110.858 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.35 39.43 1.36 Allowed Glycine 0 N--CA 1.483 1.81 0 N-CA-C 117.008 1.563 . . . . 0.0 117.008 179.144 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.442 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 26.1 mmt -126.14 -164.56 1.33 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.9 mtm180 -114.01 -64.59 1.29 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -126.07 179.95 4.99 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.384 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.448 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -128.27 153.47 19.51 Favored Glycine 0 C--O 1.216 -1.013 0 CA-C-N 113.05 -1.886 . . . . 0.0 113.576 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -145.52 137.69 25.59 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -99.31 138.83 35.86 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 179.644 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.3 mt -116.45 -79.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 117.667 2.469 . . . . 0.0 117.667 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.31 35.29 3.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.468 1.105 . . . . 0.0 111.36 -179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.36 -22.82 36.33 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 106.922 -2.471 . . . . 0.0 106.922 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -102.46 168.26 9.42 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.815 0.95 . . . . 0.0 109.064 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 35.2 t -90.43 147.57 23.34 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 12.1 t70 -131.04 141.55 50.22 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.434 ' SG ' ' HG3' ' A' ' 22' ' ' MET . 29.8 m -112.33 164.24 13.47 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 119.088 0.858 . . . . 0.0 112.315 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.3 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.781 179.82 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 34' ' ' CYS . 35.8 m . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.815 0.34 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -21.54 148.15 0.0 OUTLIER Glycine 0 N--CA 1.503 3.133 0 N-CA-C 119.478 2.551 . . . . 0.0 119.478 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.625 HG13 ' H ' ' A' ' 4' ' ' ASN . 14.6 pt -115.06 -103.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.625 ' H ' HG13 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -173.26 38.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.01 158.71 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -102.27 125.71 49.06 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 125.432 1.707 . . . . 0.0 107.635 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.7 p -114.14 167.56 10.58 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.773 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -119.5 -40.04 2.82 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 110.402 -3.09 . . . . 0.0 105.847 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.4 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.7 m-70 -129.84 176.82 7.73 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.645 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.1 m -87.46 25.52 1.42 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.815 -1.538 . . . . 0.0 109.301 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.01 -50.75 0.28 Allowed Glycine 0 N--CA 1.495 2.6 1 N-CA-C 102.48 -4.248 . . . . 0.0 102.48 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.39 -24.74 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.861 -1.669 . . . . 0.0 109.577 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 29.5 t -98.67 -37.41 9.52 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 112.551 -2.113 . . . . 0.0 111.527 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.434 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.8 tt -58.23 -43.57 87.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.432 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -60.24 -56.12 38.6 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-O 117.898 -1.049 . . . . 0.0 112.059 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.23 -34.25 28.29 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.248 1.965 . . . . 0.0 111.24 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 10.6 m -59.79 -59.96 4.6 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -52.17 -55.11 23.09 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.936 -1.483 . . . . 0.0 108.178 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.22 -23.36 55.53 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 127.089 2.743 . . . . 0.0 112.307 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 -1.4 42.79 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 123.915 0.759 . . . . 0.0 110.927 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.68 39.93 1.81 Allowed Glycine 0 N--CA 1.483 1.793 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.0 mmm -127.24 -165.74 1.51 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -111.29 -65.98 1.12 Allowed 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -123.88 -179.94 4.59 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.399 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.434 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.11 154.63 18.94 Favored Glycine 0 C--O 1.216 -1.031 0 CA-C-N 113.041 -1.89 . . . . 0.0 114.494 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -150.0 136.17 18.8 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.48 139.74 34.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -112.17 -80.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.41 34.53 3.88 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.982 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.34 -23.34 33.45 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 107.073 -2.411 . . . . 0.0 107.073 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -99.42 165.05 11.84 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.5 t -88.06 153.99 20.83 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.529 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 33.9 t70 -139.92 143.8 36.8 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.604 ' SG ' HG23 ' A' ' 3' ' ' ILE . 38.4 m -113.91 167.18 10.87 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 119.446 1.021 . . . . 0.0 112.812 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.6 m -121.38 58.75 8.28 Favored Pre-proline 0 N--CA 1.489 1.486 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.195 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.05 174.26 8.17 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.25 2.633 . . . . 0.0 111.508 -168.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -29.39 -50.53 0.1 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 125.701 1.876 . . . . 0.0 115.2 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 119.002 -2.311 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 123.355 1.55 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.583 ' N ' ' H ' ' A' ' 34' ' ' CYS . . . 124.69 176.0 14.47 Favored Glycine 0 C--N 1.301 -1.399 0 CA-C-N 112.175 -2.284 . . . . 0.0 113.258 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.622 HG13 ' H ' ' A' ' 4' ' ' ASN . 11.0 pt -121.61 -106.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.622 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.7 t30 -176.01 37.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 125.409 1.484 . . . . 0.0 107.812 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.464 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.2 t -125.88 162.28 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -99.63 135.47 41.0 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.821 1.326 . . . . 0.0 109.122 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 p -119.47 167.93 11.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.607 -2.088 . . . . 0.0 112.384 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -120.89 -43.59 2.45 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 110.023 -3.262 . . . . 0.0 105.404 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -124.13 177.34 5.87 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.678 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.4 p -89.38 26.84 1.57 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.875 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.92 -50.87 0.26 Allowed Glycine 0 N--CA 1.493 2.496 1 N-CA-C 102.544 -4.222 . . . . 0.0 102.544 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -24.06 1.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 112.803 -1.698 . . . . 0.0 109.628 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 39.6 t -98.97 -43.04 6.85 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.757 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.478 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.0 tt -55.09 -46.15 75.46 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.832 0.853 . . . . 0.0 112.104 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -56.38 -60.84 7.91 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 124.12 0.888 . . . . 0.0 111.521 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -66.11 -33.37 40.88 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.412 1.408 . . . . 0.0 109.965 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 13.2 m -58.67 -63.66 1.21 Allowed 'General case' 0 C--N 1.31 -1.15 0 O-C-N 123.599 0.562 . . . . 0.0 109.756 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -58.81 -47.28 85.32 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.284 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.11 -22.89 61.57 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 125.708 1.88 . . . . 0.0 111.695 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.27 -3.25 37.73 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 123.889 0.743 . . . . 0.0 110.594 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.67 38.1 1.11 Allowed Glycine 0 N--CA 1.482 1.727 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.449 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 25.4 mmt -126.41 -163.48 1.23 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -115.05 -63.09 1.51 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -128.16 -179.91 5.25 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.059 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.478 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -137.65 151.99 21.46 Favored Glycine 0 N--CA 1.472 1.043 0 CA-C-N 112.633 -2.076 . . . . 0.0 115.074 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -149.57 147.76 28.54 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -99.85 140.83 33.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.54 -80.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -110.33 33.67 4.36 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.141 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.47 -22.06 38.86 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -99.91 164.42 12.02 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.1 t -89.43 147.82 23.81 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.546 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 68.5 t0 -132.17 141.78 49.22 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.583 ' H ' ' N ' ' A' ' 2' ' ' GLY . 33.8 m -113.37 171.35 7.61 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 119.112 0.869 . . . . 0.0 111.916 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.0 m -118.72 64.42 6.2 Favored Pre-proline 0 N--CA 1.484 1.259 0 O-C-N 125.068 1.48 . . . . 0.0 107.496 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 73.8 Cg_endo -59.18 176.79 0.45 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 123.484 2.79 . . . . 0.0 112.677 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.18 60.29 0.6 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.918 -1.946 . . . . 0.0 107.338 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.325 0 O-C-N 119.278 -2.139 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.4 m . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.747 0.784 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.12 -163.35 28.89 Favored Glycine 0 C--N 1.306 -1.102 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.696 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.624 HG13 ' H ' ' A' ' 4' ' ' ASN . 11.8 pt -116.35 -107.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.624 ' H ' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -176.45 40.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.7 t -126.29 164.4 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -99.84 138.2 37.25 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 124.7 1.25 . . . . 0.0 108.517 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 p -123.92 167.16 14.49 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.377 -1.738 . . . . 0.0 112.563 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -119.25 -41.26 2.74 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 110.522 -3.035 . . . . 0.0 105.359 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 11' ' ' GLY . 87.2 m-70 -130.03 177.79 7.02 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.58 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 m -87.09 25.89 1.27 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 113.6 -1.636 . . . . 0.0 108.982 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -119.69 -50.26 0.3 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 103.205 -3.958 . . . . 0.0 103.205 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -24.87 3.21 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 113.012 -1.594 . . . . 0.0 109.763 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 27.3 t -97.92 -38.22 9.5 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.438 -2.165 . . . . 0.0 111.439 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.453 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.6 tt -58.06 -44.21 87.36 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.526 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -59.24 -56.85 31.85 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-O 117.877 -1.059 . . . . 0.0 112.079 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -67.55 -36.1 20.77 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.214 1.942 . . . . 0.0 111.418 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.64 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 12.5 m -58.96 -59.59 5.22 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -52.37 -55.33 22.36 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.658 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -57.38 -24.49 55.67 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 127.165 2.791 . . . . 0.0 112.086 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.21 -1.28 42.42 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.596 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.76 39.62 1.56 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 116.343 1.297 . . . . 0.0 116.343 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.44 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 13.5 mmm -127.51 -165.83 1.53 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -111.32 -66.21 1.1 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -123.84 -178.23 3.99 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.488 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.453 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.6 154.4 20.39 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 113.352 -1.749 . . . . 0.0 114.214 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -149.56 137.97 20.74 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -99.44 138.51 36.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.9 mm -112.82 -78.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -110.17 34.45 3.89 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.381 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.94 -26.21 23.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -99.77 165.06 11.76 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.375 0.691 . . . . 0.0 109.395 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.64 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 38.6 t -84.89 150.78 24.74 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.53 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.0 t70 -135.69 141.69 44.99 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.519 ' SG ' HG23 ' A' ' 3' ' ' ILE . 38.4 m -110.6 170.38 8.13 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 119.462 1.028 . . . . 0.0 112.819 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.1 m -121.51 56.83 6.61 Favored Pre-proline 0 N--CA 1.49 1.533 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.208 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.44 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 98.1 Cg_endo -64.93 178.29 1.93 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.609 2.873 . . . . 0.0 113.233 -165.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -94.31 173.02 7.85 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.067 -1.879 . . . . 0.0 107.3 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.363 0 O-C-N 118.38 -2.7 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -33.99 172.04 0.01 OUTLIER Glycine 0 N--CA 1.499 2.862 0 N-CA-C 120.674 3.03 . . . . 0.0 120.674 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.626 HG23 ' SG ' ' A' ' 34' ' ' CYS . 12.1 pt -113.99 -104.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 112.11 -2.045 . . . . 0.0 106.893 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.62 ' H ' HG13 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -174.48 34.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 124.511 1.132 . . . . 0.0 108.213 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.428 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.6 t -124.77 162.1 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -99.83 137.08 38.8 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.225 0.953 . . . . 0.0 110.77 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 p -123.06 167.58 13.46 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.834 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -119.71 -40.36 2.77 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 110.472 -3.058 . . . . 0.0 105.756 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.428 ' H ' ' HB2' ' A' ' 12' ' ' GLN . 21.9 m80 -128.34 177.69 6.78 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.902 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.9 t -84.2 19.26 1.88 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.961 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.29 -49.17 0.37 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 103.639 -3.784 . . . . 0.0 103.639 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.428 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -51.35 -24.16 4.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.905 -1.647 . . . . 0.0 109.882 179.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 25.4 t -98.96 -38.5 8.97 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 112.888 -1.96 . . . . 0.0 111.013 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.428 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.8 tt -57.34 -43.93 83.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.688 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -60.05 -55.62 43.62 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-O 118.137 -0.935 . . . . 0.0 112.942 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -67.38 -35.63 23.12 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.739 1.626 . . . . 0.0 109.97 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.695 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 19.2 m -56.73 -64.76 0.77 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -47.59 81.72 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.017 0.823 . . . . 0.0 109.665 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.0 -23.19 53.04 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 126.098 2.124 . . . . 0.0 112.022 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.14 -5.32 33.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.057 0.848 . . . . 0.0 110.758 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.79 38.87 1.02 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.533 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 11.1 mmm -127.13 -162.36 1.15 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -116.67 -64.67 1.28 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.85 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -124.66 179.4 4.99 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.499 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -127.75 160.74 21.75 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 112.701 -2.045 . . . . 0.0 113.56 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.444 ' HE3' ' H ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -156.24 135.84 12.45 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.444 ' H ' ' HE3' ' A' ' 26' ' ' LYS . 11.0 t -99.28 141.24 32.31 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 105.518 -2.031 . . . . 0.0 105.518 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.2 mt -115.21 -79.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.35 35.69 3.34 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 124.486 1.116 . . . . 0.0 111.343 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.63 -22.15 39.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -100.71 166.82 10.69 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.695 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.4 t -88.28 147.68 24.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.523 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 37.3 t70 -131.02 132.35 44.92 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.626 ' SG ' HG23 ' A' ' 3' ' ' ILE . 27.9 m -109.48 166.16 11.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.62 1.1 . . . . 0.0 113.675 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.9 m -121.24 60.82 9.98 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.646 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.533 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 76.7 Cg_endo -66.44 177.59 3.18 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 123.529 2.819 . . . . 0.0 113.442 -166.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.419 ' HG2' ' H ' ' A' ' 37' ' ' LYS . 69.9 mmtt -29.81 156.35 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 126.131 2.145 . . . . 0.0 116.123 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.343 0 O-C-N 119.046 -2.284 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.941 0.877 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.812 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 54.11 -179.46 0.18 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 113.093 -1.867 . . . . 0.0 115.214 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.611 HG13 ' H ' ' A' ' 4' ' ' ASN . 12.4 pt -121.58 -107.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.611 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.6 t30 -175.63 38.29 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 O-C-N 124.959 1.412 . . . . 0.0 107.868 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.462 ' H ' HG13 ' A' ' 3' ' ' ILE . 44.8 t -125.18 164.96 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HZ3' ' HB2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -99.62 145.97 26.98 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 124.875 1.359 . . . . 0.0 108.535 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 p -126.15 168.38 14.11 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.193 -1.821 . . . . 0.0 113.846 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -121.31 -43.07 2.43 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 110.047 -3.251 . . . . 0.0 105.554 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -131.72 179.2 6.21 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.545 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.3 m -89.44 34.61 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.977 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.77 -51.28 0.18 Allowed Glycine 0 N--CA 1.494 2.545 1 N-CA-C 102.998 -4.041 . . . . 0.0 102.998 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -23.04 1.9 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 112.668 -1.766 . . . . 0.0 109.934 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 39.4 t -98.7 -44.2 6.51 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.399 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.512 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.6 tt -54.3 -45.09 72.48 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.585 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.04 -56.86 31.31 Favored Pre-proline 0 C--N 1.306 -1.324 0 O-C-N 124.294 0.997 . . . . 0.0 113.032 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -67.62 -33.33 28.59 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.973 1.782 . . . . 0.0 110.418 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 16.9 m -59.58 -64.05 1.08 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -56.95 -47.78 79.87 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.238 0.961 . . . . 0.0 108.975 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -58.1 -24.53 59.02 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 126.119 2.137 . . . . 0.0 111.944 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.3 -2.36 39.65 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 124.039 0.837 . . . . 0.0 110.842 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.2 40.32 1.17 Allowed Glycine 0 N--CA 1.483 1.794 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.439 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 14.8 mmm -128.44 -163.02 1.24 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.529 ' HE ' ' C ' ' A' ' 36' ' ' PRO . 49.0 mtm180 -114.56 -66.1 1.12 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.452 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -125.79 177.74 6.11 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.613 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.512 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -142.38 145.01 14.85 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 112.634 -2.076 . . . . 0.0 114.624 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 25' ' ' GLY . 12.6 mptt -138.51 153.47 48.77 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.5 t -99.97 132.41 45.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.24 -73.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -110.15 34.1 4.08 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.046 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.88 -25.16 29.36 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -100.92 168.11 9.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 21.3 t -86.77 145.58 26.58 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.465 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 36.6 t70 -131.59 136.46 47.81 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.812 ' H ' ' H ' ' A' ' 2' ' ' GLY . 29.3 m -108.56 166.94 10.4 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.872 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.3 m -120.36 66.31 12.13 Favored Pre-proline 0 N--CA 1.486 1.335 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.831 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' C ' ' HE ' ' A' ' 23' ' ' ARG . 70.2 Cg_endo -68.4 174.96 7.49 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 123.243 2.629 . . . . 0.0 111.457 -175.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' N ' ' HE ' ' A' ' 23' ' ' ARG . 16.9 tppt? -29.57 -58.57 0.16 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 113.163 -1.835 . . . . 0.0 114.003 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.348 0 O-C-N 119.422 -2.049 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.845 0.831 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.717 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 63.73 177.16 4.39 Favored Glycine 0 C--N 1.306 -1.118 0 CA-C-N 113.46 -1.7 . . . . 0.0 114.115 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.621 HG13 ' H ' ' A' ' 4' ' ' ASN . 11.8 pt -121.32 -107.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.621 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.7 t30 -175.71 38.47 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 124.972 1.42 . . . . 0.0 108.085 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.7 t -124.88 165.37 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -99.86 140.58 33.86 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 124.556 1.16 . . . . 0.0 109.471 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 p -124.7 168.26 13.43 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.023 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -120.24 -43.92 2.51 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 109.977 -3.283 . . . . 0.0 104.96 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.412 ' C ' ' H ' ' A' ' 11' ' ' GLY . 43.1 m170 -128.06 177.26 7.01 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 124.968 1.417 . . . . 0.0 111.476 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.4 t -84.74 23.07 1.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.295 -1.775 . . . . 0.0 108.81 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.15 -49.89 0.29 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 103.475 -3.85 . . . . 0.0 103.475 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 -24.96 3.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 112.869 -1.666 . . . . 0.0 109.835 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 21.7 t -98.07 -38.79 9.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 112.578 -2.101 . . . . 0.0 111.748 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.438 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.7 tt -56.44 -44.55 80.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.78 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -59.76 -56.5 35.12 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 124.102 0.876 . . . . 0.0 112.611 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.61 -34.01 26.67 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.808 1.672 . . . . 0.0 110.32 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 9.9 m -59.01 -63.65 1.23 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.19 -47.67 80.68 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 124.088 0.868 . . . . 0.0 109.16 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.76 -25.32 60.29 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 125.976 2.048 . . . . 0.0 111.33 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.15 -1.94 41.06 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 123.876 0.735 . . . . 0.0 111.422 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.75 38.42 1.18 Allowed Glycine 0 N--CA 1.481 1.682 0 N-CA-C 116.929 1.531 . . . . 0.0 116.929 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.45 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 27.3 mmt -125.98 -164.34 1.31 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -114.29 -62.99 1.52 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -127.25 179.69 5.32 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 123.887 0.742 . . . . 0.0 110.734 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -128.24 156.75 20.98 Favored Glycine 0 C--O 1.216 -1.013 0 CA-C-N 113.064 -1.88 . . . . 0.0 114.295 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -149.25 138.1 21.19 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -99.43 132.95 44.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.2 mt -112.08 -74.15 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -110.08 35.22 3.48 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.905 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.79 -22.84 38.74 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 107.356 -2.298 . . . . 0.0 107.356 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 32' ' ' CYS . 19.8 ttpp -99.94 168.35 9.92 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 43.1 t -86.37 146.19 26.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.528 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 36.6 t70 -130.85 141.37 50.32 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.717 ' H ' ' H ' ' A' ' 2' ' ' GLY . 33.6 m -115.12 162.56 16.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 119.147 0.885 . . . . 0.0 112.076 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.5 m -122.27 60.61 13.24 Favored Pre-proline 0 N--CA 1.487 1.423 0 CA-C-N 113.967 -1.47 . . . . 0.0 108.128 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.45 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 78.3 Cg_endo -67.15 175.61 5.52 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 123.236 2.624 . . . . 0.0 111.58 -172.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -29.37 -53.59 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 125.762 1.914 . . . . 0.0 113.444 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.37 0 O-C-N 119.346 -2.096 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.622 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 53.4 -174.75 0.33 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-N 115.27 -0.877 . . . . 0.0 114.544 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.617 HG13 ' H ' ' A' ' 4' ' ' ASN . 12.4 pt -122.48 -107.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.617 ' H ' HG13 ' A' ' 3' ' ' ILE . 49.8 t30 -176.65 37.5 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 125.439 1.496 . . . . 0.0 108.171 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.462 ' H ' HG13 ' A' ' 3' ' ' ILE . 45.1 t -124.5 165.45 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -99.78 138.51 36.77 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 124.427 1.08 . . . . 0.0 109.906 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 p -121.86 167.45 13.02 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 112.693 -2.049 . . . . 0.0 112.212 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -117.87 -41.61 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.47 -3.059 . . . . 0.0 105.275 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' ' 11' ' ' GLY . 82.7 m-70 -131.8 177.2 7.71 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.985 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.3 m -86.58 26.63 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.17 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.12 -51.26 0.27 Allowed Glycine 0 N--CA 1.495 2.61 1 N-CA-C 102.636 -4.186 . . . . 0.0 102.636 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -24.07 3.73 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.623 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 14.9 t -98.19 -36.97 9.88 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.442 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.41 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.5 tt -57.62 -44.7 85.73 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.863 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.08 -54.37 54.63 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.245 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -67.01 -35.67 24.93 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.576 1.518 . . . . 0.0 110.335 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.625 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 6.5 m -57.62 -63.18 1.32 Allowed 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.37 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.8 -47.84 81.44 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 124.077 0.86 . . . . 0.0 109.365 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.49 -23.16 57.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 125.925 2.016 . . . . 0.0 112.048 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.33 -4.61 34.63 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 124.023 0.827 . . . . 0.0 110.521 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.25 39.94 1.0 Allowed Glycine 0 N--CA 1.483 1.786 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.422 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 19.2 mmm -128.27 -164.01 1.33 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -111.43 -65.87 1.13 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.444 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -127.09 -178.93 4.61 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 123.838 0.711 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.41 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -123.83 157.47 18.25 Favored Glycine 0 C--O 1.216 -1.003 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.846 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -150.7 133.46 15.83 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.1 t -99.43 140.33 33.76 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.55 -82.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -110.24 34.73 3.74 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.192 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.63 -23.41 31.42 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -101.04 165.6 11.23 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.625 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 39.4 t -88.52 150.12 23.26 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.521 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 31.5 t70 -134.46 143.4 47.5 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.622 ' H ' ' H ' ' A' ' 2' ' ' GLY . 55.7 m -112.91 166.28 11.54 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.682 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.5 m -123.3 60.67 17.79 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -74.83 173.4 14.5 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 123.348 2.699 . . . . 0.0 111.688 -168.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -29.6 83.6 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 125.898 1.999 . . . . 0.0 115.277 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.401 0 O-C-N 118.656 -2.528 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 34' ' ' CYS . 35.6 m . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.872 0.367 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -30.69 170.61 0.0 OUTLIER Glycine 0 N--CA 1.501 2.993 0 N-CA-C 121.093 3.197 . . . . 0.0 121.093 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.624 HG13 ' H ' ' A' ' 4' ' ' ASN . 12.9 pt -114.27 -105.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 111.721 -2.24 . . . . 0.0 105.682 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.624 ' H ' HG13 ' A' ' 3' ' ' ILE . 50.1 t30 -175.22 34.92 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 124.792 1.237 . . . . 0.0 108.635 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' H ' HG13 ' A' ' 3' ' ' ILE . 46.6 t -125.52 162.96 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -99.78 140.06 34.54 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 124.608 1.192 . . . . 0.0 110.549 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.6 p -121.64 167.84 12.45 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.459 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.494 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 7.2 mmpt? -118.78 -42.66 2.71 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.3 -3.137 . . . . 0.0 104.463 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.407 ' C ' ' H ' ' A' ' 11' ' ' GLY . 26.7 m80 -128.41 176.19 7.91 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.179 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.1 m -87.49 25.75 1.38 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.922 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.82 -49.92 0.33 Allowed Glycine 0 N--CA 1.493 2.488 1 N-CA-C 102.353 -4.299 . . . . 0.0 102.353 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -23.83 4.55 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 113.18 -1.51 . . . . 0.0 109.587 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 26.3 t -97.45 -38.57 9.55 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 112.918 -1.946 . . . . 0.0 111.047 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.44 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.6 tt -59.54 -41.88 91.06 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.123 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -58.21 -58.92 15.32 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-O 117.871 -1.061 . . . . 0.0 111.301 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -68.42 -39.08 10.25 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.185 1.923 . . . . 0.0 111.055 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.712 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 14.4 m -55.39 -58.39 7.93 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -56.36 -52.77 63.35 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.385 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -62.45 -17.88 60.45 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 126.037 2.086 . . . . 0.0 112.303 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.46 -5.67 31.96 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 124.056 0.847 . . . . 0.0 109.659 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.76 37.21 1.31 Allowed Glycine 0 N--CA 1.481 1.665 0 N-CA-C 116.596 1.399 . . . . 0.0 116.596 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 14.3 mmm -127.32 -164.81 1.39 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HE ' ' C ' ' A' ' 36' ' ' PRO . 42.0 mtm180 -112.3 -64.54 1.28 Allowed 'General case' 0 C--N 1.309 -1.169 0 O-C-N 123.993 0.808 . . . . 0.0 110.389 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -124.35 -179.68 4.56 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.088 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.17 153.99 20.09 Favored Glycine 0 C--O 1.216 -0.98 0 CA-C-N 113.218 -1.81 . . . . 0.0 114.43 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -144.39 135.99 25.76 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -99.69 136.38 39.7 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 103.679 -2.711 . . . . 0.0 103.679 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.2 mm -113.26 -81.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 116.917 2.192 . . . . 0.0 116.917 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.22 34.38 3.93 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.426 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.27 -22.77 33.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -102.25 166.98 10.28 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.629 0.841 . . . . 0.0 109.269 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.712 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 37.3 t -90.09 148.78 22.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.503 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 39.2 t70 -132.63 137.12 46.9 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.561 ' SG ' HG23 ' A' ' 3' ' ' ILE . 17.0 m -108.74 162.77 13.86 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 119.796 1.18 . . . . 0.0 112.517 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.1 m -121.62 65.93 18.48 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.363 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.504 ' C ' ' HE ' ' A' ' 23' ' ' ARG . 92.3 Cg_endo -65.2 178.26 2.09 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 123.486 2.791 . . . . 0.0 112.384 -174.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -29.12 83.75 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 O-C-N 125.829 1.956 . . . . 0.0 114.415 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.332 0 O-C-N 119.107 -2.246 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.731 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 41.87 -175.38 0.01 OUTLIER Glycine 0 N--CA 1.499 2.878 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.585 HG13 ' H ' ' A' ' 4' ' ' ASN . 12.4 pt -124.26 -106.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.585 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.4 t30 -176.69 36.49 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 125.444 1.498 . . . . 0.0 108.132 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' H ' HG13 ' A' ' 3' ' ' ILE . 44.2 t -126.72 166.51 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' N ' HG12 ' A' ' 5' ' ' VAL . 35.3 ttmt -99.96 138.01 37.63 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 124.841 1.338 . . . . 0.0 108.993 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 p -123.22 164.36 18.88 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.497 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 10.2 mmpt? -115.61 -41.11 3.28 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 111.168 -2.742 . . . . 0.0 104.108 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -126.1 175.31 7.84 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.308 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.1 p -91.37 24.73 2.84 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.525 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 13' ' ' CYS . . . -121.68 -43.02 0.43 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 105.63 -2.988 . . . . 0.0 105.63 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -74.4 5.4 4.67 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.28 -0.96 . . . . 0.0 109.762 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 14.3 t -114.53 -38.26 4.08 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 113.218 -1.81 . . . . 0.0 106.381 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tt -63.61 -39.36 94.18 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.748 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.493 ' N ' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -55.75 -61.51 6.17 Favored Pre-proline 0 N--CA 1.48 1.053 0 O-C-N 124.028 0.83 . . . . 0.0 109.594 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -66.96 -37.02 20.65 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.982 1.788 . . . . 0.0 110.634 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 7.7 m -55.54 -64.73 0.75 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.319 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -45.63 91.86 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.339 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.41 -22.66 54.89 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 125.504 1.753 . . . . 0.0 111.749 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.08 -6.67 31.23 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 123.994 0.809 . . . . 0.0 110.64 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.3 40.46 0.8 Allowed Glycine 0 N--CA 1.479 1.506 0 N-CA-C 116.466 1.347 . . . . 0.0 116.466 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.415 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 15.0 mmm -127.62 -166.01 1.55 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -111.27 -64.16 1.32 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.825 0.703 . . . . 0.0 109.531 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.34 179.91 4.89 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.934 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -124.57 154.32 17.97 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-N 113.166 -1.834 . . . . 0.0 114.748 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.23 134.46 15.09 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.4 t -99.52 139.63 34.89 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.27 -79.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 116.879 2.178 . . . . 0.0 116.879 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.16 34.61 3.8 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.47 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.97 -22.56 37.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -100.22 165.82 11.3 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 44.2 t -90.15 151.09 21.74 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.479 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.456 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.4 t70 -133.46 146.98 51.64 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.731 ' H ' ' H ' ' A' ' 2' ' ' GLY . 37.4 m -117.94 162.39 18.22 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.0 m -121.4 62.05 11.9 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.7 176.0 6.48 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 C-N-CA 123.393 2.728 . . . . 0.0 111.361 -169.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 38' ' ' NH2 . 2.4 pptp? -29.45 -46.8 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 125.695 1.872 . . . . 0.0 114.614 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . 0.413 ' N ' ' HD2' ' A' ' 37' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.326 0 O-C-N 119.023 -2.298 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 122.134 0.969 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -131.22 -171.19 12.83 Favored Glycine 0 C--O 1.215 -1.034 0 CA-C-N 113.517 -1.674 . . . . 0.0 112.865 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.62 HG13 ' H ' ' A' ' 4' ' ' ASN . 15.1 pt -111.69 -105.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.62 ' H ' HG13 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -173.18 35.75 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 124.483 1.115 . . . . 0.0 108.126 -179.76 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.66 163.95 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.41 145.61 28.7 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 124.526 1.141 . . . . 0.0 110.266 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.3 p -128.38 167.21 17.31 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.808 -1.996 . . . . 0.0 112.991 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -121.17 -42.74 2.46 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 110.097 -3.228 . . . . 0.0 104.928 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.423 ' C ' ' H ' ' A' ' 11' ' ' GLY . 22.5 m80 -128.55 176.31 7.86 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.667 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.1 m -87.9 28.76 0.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.088 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.94 -50.93 0.26 Allowed Glycine 0 N--CA 1.495 2.567 1 N-CA-C 102.075 -4.41 . . . . 0.0 102.075 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.58 -25.93 1.96 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 113.239 -1.48 . . . . 0.0 109.384 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 31.0 t -96.75 -38.83 9.73 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.469 -2.15 . . . . 0.0 111.094 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.441 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -56.84 -45.64 82.24 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.514 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -57.65 -59.58 12.57 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.42 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.12 -33.39 40.71 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.428 1.419 . . . . 0.0 109.417 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.696 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.8 m -58.18 -64.29 0.97 Allowed 'General case' 0 C--N 1.307 -1.239 0 O-C-N 123.739 0.649 . . . . 0.0 109.932 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.515 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -57.97 -45.36 86.84 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.121 0.888 . . . . 0.0 109.553 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.515 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 40.4 m-20 -64.74 -18.53 65.13 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 125.59 1.806 . . . . 0.0 112.092 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.14 -3.89 36.79 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.24 41.08 1.31 Allowed Glycine 0 N--CA 1.483 1.811 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.423 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 13.1 mmm -128.49 -163.51 1.29 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -113.51 -64.12 1.35 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.611 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -125.79 179.15 5.32 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.469 0.652 . . . . 0.0 111.506 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.441 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -130.01 150.86 19.2 Favored Glycine 0 C--O 1.215 -1.076 0 CA-C-N 113.152 -1.84 . . . . 0.0 114.737 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -143.49 138.36 29.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.4 t -99.89 133.5 44.17 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.3 mm -114.33 -77.45 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -110.26 34.94 3.62 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.855 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.05 -19.69 52.04 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 32' ' ' CYS . 19.2 ttpp -106.41 168.54 9.09 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.696 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 35.0 t -88.28 149.7 23.66 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.507 -1.224 . . . . 0.0 114.186 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.544 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 11.3 t70 -134.94 123.61 23.65 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.586 ' SG ' HG23 ' A' ' 3' ' ' ILE . 31.5 m -99.94 162.18 13.15 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.153 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.9 m -121.52 64.75 16.02 Favored Pre-proline 0 N--CA 1.488 1.441 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.144 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.19 176.02 7.66 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 123.343 2.696 . . . . 0.0 111.293 -171.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -29.36 -51.34 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 125.625 1.828 . . . . 0.0 115.148 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.391 0 O-C-N 119.095 -2.253 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.828 0.346 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -35.46 171.03 0.01 OUTLIER Glycine 0 N--CA 1.501 2.972 0 N-CA-C 119.411 2.524 . . . . 0.0 119.411 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.616 HG13 ' H ' ' A' ' 4' ' ' ASN . 13.2 pt -114.71 -106.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 112.639 -1.781 . . . . 0.0 106.399 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.616 ' H ' HG13 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -174.38 36.63 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 124.667 1.229 . . . . 0.0 107.714 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.428 ' H ' HG13 ' A' ' 3' ' ' ILE . 46.5 t -126.92 165.56 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -99.88 147.58 25.38 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 124.595 1.184 . . . . 0.0 110.499 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p -127.67 168.14 15.46 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 112.547 -2.115 . . . . 0.0 113.114 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -119.95 -43.04 2.57 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 110.098 -3.228 . . . . 0.0 105.003 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.431 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.5 m-70 -132.88 176.88 8.09 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.536 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -85.63 28.89 0.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.455 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.37 -50.62 0.28 Allowed Glycine 0 N--CA 1.495 2.61 1 N-CA-C 102.551 -4.219 . . . . 0.0 102.551 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -25.68 3.87 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 112.962 -1.619 . . . . 0.0 109.593 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 25.7 t -97.01 -39.27 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 112.691 -2.05 . . . . 0.0 111.29 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.433 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.2 tt -57.28 -43.65 83.31 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.545 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -58.89 -57.45 26.87 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.605 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -68.09 -34.41 22.65 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.199 1.933 . . . . 0.0 109.985 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 14.8 m -58.06 -63.99 1.07 Allowed 'General case' 0 C--N 1.31 -1.127 0 O-C-N 123.837 0.711 . . . . 0.0 109.398 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -57.78 -47.3 82.93 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.265 0.978 . . . . 0.0 109.231 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -57.82 -24.37 57.05 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 126.02 2.075 . . . . 0.0 111.597 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.25 -3.41 37.46 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.137 0.898 . . . . 0.0 110.929 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.0 38.44 1.15 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.474 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.7 mmt -124.44 -164.71 1.29 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -115.43 -62.0 1.66 Allowed 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -126.92 179.44 5.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 123.883 0.739 . . . . 0.0 111.223 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.33 154.86 20.53 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-N 113.136 -1.847 . . . . 0.0 114.41 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -144.65 137.2 26.48 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -99.78 130.85 46.02 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.28 -78.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.23 34.53 3.85 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.831 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.46 -19.2 53.64 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 32' ' ' CYS . 18.4 ttpp -107.0 169.55 8.48 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 38.3 t -90.19 148.27 23.05 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.497 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 65.5 t0 -133.84 135.06 43.51 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.522 ' SG ' HG23 ' A' ' 3' ' ' ILE . 20.1 m -109.87 163.16 13.8 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 119.851 1.205 . . . . 0.0 113.421 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.6 m -122.29 62.57 16.24 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.689 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 81.4 Cg_endo -67.1 176.36 4.68 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 123.218 2.612 . . . . 0.0 111.551 -174.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -29.3 -41.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.36 0 O-C-N 118.0 -2.938 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.875 0.369 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -38.33 173.72 0.01 OUTLIER Glycine 0 N--CA 1.5 2.907 0 N-CA-C 119.228 2.451 . . . . 0.0 119.228 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.638 HG23 ' SG ' ' A' ' 34' ' ' CYS . 11.5 pt -113.62 -104.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 112.759 -1.721 . . . . 0.0 107.149 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.627 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.6 t30 -175.3 35.6 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 O-C-N 124.747 1.279 . . . . 0.0 108.496 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' H ' HG13 ' A' ' 3' ' ' ILE . 46.9 t -125.12 165.65 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -99.8 142.17 31.64 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 124.602 1.189 . . . . 0.0 109.027 -179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 p -123.59 166.53 15.31 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 112.43 -2.168 . . . . 0.0 112.041 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -121.79 -40.54 2.53 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 110.359 -3.109 . . . . 0.0 106.034 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.417 ' C ' ' H ' ' A' ' 11' ' ' GLY . 85.6 m-70 -134.13 179.82 6.02 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.05 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 t -84.71 29.42 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.167 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -125.93 -50.86 0.18 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 103.768 -3.733 . . . . 0.0 103.768 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -48.52 -24.87 1.44 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 112.958 -1.621 . . . . 0.0 110.069 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 33' ' ' ASP . 40.9 t -97.01 -42.05 8.08 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.64 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.51 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.6 tt -55.51 -45.89 77.06 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.394 0.677 . . . . 0.0 112.395 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -56.77 -58.92 14.23 Favored Pre-proline 0 C--N 1.309 -1.17 0 O-C-N 123.888 0.743 . . . . 0.0 112.379 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -68.25 -33.03 25.36 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.992 1.794 . . . . 0.0 110.458 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.6 m -59.87 -65.16 0.72 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.71 0.631 . . . . 0.0 109.305 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.499 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -56.56 -45.2 81.41 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.425 1.078 . . . . 0.0 108.952 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.499 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 52.8 t0 -60.85 -24.77 66.15 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 125.934 2.021 . . . . 0.0 110.752 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 -0.01 45.54 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.582 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.48 39.32 1.49 Allowed Glycine 0 N--CA 1.484 1.878 0 N-CA-C 116.691 1.436 . . . . 0.0 116.691 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.48 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 29.6 mmt -124.49 -163.74 1.19 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -118.49 -60.96 1.72 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.16 176.54 6.98 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.37 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -139.37 145.16 16.2 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.818 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HD2' ' C ' ' A' ' 25' ' ' GLY . 12.7 mptt -139.65 149.21 43.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.5 t -99.83 137.82 37.76 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.3 mt -115.12 -78.49 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -110.29 35.0 3.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.368 1.043 . . . . 0.0 111.282 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.3 -23.21 35.08 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -103.97 163.21 12.52 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 124.397 0.704 . . . . 0.0 109.151 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 25.3 t -82.14 148.46 28.49 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.346 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 36.8 t70 -131.94 129.22 39.95 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.638 ' SG ' HG23 ' A' ' 3' ' ' ILE . 13.4 m -106.84 164.15 12.35 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.977 1.262 . . . . 0.0 113.493 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.4 m -122.15 68.45 27.32 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-N 113.329 -1.759 . . . . 0.0 108.942 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 17.1 Cg_endo -79.73 177.68 8.15 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 123.554 2.836 . . . . 0.0 112.072 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -110.07 69.92 0.71 Allowed 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.119 -1.855 . . . . 0.0 106.237 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.356 0 O-C-N 119.194 -2.191 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.757 0.789 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.67 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 71.65 176.3 25.23 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 113.696 -1.593 . . . . 0.0 114.087 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.638 HG13 ' H ' ' A' ' 4' ' ' ASN . 11.6 pt -121.24 -105.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.638 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.8 t30 -175.7 36.6 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 125.242 1.417 . . . . 0.0 108.237 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 3' ' ' ILE . 46.6 t -125.57 164.83 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.441 ' C ' ' HD3' ' A' ' 6' ' ' LYS . 1.6 tmtm? -99.76 144.04 29.29 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 124.515 1.135 . . . . 0.0 109.783 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.4 p -125.09 167.41 14.82 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.613 -2.085 . . . . 0.0 112.898 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -119.43 -41.95 2.68 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 110.163 -3.199 . . . . 0.0 105.21 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.422 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.1 m-70 -132.23 176.2 8.6 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.521 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.7 p -85.37 26.42 0.91 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.564 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -119.39 -51.27 0.29 Allowed Glycine 0 N--CA 1.494 2.556 1 N-CA-C 102.832 -4.107 . . . . 0.0 102.832 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.66 -27.84 2.11 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.234 -1.483 . . . . 0.0 109.479 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 23.6 t -96.04 -35.84 11.24 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.116 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tt -59.24 -44.99 92.33 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.431 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 5.7 mptp? -56.1 -57.57 21.57 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.146 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 94.6 Cg_endo -68.35 -37.48 13.54 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.353 2.035 . . . . 0.0 111.845 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 7.4 m -57.78 -59.11 5.72 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -53.37 -54.65 33.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.585 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.18 -23.19 54.59 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 126.701 2.5 . . . . 0.0 112.402 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.38 -2.51 39.04 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 124.159 0.912 . . . . 0.0 111.282 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.84 38.31 1.44 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.442 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.1 mmt -123.82 -165.74 1.39 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -112.88 -62.86 1.52 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.45 -179.87 4.97 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.036 0.835 . . . . 0.0 110.433 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.13 157.04 16.14 Favored Glycine 0 C--O 1.216 -1.011 0 CA-C-N 113.147 -1.842 . . . . 0.0 113.53 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -149.46 132.77 16.5 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.2 t -99.5 132.28 44.93 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.0 mt -112.59 -78.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.37 34.91 3.66 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.364 1.04 . . . . 0.0 111.708 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.77 -17.05 58.85 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -105.01 168.22 9.2 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 43.2 t -90.75 147.62 23.11 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.535 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 13.3 t70 -132.29 144.01 50.29 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.67 ' H ' ' H ' ' A' ' 2' ' ' GLY . 29.8 m -114.5 160.39 19.28 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.449 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.0 m -121.9 61.38 13.0 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.172 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.8 175.81 6.82 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 123.375 2.717 . . . . 0.0 111.553 -172.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -29.32 -59.36 0.15 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 125.741 1.901 . . . . 0.0 113.823 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.327 0 O-C-N 119.377 -2.077 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -31.98 170.67 0.0 OUTLIER Glycine 0 N--CA 1.501 2.97 0 N-CA-C 120.898 3.119 . . . . 0.0 120.898 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.632 HG13 ' H ' ' A' ' 4' ' ' ASN . 12.6 pt -113.81 -105.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 111.877 -2.161 . . . . 0.0 106.168 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.632 ' H ' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -174.67 36.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 124.641 1.213 . . . . 0.0 108.059 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.42 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.6 t -125.73 165.5 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.93 143.31 30.3 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.256 1.027 . . . . 0.0 110.276 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 p -126.71 166.46 17.34 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 112.37 -2.196 . . . . 0.0 112.705 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -120.08 -40.68 2.7 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 110.44 -3.073 . . . . 0.0 105.847 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 11' ' ' GLY . 84.2 m-70 -131.87 178.5 6.72 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.386 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.4 m -85.1 23.14 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.329 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.34 -50.32 0.34 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 103.272 -3.931 . . . . 0.0 103.272 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.411 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -48.76 -25.79 2.02 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.3 -1.45 . . . . 0.0 109.595 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 34.6 t -97.28 -37.44 10.06 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 112.335 -2.211 . . . . 0.0 111.551 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.43 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -58.67 -43.98 90.06 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.063 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.403 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 2.1 mptm? -56.95 -58.2 19.3 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-O 118.24 -0.886 . . . . 0.0 112.036 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 91.2 Cg_endo -67.83 -36.61 17.89 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.396 2.064 . . . . 0.0 111.376 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 19.1 m -58.3 -60.54 3.62 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -52.26 -54.69 28.01 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.055 -1.43 . . . . 0.0 108.63 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.34 -23.11 55.73 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 126.954 2.659 . . . . 0.0 112.665 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.21 -2.37 39.88 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.131 0.894 . . . . 0.0 110.82 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.34 39.87 1.58 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 116.005 1.162 . . . . 0.0 116.005 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.4 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 12.4 mmm -126.73 -165.24 1.43 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -111.65 -67.42 1.0 Allowed 'General case' 0 C--N 1.31 -1.143 0 O-C-N 123.98 0.8 . . . . 0.0 109.474 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -123.47 179.53 4.71 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.739 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.43 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.77 156.27 20.02 Favored Glycine 0 C--O 1.215 -1.079 0 CA-C-N 112.918 -1.947 . . . . 0.0 114.099 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -151.4 138.32 19.02 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.3 t -99.6 138.71 36.3 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.2 mt -116.12 -79.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -110.38 35.34 3.48 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.413 1.07 . . . . 0.0 111.859 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.39 -22.08 38.9 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -103.93 166.36 10.46 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.594 0.82 . . . . 0.0 108.831 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 32.4 t -85.79 149.13 25.48 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.516 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 37.1 t70 -132.34 134.8 45.63 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.578 ' SG ' HG23 ' A' ' 3' ' ' ILE . 27.3 m -108.45 163.61 13.06 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 119.726 1.148 . . . . 0.0 112.537 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.5 m -121.32 59.66 9.05 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.838 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -74.35 172.41 16.14 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 123.286 2.657 . . . . 0.0 111.866 -167.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -29.61 83.08 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 126.061 2.101 . . . . 0.0 115.217 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.442 0 O-C-N 118.455 -2.653 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.478 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -28.75 168.66 0.0 OUTLIER Glycine 0 N--CA 1.501 3.021 0 N-CA-C 121.023 3.169 . . . . 0.0 121.023 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.608 HG13 ' H ' ' A' ' 4' ' ' ASN . 13.1 pt -113.81 -104.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 112.092 -2.054 . . . . 0.0 107.077 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.608 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.2 t30 -174.67 34.8 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 124.641 1.213 . . . . 0.0 108.2 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.7 t -128.06 163.14 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -102.27 141.19 35.5 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 124.517 1.135 . . . . 0.0 109.711 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 p -118.52 168.73 10.4 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.064 -1.88 . . . . 0.0 112.938 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -118.17 -42.52 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 110.001 -3.272 . . . . 0.0 104.896 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.438 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.6 m-70 -132.9 175.7 9.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.627 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.0 m -85.6 28.9 0.73 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.255 -1.338 . . . . 0.0 109.296 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -121.28 -49.95 0.26 Allowed Glycine 0 N--CA 1.495 2.597 1 N-CA-C 102.916 -4.074 . . . . 0.0 102.916 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -23.07 4.88 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.109 -1.545 . . . . 0.0 109.753 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 33.8 t -97.72 -37.69 9.79 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 112.997 -1.911 . . . . 0.0 110.863 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.485 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.3 tt -59.21 -42.56 91.25 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.23 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -58.67 -57.17 28.65 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.251 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.9 -37.12 11.9 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.567 2.178 . . . . 0.0 111.855 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.692 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 12.8 m -58.82 -58.6 7.91 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -53.28 -54.81 30.88 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.242 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -57.81 -23.77 54.14 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 126.809 2.568 . . . . 0.0 112.34 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.38 -1.3 41.89 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 124.078 0.861 . . . . 0.0 111.301 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.12 38.61 1.65 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.447 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.6 mmt -124.25 -165.44 1.37 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -113.44 -62.7 1.55 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -126.25 178.57 5.74 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.045 0.84 . . . . 0.0 110.84 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.485 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -127.98 145.28 15.86 Favored Glycine 0 C--O 1.215 -1.083 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.571 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.22 136.58 45.69 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.8 t -99.6 132.29 45.04 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.1 mm -109.72 -83.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.35 33.94 4.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.439 1.087 . . . . 0.0 111.436 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.36 -19.08 46.65 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.015 -2.434 . . . . 0.0 107.015 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -103.01 165.42 11.03 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.757 0.916 . . . . 0.0 109.708 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.692 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 36.7 t -92.74 145.76 24.17 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.478 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 38.5 t70 -131.57 141.41 49.68 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.538 ' SG ' HG23 ' A' ' 3' ' ' ILE . 20.6 m -110.48 159.91 17.09 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 119.822 1.192 . . . . 0.0 112.553 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.2 m -121.56 62.02 12.48 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.476 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.406 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 66.2 Cg_endo -68.22 175.95 6.11 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 123.356 2.704 . . . . 0.0 111.652 -174.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -29.42 -59.31 0.15 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 125.751 1.907 . . . . 0.0 113.83 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.349 0 O-C-N 119.52 -1.988 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.955 0.883 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -129.78 -169.76 12.59 Favored Glycine 0 C--N 1.307 -1.044 0 CA-C-N 113.562 -1.654 . . . . 0.0 113.153 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.624 HG23 ' SG ' ' A' ' 34' ' ' CYS . 13.1 pt -110.3 -104.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.616 ' H ' HG13 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -173.91 35.29 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 O-C-N 124.42 1.075 . . . . 0.0 108.347 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -126.87 158.26 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 8.0 mtpm? -102.89 133.85 47.28 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 124.503 1.127 . . . . 0.0 110.764 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 p -126.57 166.66 16.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.613 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -117.98 -35.63 3.82 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 111.659 -2.519 . . . . 0.0 105.705 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -123.56 173.32 8.13 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.07 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.6 p -91.26 35.22 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.059 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.57 -47.92 0.24 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 105.405 -3.078 . . . . 0.0 105.405 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -61.94 -8.41 5.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.618 1.567 . . . . 0.0 111.116 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 37.4 t -106.51 -41.76 5.19 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.671 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.48 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.8 tt -58.28 -41.09 83.61 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.995 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -62.81 -57.09 23.54 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-O 118.128 -0.939 . . . . 0.0 112.138 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -67.68 -32.59 30.1 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.467 2.111 . . . . 0.0 110.99 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.5 m -61.4 -60.71 3.31 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -51.28 -54.97 20.89 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.792 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -58.3 -23.75 57.36 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 127.09 2.744 . . . . 0.0 112.769 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.22 0.11 45.17 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 124.011 0.819 . . . . 0.0 110.833 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.53 40.57 2.02 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.48 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 12.6 mmm -127.15 -165.5 1.48 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -112.96 -65.51 1.18 Allowed 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.982 0.801 . . . . 0.0 109.16 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -123.83 -179.77 4.51 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.662 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.48 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -134.54 152.39 20.65 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-N 113.246 -1.797 . . . . 0.0 114.377 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -148.47 140.26 23.76 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -99.62 142.19 31.44 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 105.15 -2.166 . . . . 0.0 105.15 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.1 mm -115.11 -78.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.27 35.27 3.49 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.45 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.53 -24.51 29.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.223 -2.351 . . . . 0.0 107.223 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -99.95 167.92 10.19 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 124.761 0.918 . . . . 0.0 109.294 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 32.0 t -89.69 151.09 22.04 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.475 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 26.7 t70 -136.75 124.87 22.97 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' HG23 ' A' ' 3' ' ' ILE . 23.8 m -99.8 164.9 11.83 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 118.981 0.81 . . . . 0.0 112.367 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.7 m -120.93 61.85 9.92 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.075 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 58.9 Cg_endo -68.75 176.64 5.73 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 123.103 2.535 . . . . 0.0 111.663 -168.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -29.76 167.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 119.515 3.154 . . . . 0.0 119.515 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.34 0 O-C-N 118.799 -2.438 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.727 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 44.15 -173.39 0.01 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.609 HG13 ' H ' ' A' ' 4' ' ' ASN . 12.3 pt -122.54 -106.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.609 ' H ' HG13 ' A' ' 3' ' ' ILE . 49.5 t30 -177.24 34.6 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 125.509 1.524 . . . . 0.0 108.375 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' H ' HG13 ' A' ' 3' ' ' ILE . 42.6 t -124.57 164.54 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -99.74 137.94 37.51 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 124.583 1.177 . . . . 0.0 110.432 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 p -121.7 167.88 12.44 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 112.387 -2.188 . . . . 0.0 111.778 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -120.18 -40.35 2.72 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 110.387 -3.097 . . . . 0.0 105.643 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.421 ' H ' ' HB2' ' A' ' 12' ' ' GLN . 20.3 m80 -128.89 177.9 6.77 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.946 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.5 t -85.8 21.99 1.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 113.24 -1.8 . . . . 0.0 108.758 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.91 -49.07 0.29 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 103.571 -3.812 . . . . 0.0 103.571 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.421 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -52.13 -21.99 3.8 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 113.004 -1.598 . . . . 0.0 110.067 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 32.8 t -99.95 -38.9 8.41 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 112.98 -1.918 . . . . 0.0 110.939 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.484 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.9 tt -58.98 -38.42 79.1 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.776 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.97 -56.67 22.91 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.997 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.14 -31.8 35.51 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.137 1.891 . . . . 0.0 110.824 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.5 m -62.26 -58.22 8.55 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HZ2' ' HB3' ' A' ' 18' ' ' LYS . 2.3 mmmp? -48.89 -57.51 6.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.617 1.198 . . . . 0.0 108.171 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -55.62 -27.17 48.11 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 128.186 3.429 . . . . 0.0 112.455 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 1.97 48.45 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 124.264 0.978 . . . . 0.0 111.458 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.86 43.72 2.05 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 115.241 0.856 . . . . 0.0 115.241 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.494 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 27.0 mmt -124.85 -166.57 1.54 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 116.972 0.386 . . . . 0.0 109.974 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -113.87 -62.94 1.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.19 177.27 6.79 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.971 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -132.01 150.91 19.68 Favored Glycine 0 C--O 1.216 -0.986 0 CA-C-N 112.504 -2.135 . . . . 0.0 112.98 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -146.98 140.93 25.94 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.64 141.08 32.91 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.96 -81.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -110.32 34.41 3.93 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.226 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.56 -24.15 29.48 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.401 -2.279 . . . . 0.0 107.401 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -100.7 165.65 11.28 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.694 0.879 . . . . 0.0 109.157 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 25.7 t -89.48 149.6 22.85 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.44 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.6 t70 -133.11 134.75 44.66 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.727 ' H ' ' H ' ' A' ' 2' ' ' GLY . 33.4 m -110.46 163.82 13.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 119.079 0.854 . . . . 0.0 111.489 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.1 m -122.06 58.78 10.03 Favored Pre-proline 0 N--CA 1.49 1.541 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.639 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.494 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 37.1 Cg_endo -73.33 169.87 21.24 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 122.948 2.432 . . . . 0.0 111.832 -169.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -29.69 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 126.147 2.154 . . . . 0.0 114.987 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.36 0 O-C-N 118.839 -2.413 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.647 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 53.77 -175.91 0.33 Allowed Glycine 0 N--CA 1.485 1.928 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.545 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.593 HG13 ' H ' ' A' ' 4' ' ' ASN . 15.4 pt -122.5 -107.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.593 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.4 t30 -175.63 35.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 125.474 1.51 . . . . 0.0 108.339 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' H ' HG13 ' A' ' 3' ' ' ILE . 42.8 t -126.21 166.06 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -100.47 140.71 34.33 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 124.906 1.379 . . . . 0.0 108.638 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.3 p -125.27 166.83 15.81 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 113.266 -1.788 . . . . 0.0 112.532 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -120.97 -40.95 2.57 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 110.635 -2.984 . . . . 0.0 104.973 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -124.11 175.02 7.26 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.546 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.1 p -94.67 34.14 1.37 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.552 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 13' ' ' CYS . . . -126.7 -44.69 0.24 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -73.17 7.51 2.12 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.95 1.3 . . . . 0.0 110.604 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 37.6 t -114.19 -41.04 3.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.117 -1.856 . . . . 0.0 106.204 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.493 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 7.6 tt -61.94 -35.45 78.47 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.794 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -66.82 -56.23 14.87 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.815 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.13 -31.96 44.15 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.047 1.831 . . . . 0.0 111.327 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.6 m -63.51 -56.3 17.14 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -48.67 -58.69 4.37 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -56.09 -25.84 47.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 128.245 3.466 . . . . 0.0 113.241 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.12 1.67 47.79 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 124.522 1.139 . . . . 0.0 111.133 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.96 43.08 2.3 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 115.166 0.826 . . . . 0.0 115.166 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.403 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 21.5 mmm -128.57 -167.32 1.75 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HE ' ' C ' ' A' ' 36' ' ' PRO . 45.8 mtm180 -112.85 -66.46 1.08 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.066 0.854 . . . . 0.0 109.442 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -121.27 179.26 4.47 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.987 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.493 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -137.59 148.12 19.64 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-N 112.81 -1.995 . . . . 0.0 114.676 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.405 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -147.36 148.79 31.72 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -99.58 140.12 34.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.22 -77.65 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.37 33.72 4.33 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.656 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.57 -21.88 40.87 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -102.62 165.41 11.09 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.504 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 15.6 t -90.16 148.36 23.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.511 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 29.0 t70 -131.18 146.41 52.32 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 103.366 -2.828 . . . . 0.0 103.366 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.647 ' H ' ' H ' ' A' ' 2' ' ' GLY . 58.5 m -111.6 173.75 6.2 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.685 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.8 m -121.03 64.88 13.07 Favored Pre-proline 0 N--CA 1.486 1.331 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.465 ' C ' ' HE ' ' A' ' 23' ' ' ARG . 59.6 Cg_endo -57.5 174.8 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 123.286 2.657 . . . . 0.0 113.397 -173.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -29.26 -60.38 0.14 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 112.995 -1.911 . . . . 0.0 113.667 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.333 0 O-C-N 119.412 -2.055 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.413 ' C ' ' H ' ' A' ' 34' ' ' CYS . 35.7 m . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.773 0.321 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -21.12 149.78 0.0 OUTLIER Glycine 0 N--CA 1.503 3.133 0 N-CA-C 119.541 2.576 . . . . 0.0 119.541 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.632 HG13 ' H ' ' A' ' 4' ' ' ASN . 13.3 pt -114.25 -103.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.632 ' H ' HG13 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -173.81 31.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.459 ' H ' HG13 ' A' ' 3' ' ' ILE . 46.3 t -131.52 165.71 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' N ' HG12 ' A' ' 5' ' ' VAL . 38.3 mtpt -103.6 140.86 36.98 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 125.016 1.448 . . . . 0.0 108.956 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 p -122.98 166.4 15.14 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.485 -1.689 . . . . 0.0 112.511 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -40.5 2.91 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 110.764 -2.925 . . . . 0.0 105.775 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -131.87 179.59 5.99 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.67 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.0 t -86.69 28.91 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.188 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.87 -51.16 0.19 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 103.294 -3.922 . . . . 0.0 103.294 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -22.6 2.03 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.506 -1.847 . . . . 0.0 110.077 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 44.3 t -99.24 -43.23 6.69 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.937 -1.938 . . . . 0.0 111.478 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.508 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.3 tt -53.73 -43.97 69.5 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.859 0.863 . . . . 0.0 112.329 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -61.46 -56.51 32.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 124.189 0.931 . . . . 0.0 112.707 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -67.57 -31.3 33.75 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.837 1.691 . . . . 0.0 110.323 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 9.2 m -61.44 -63.52 1.25 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -56.52 -47.82 78.53 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -59.03 -23.77 62.25 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 126.126 2.142 . . . . 0.0 111.486 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.91 -1.19 43.49 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 123.703 0.627 . . . . 0.0 110.391 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.67 40.8 1.54 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 116.112 1.205 . . . . 0.0 116.112 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.409 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 14.8 mmm -128.22 -164.04 1.34 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.3 mtm180 -111.57 -66.53 1.07 Allowed 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.14 178.86 5.33 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.234 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -140.6 149.0 20.63 Favored Glycine 0 C--O 1.215 -1.087 0 CA-C-N 113.101 -1.863 . . . . 0.0 114.502 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 21.5 ptmt -144.73 152.15 39.96 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -99.61 143.38 29.92 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.122 -1.431 . . . . 0.0 107.359 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.8 mm -114.68 -81.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.45 33.6 4.41 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.453 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.76 -22.57 35.13 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.103 -2.399 . . . . 0.0 107.103 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -99.97 163.81 12.28 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 11.4 t -90.44 150.78 21.69 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.557 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 32.5 t70 -135.01 144.23 47.24 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.573 ' SG ' HG23 ' A' ' 3' ' ' ILE . 35.9 m -112.37 167.48 10.4 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 119.317 0.962 . . . . 0.0 113.34 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.2 m -122.21 58.85 10.51 Favored Pre-proline 0 N--CA 1.487 1.421 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.072 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -68.41 173.67 9.38 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 123.25 2.634 . . . . 0.0 111.501 -168.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -29.35 -59.2 0.15 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 125.848 1.967 . . . . 0.0 113.761 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.338 0 O-C-N 119.391 -2.068 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 122.087 0.946 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -125.78 -170.29 13.0 Favored Glycine 0 C--N 1.306 -1.094 0 CA-C-N 113.391 -1.731 . . . . 0.0 113.67 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.625 HG13 ' H ' ' A' ' 4' ' ' ASN . 14.7 pt -111.62 -105.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.625 ' H ' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -173.8 36.81 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 124.415 1.072 . . . . 0.0 108.326 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.83 163.27 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.26 143.61 31.12 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 122.111 0.958 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.6 p -128.85 167.49 17.28 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 112.52 -2.127 . . . . 0.0 113.159 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -121.93 -42.64 2.38 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 110.216 -3.175 . . . . 0.0 105.272 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.0 m80 -127.13 177.37 6.7 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.293 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.2 m -88.64 28.16 1.18 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.902 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -121.22 -50.54 0.26 Allowed Glycine 0 N--CA 1.494 2.53 1 N-CA-C 102.504 -4.239 . . . . 0.0 102.504 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -24.96 2.05 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 113.053 -1.574 . . . . 0.0 109.523 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 35.6 t -97.58 -39.33 9.17 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 112.559 -2.109 . . . . 0.0 110.77 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.457 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -56.17 -45.3 79.77 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.198 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -58.05 -58.96 14.96 Favored Pre-proline 0 C--N 1.308 -1.196 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.829 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -66.97 -31.62 37.12 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.335 2.023 . . . . 0.0 110.888 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.748 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 32.8 m -61.38 -62.3 1.93 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -50.47 -54.42 22.28 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 113.82 -1.537 . . . . 0.0 107.997 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.19 -26.6 60.91 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 127.196 2.81 . . . . 0.0 112.072 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.08 2.19 48.43 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 124.004 0.815 . . . . 0.0 111.529 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.98 39.65 2.11 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.493 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 26.6 mmt -125.15 -164.27 1.27 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.42 ' HE ' ' C ' ' A' ' 36' ' ' PRO . 52.2 mtm180 -117.43 -62.04 1.62 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.19 178.82 5.36 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.167 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.457 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -131.9 150.74 19.63 Favored Glycine 0 C--O 1.216 -1.023 0 CA-C-N 113.15 -1.841 . . . . 0.0 113.792 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -145.15 140.72 28.17 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t -99.89 139.38 35.64 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 mt -116.91 -78.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 117.171 2.285 . . . . 0.0 117.171 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.38 35.36 3.47 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.353 1.033 . . . . 0.0 111.945 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.05 -21.38 41.97 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -105.11 166.37 10.44 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.748 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 37.9 t -84.97 149.54 25.54 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.877 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 26.6 t70 -134.71 120.91 20.06 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.593 ' SG ' HG23 ' A' ' 3' ' ' ILE . 21.8 m -99.66 166.06 11.3 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.646 1.112 . . . . 0.0 113.044 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.6 m -120.8 67.36 14.64 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.495 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.493 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 13.4 Cg_endo -80.92 176.37 9.02 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 123.175 2.583 . . . . 0.0 111.863 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -110.26 -58.72 2.03 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.278 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.381 0 O-C-N 119.456 -2.028 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -144.56 -170.94 14.11 Favored Glycine 0 C--O 1.216 -0.979 0 O-C-N 124.15 0.906 . . . . 0.0 111.124 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.648 HG23 ' SG ' ' A' ' 34' ' ' CYS . 12.9 pt -111.82 -104.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.622 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.7 t30 -176.01 33.76 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 124.714 1.259 . . . . 0.0 108.79 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' H ' HG13 ' A' ' 3' ' ' ILE . 46.6 t -125.65 164.0 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.471 ' C ' ' HD2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -99.96 139.38 35.71 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 124.732 1.27 . . . . 0.0 109.059 -179.723 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 p -123.36 166.75 14.8 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 112.616 -2.084 . . . . 0.0 111.525 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -42.79 2.21 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 110.513 -3.04 . . . . 0.0 103.953 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.405 ' C ' ' H ' ' A' ' 11' ' ' GLY . 18.7 m80 -124.32 179.0 5.08 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.081 0.944 . . . . 0.0 111.745 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.4 t -89.04 28.62 1.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.211 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -124.63 -50.59 0.2 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 103.301 -3.92 . . . . 0.0 103.301 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.95 -22.84 1.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.718 -1.741 . . . . 0.0 109.788 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 43.0 t -99.4 -43.89 6.39 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.493 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.5 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.4 tt -54.8 -44.09 73.49 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.616 0.766 . . . . 0.0 112.499 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -60.85 -56.44 35.02 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.877 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.53 -32.93 23.75 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.336 2.024 . . . . 0.0 111.287 178.535 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.728 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.1 m -61.07 -61.07 2.84 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -52.72 -52.79 54.77 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.888 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.82 -24.66 62.29 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 126.431 2.332 . . . . 0.0 111.817 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.28 1.71 47.45 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.077 0.861 . . . . 0.0 111.073 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.69 38.31 2.07 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 116.592 1.397 . . . . 0.0 116.592 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.441 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 25.7 mmt -125.64 -164.85 1.34 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -113.27 -63.78 1.4 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.75 178.37 5.73 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 123.954 0.784 . . . . 0.0 111.036 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.5 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -143.91 150.93 22.94 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-N 113.154 -1.839 . . . . 0.0 114.145 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.72 153.14 41.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.84 141.96 31.96 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.08 -78.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 116.509 2.041 . . . . 0.0 116.509 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -110.28 34.84 3.68 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 124.526 1.141 . . . . 0.0 111.223 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.6 -24.2 31.59 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -103.58 163.07 12.54 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.443 0.731 . . . . 0.0 109.138 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.728 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 12.7 t -84.13 146.97 27.59 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.474 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 9.9 t70 -129.8 130.48 45.38 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.648 ' SG ' HG23 ' A' ' 3' ' ' ILE . 15.4 m -103.8 161.22 14.13 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 119.745 1.157 . . . . 0.0 112.439 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.2 m -123.37 63.09 23.85 Favored Pre-proline 0 N--CA 1.488 1.442 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.831 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.441 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 32.8 Cg_endo -74.6 171.96 17.13 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.955 2.437 . . . . 0.0 111.377 -172.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -29.58 81.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 126.219 2.199 . . . . 0.0 116.128 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.379 0 O-C-N 118.79 -2.444 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.769 0.795 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -129.77 -170.98 12.84 Favored Glycine 0 C--O 1.216 -1.012 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.184 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.64 HG23 ' SG ' ' A' ' 34' ' ' CYS . 14.2 pt -112.06 -104.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.629 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.7 t30 -173.01 33.4 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 O-C-N 124.64 1.213 . . . . 0.0 108.932 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' H ' HG13 ' A' ' 3' ' ' ILE . 61.3 t -126.25 155.01 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -99.96 133.22 44.66 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 125.06 1.475 . . . . 0.0 111.226 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -123.61 167.13 14.35 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 112.458 -2.156 . . . . 0.0 111.959 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.466 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 6.9 mmpt? -117.79 -38.26 3.29 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 111.081 -2.781 . . . . 0.0 105.206 179.436 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -126.31 174.22 8.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.604 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -88.59 35.54 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.758 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.46 -50.63 0.21 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 104.531 -3.428 . . . . 0.0 104.531 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -56.15 -16.59 5.44 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 113.593 -1.304 . . . . 0.0 110.526 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 39.4 t -100.83 -41.31 6.91 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.255 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.428 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.9 tt -55.91 -46.13 78.51 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.023 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -57.93 -60.19 10.79 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.651 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -66.43 -32.75 39.65 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.102 1.868 . . . . 0.0 110.314 -177.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 33.5 m -59.84 -58.96 6.32 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -52.09 -56.0 17.19 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 124.888 1.367 . . . . 0.0 108.417 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -20.18 61.07 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 126.891 2.619 . . . . 0.0 113.268 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.3 -1.96 40.57 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 124.037 0.836 . . . . 0.0 109.841 179.557 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.93 38.19 2.06 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 115.735 1.054 . . . . 0.0 115.735 179.337 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.467 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 22.1 mmt -125.15 -165.71 1.44 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.21 -61.37 1.76 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.82 -178.21 4.2 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.195 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -131.05 154.17 20.68 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 112.267 -2.242 . . . . 0.0 113.361 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -151.83 136.13 16.75 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 t -99.74 143.06 30.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.6 -82.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.34 34.61 3.82 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.409 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.66 -20.99 40.09 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.082 -2.407 . . . . 0.0 107.082 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -100.02 166.61 10.96 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 36.4 t -91.6 150.95 20.93 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.488 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 25.1 t70 -137.01 124.04 21.54 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.64 ' SG ' HG23 ' A' ' 3' ' ' ILE . 28.5 m -99.75 176.5 5.43 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.466 1.03 . . . . 0.0 112.444 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.7 m -116.76 66.28 3.64 Favored Pre-proline 0 N--CA 1.486 1.327 0 CA-C-N 112.917 -1.947 . . . . 0.0 106.877 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.467 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 97.5 Cg_endo -63.04 179.05 0.86 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 123.962 3.108 . . . . 0.0 113.076 -176.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.75 179.28 4.31 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 112.844 -1.98 . . . . 0.0 111.671 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.3 0 O-C-N 119.208 -2.182 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 122.096 0.951 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -130.78 -170.38 12.67 Favored Glycine 0 C--N 1.308 -1.026 0 CA-C-N 113.513 -1.676 . . . . 0.0 113.022 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.63 HG23 ' SG ' ' A' ' 34' ' ' CYS . 13.7 pt -110.47 -104.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.617 ' H ' HG13 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -173.95 33.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 O-C-N 124.416 1.073 . . . . 0.0 108.585 -179.829 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' H ' HG13 ' A' ' 3' ' ' ILE . 59.1 t -125.48 158.53 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -100.82 138.47 37.83 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.305 1.003 . . . . 0.0 111.131 -179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 p -126.85 167.28 16.02 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.595 -2.093 . . . . 0.0 112.328 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -118.35 -39.0 3.08 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 110.955 -2.839 . . . . 0.0 105.645 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -126.32 175.09 8.08 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.956 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.4 m -89.5 34.16 0.82 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.511 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.9 -48.38 0.25 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 104.959 -3.256 . . . . 0.0 104.959 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.86 -11.88 6.38 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 113.536 -1.332 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 38.7 t -103.24 -41.6 6.01 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.775 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.501 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.4 tt -57.31 -43.04 82.92 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.353 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -60.85 -57.23 27.97 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.203 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.29 -32.22 26.91 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.531 2.154 . . . . 0.0 111.065 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 22.4 m -61.54 -60.92 2.97 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.36 -54.51 30.91 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -57.75 -23.81 53.93 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 126.577 2.423 . . . . 0.0 112.601 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.25 0.76 46.32 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 124.098 0.874 . . . . 0.0 111.013 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.7 39.07 2.26 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.526 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 25.7 mmt -124.82 -165.95 1.46 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -112.36 -64.93 1.23 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -124.87 179.08 5.16 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.692 0.758 . . . . 0.0 110.62 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.501 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -132.92 149.56 19.6 Favored Glycine 0 C--O 1.216 -0.992 0 CA-C-N 112.802 -1.999 . . . . 0.0 113.252 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -144.25 141.63 29.96 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 104.47 -2.418 . . . . 0.0 104.47 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.3 t -99.65 141.03 32.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.6 mt -117.13 -78.45 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.26 35.58 3.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.57 1.169 . . . . 0.0 111.465 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.23 -23.35 34.69 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -101.93 167.82 9.81 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.75 0.912 . . . . 0.0 109.055 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.1 t -88.38 148.84 24.04 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.667 -1.151 . . . . 0.0 113.946 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.518 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 13.5 t70 -132.97 124.14 27.2 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.63 ' SG ' HG23 ' A' ' 3' ' ' ILE . 22.0 m -99.83 162.45 12.99 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 119.605 1.093 . . . . 0.0 111.946 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.3 m -121.79 61.12 12.27 Favored Pre-proline 0 N--CA 1.489 1.496 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.536 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 66.7 Cg_endo -68.2 175.24 6.94 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 C-N-CA 123.172 2.581 . . . . 0.0 111.659 -172.443 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -29.38 -59.21 0.15 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 125.775 1.922 . . . . 0.0 113.894 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.337 0 O-C-N 119.425 -2.047 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.504 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -32.53 171.01 0.0 OUTLIER Glycine 0 N--CA 1.5 2.948 0 N-CA-C 120.304 2.882 . . . . 0.0 120.304 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.633 HG13 ' H ' ' A' ' 4' ' ' ASN . 13.5 pt -114.55 -105.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 112.434 -1.883 . . . . 0.0 106.705 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.633 ' H ' HG13 ' A' ' 3' ' ' ILE . 49.2 t30 -175.15 33.58 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 124.71 1.257 . . . . 0.0 108.951 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.457 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.3 t -124.25 163.22 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -99.98 136.87 39.23 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 124.457 1.098 . . . . 0.0 111.609 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 p -122.0 167.12 13.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.73 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -118.8 -41.12 2.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 110.598 -3.001 . . . . 0.0 105.405 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -126.21 177.22 6.53 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.607 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.5 p -87.33 21.05 2.56 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.904 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.58 -48.93 0.4 Allowed Glycine 0 N--CA 1.495 2.567 1 N-CA-C 103.088 -4.005 . . . . 0.0 103.088 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -23.91 4.37 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 113.071 -1.565 . . . . 0.0 109.522 179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 23.1 t -98.42 -36.01 10.1 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.827 -1.988 . . . . 0.0 111.035 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.428 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.0 tt -59.14 -42.3 90.34 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.288 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -60.17 -55.84 41.34 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-O 117.796 -1.097 . . . . 0.0 112.538 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -68.49 -36.81 14.36 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.289 1.992 . . . . 0.0 111.374 178.156 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 15.6 m -58.45 -59.43 5.36 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -52.85 -54.77 29.66 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.37 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.47 -24.74 57.53 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 126.764 2.54 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.41 -0.72 43.07 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 124.167 0.917 . . . . 0.0 111.541 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.38 38.78 1.58 Allowed Glycine 0 N--CA 1.483 1.809 0 N-CA-C 116.831 1.493 . . . . 0.0 116.831 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.445 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.8 mmt -124.18 -165.62 1.39 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -114.09 -62.41 1.6 Allowed 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -126.28 179.59 5.2 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.048 0.842 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.57 158.1 20.54 Favored Glycine 0 C--O 1.217 -0.913 0 CA-C-N 113.001 -1.909 . . . . 0.0 113.247 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.38 137.03 15.17 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 102.138 -3.282 . . . . 0.0 102.138 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t -99.62 142.39 31.17 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 117.928 -1.509 . . . . 0.0 107.601 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 33' ' ' ASP . 33.0 mt -109.63 -85.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -179.361 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 28' ' ' ILE . 22.9 p30 -110.38 35.35 3.48 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.272 0.982 . . . . 0.0 111.329 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.22 -22.06 33.94 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 106.382 -2.687 . . . . 0.0 106.382 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -99.68 166.4 11.13 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 39.1 t -89.9 146.3 24.51 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -179.477 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.504 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 37.6 t70 -129.64 137.35 50.62 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.573 ' SG ' HG23 ' A' ' 3' ' ' ILE . 17.1 m -110.66 160.17 16.93 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.276 -0.969 . . . . 0.0 112.39 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.5 m -122.42 62.65 16.92 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.409 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 66.6 Cg_endo -68.33 176.36 5.72 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 123.525 2.817 . . . . 0.0 111.665 -173.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 38' ' ' NH2 . 0.0 OUTLIER -29.43 -37.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.929 2.196 . . . . 0.0 116.929 179.993 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . 0.53 ' N ' ' HD3' ' A' ' 37' ' ' LYS . . . . . . . . 0 C--N 1.304 -1.38 0 O-C-N 118.555 -2.591 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.746 0.784 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.655 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 74.63 177.24 38.1 Favored Glycine 0 C--N 1.307 -1.075 0 CA-C-N 113.853 -1.522 . . . . 0.0 113.927 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.615 HG13 ' H ' ' A' ' 4' ' ' ASN . 12.4 pt -120.92 -106.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.615 ' H ' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -175.76 35.43 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 124.979 1.312 . . . . 0.0 108.022 -179.868 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.468 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.3 t -123.92 161.27 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 8.7 mtpm? -99.98 139.0 36.28 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 122.213 1.006 . . . . 0.0 111.244 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.0 p -125.44 167.37 15.08 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.709 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -117.51 -38.76 3.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 110.884 -2.871 . . . . 0.0 105.342 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -129.61 175.48 8.77 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.653 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.5 t -85.46 34.52 0.58 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.08 -48.47 0.19 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 106.598 -2.601 . . . . 0.0 106.598 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -62.65 -7.59 5.07 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.753 -1.224 . . . . 0.0 110.864 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 35.4 t -105.85 -40.6 5.66 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.301 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.448 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.0 tt -57.46 -45.11 85.13 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.341 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -60.36 -56.15 38.18 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-O 117.995 -1.002 . . . . 0.0 112.846 -179.688 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -67.23 -34.7 26.91 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.694 1.596 . . . . 0.0 110.928 178.578 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 11.9 m -60.39 -63.97 1.11 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -56.3 -45.08 80.37 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.122 0.889 . . . . 0.0 109.347 -179.73 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 10.7 t70 -61.3 -25.19 66.95 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 125.832 1.958 . . . . 0.0 111.091 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.99 0.57 46.59 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 123.929 0.768 . . . . 0.0 110.858 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.35 39.43 1.36 Allowed Glycine 0 N--CA 1.483 1.81 0 N-CA-C 117.008 1.563 . . . . 0.0 117.008 179.144 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.501 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 26.1 mmt -126.14 -164.56 1.33 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.9 mtm180 -114.01 -64.59 1.29 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -126.07 179.95 4.99 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.384 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.448 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -128.27 153.47 19.51 Favored Glycine 0 C--O 1.216 -1.013 0 CA-C-N 113.05 -1.886 . . . . 0.0 113.576 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -145.52 137.69 25.59 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -99.31 138.83 35.86 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 179.644 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.3 mt -116.45 -79.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 117.667 2.469 . . . . 0.0 117.667 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.31 35.29 3.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.468 1.105 . . . . 0.0 111.36 -179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.36 -22.82 36.33 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 106.922 -2.471 . . . . 0.0 106.922 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -102.46 168.26 9.42 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.815 0.95 . . . . 0.0 109.064 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 35.2 t -90.43 147.57 23.34 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 12.1 t70 -131.04 141.55 50.22 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.655 ' H ' ' H ' ' A' ' 2' ' ' GLY . 29.8 m -112.33 164.24 13.47 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 119.088 0.858 . . . . 0.0 112.315 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.3 m -121.5 58.12 7.94 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.781 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.501 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 36.7 Cg_endo -73.61 168.67 24.2 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.927 2.418 . . . . 0.0 111.51 -169.256 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -29.39 81.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 126.33 2.269 . . . . 0.0 115.69 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.401 0 O-C-N 118.711 -2.493 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.01 158.71 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -102.27 125.71 49.06 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 125.432 1.707 . . . . 0.0 107.635 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.7 p -114.14 167.56 10.58 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.773 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -119.5 -40.04 2.82 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 110.402 -3.09 . . . . 0.0 105.847 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.4 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.7 m-70 -129.84 176.82 7.73 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.645 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.1 m -87.46 25.52 1.42 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.815 -1.538 . . . . 0.0 109.301 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.01 -50.75 0.28 Allowed Glycine 0 N--CA 1.495 2.6 1 N-CA-C 102.48 -4.248 . . . . 0.0 102.48 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.39 -24.74 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.861 -1.669 . . . . 0.0 109.577 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 29.5 t -98.67 -37.41 9.52 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 112.551 -2.113 . . . . 0.0 111.527 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.434 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.8 tt -58.23 -43.57 87.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.432 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -60.24 -56.12 38.6 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-O 117.898 -1.049 . . . . 0.0 112.059 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.23 -34.25 28.29 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.248 1.965 . . . . 0.0 111.24 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 10.6 m -59.79 -59.96 4.6 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -52.17 -55.11 23.09 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.936 -1.483 . . . . 0.0 108.178 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.22 -23.36 55.53 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 127.089 2.743 . . . . 0.0 112.307 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 -1.4 42.79 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 123.915 0.759 . . . . 0.0 110.927 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.68 39.93 1.81 Allowed Glycine 0 N--CA 1.483 1.793 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.0 mmm -127.24 -165.74 1.51 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -111.29 -65.98 1.12 Allowed 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -123.88 -179.94 4.59 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.399 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.434 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.11 154.63 18.94 Favored Glycine 0 C--O 1.216 -1.031 0 CA-C-N 113.041 -1.89 . . . . 0.0 114.494 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -150.0 136.17 18.8 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.48 139.74 34.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -112.17 -80.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.41 34.53 3.88 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.982 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.34 -23.34 33.45 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 107.073 -2.411 . . . . 0.0 107.073 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -99.42 165.05 11.84 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.5 t -88.06 153.99 20.83 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.529 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 33.9 t70 -139.92 143.8 36.8 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.4 m -113.91 167.18 10.87 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 119.446 1.021 . . . . 0.0 112.812 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.6 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.195 179.79 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -125.88 162.28 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -99.63 135.47 41.0 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.821 1.326 . . . . 0.0 109.122 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 p -119.47 167.93 11.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.607 -2.088 . . . . 0.0 112.384 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -120.89 -43.59 2.45 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 110.023 -3.262 . . . . 0.0 105.404 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -124.13 177.34 5.87 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.678 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.4 p -89.38 26.84 1.57 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.875 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.92 -50.87 0.26 Allowed Glycine 0 N--CA 1.493 2.496 1 N-CA-C 102.544 -4.222 . . . . 0.0 102.544 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -24.06 1.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 112.803 -1.698 . . . . 0.0 109.628 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 39.6 t -98.97 -43.04 6.85 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.757 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.478 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.0 tt -55.09 -46.15 75.46 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.832 0.853 . . . . 0.0 112.104 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -56.38 -60.84 7.91 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 124.12 0.888 . . . . 0.0 111.521 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -66.11 -33.37 40.88 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.412 1.408 . . . . 0.0 109.965 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 13.2 m -58.67 -63.66 1.21 Allowed 'General case' 0 C--N 1.31 -1.15 0 O-C-N 123.599 0.562 . . . . 0.0 109.756 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -58.81 -47.28 85.32 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.284 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.11 -22.89 61.57 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 125.708 1.88 . . . . 0.0 111.695 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.27 -3.25 37.73 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 123.889 0.743 . . . . 0.0 110.594 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.67 38.1 1.11 Allowed Glycine 0 N--CA 1.482 1.727 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.449 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 25.4 mmt -126.41 -163.48 1.23 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -115.05 -63.09 1.51 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -128.16 -179.91 5.25 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.059 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.478 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -137.65 151.99 21.46 Favored Glycine 0 N--CA 1.472 1.043 0 CA-C-N 112.633 -2.076 . . . . 0.0 115.074 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -149.57 147.76 28.54 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -99.85 140.83 33.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.54 -80.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -110.33 33.67 4.36 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.141 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.47 -22.06 38.86 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -99.91 164.42 12.02 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.1 t -89.43 147.82 23.81 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.546 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 68.5 t0 -132.17 141.78 49.22 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.8 m -113.37 171.35 7.61 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 119.112 0.869 . . . . 0.0 111.916 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.0 m . . . . . 0 N--CA 1.484 1.259 0 O-C-N 125.068 1.48 . . . . 0.0 107.496 179.708 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.29 164.4 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -99.84 138.2 37.25 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 124.7 1.25 . . . . 0.0 108.517 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 p -123.92 167.16 14.49 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.377 -1.738 . . . . 0.0 112.563 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -119.25 -41.26 2.74 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 110.522 -3.035 . . . . 0.0 105.359 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 11' ' ' GLY . 87.2 m-70 -130.03 177.79 7.02 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.58 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 m -87.09 25.89 1.27 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 113.6 -1.636 . . . . 0.0 108.982 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -119.69 -50.26 0.3 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 103.205 -3.958 . . . . 0.0 103.205 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -24.87 3.21 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 113.012 -1.594 . . . . 0.0 109.763 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 27.3 t -97.92 -38.22 9.5 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.438 -2.165 . . . . 0.0 111.439 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.453 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.6 tt -58.06 -44.21 87.36 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.526 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -59.24 -56.85 31.85 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-O 117.877 -1.059 . . . . 0.0 112.079 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -67.55 -36.1 20.77 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.214 1.942 . . . . 0.0 111.418 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.64 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 12.5 m -58.96 -59.59 5.22 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -52.37 -55.33 22.36 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.658 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -57.38 -24.49 55.67 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 127.165 2.791 . . . . 0.0 112.086 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.21 -1.28 42.42 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.596 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.76 39.62 1.56 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 116.343 1.297 . . . . 0.0 116.343 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 13.5 mmm -127.51 -165.83 1.53 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -111.32 -66.21 1.1 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -123.84 -178.23 3.99 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.488 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.453 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.6 154.4 20.39 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 113.352 -1.749 . . . . 0.0 114.214 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -149.56 137.97 20.74 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -99.44 138.51 36.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.9 mm -112.82 -78.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -110.17 34.45 3.89 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.381 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.94 -26.21 23.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -99.77 165.06 11.76 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.375 0.691 . . . . 0.0 109.395 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.64 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 38.6 t -84.89 150.78 24.74 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.53 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.0 t70 -135.69 141.69 44.99 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.4 m -110.6 170.38 8.13 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 119.462 1.028 . . . . 0.0 112.819 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 N--CA 1.49 1.533 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.208 179.674 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.77 162.1 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -99.83 137.08 38.8 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.225 0.953 . . . . 0.0 110.77 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 p -123.06 167.58 13.46 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.834 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -119.71 -40.36 2.77 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 110.472 -3.058 . . . . 0.0 105.756 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.428 ' H ' ' HB2' ' A' ' 12' ' ' GLN . 21.9 m80 -128.34 177.69 6.78 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.902 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.9 t -84.2 19.26 1.88 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.961 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.29 -49.17 0.37 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 103.639 -3.784 . . . . 0.0 103.639 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.428 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -51.35 -24.16 4.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.905 -1.647 . . . . 0.0 109.882 179.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 25.4 t -98.96 -38.5 8.97 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 112.888 -1.96 . . . . 0.0 111.013 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.428 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.8 tt -57.34 -43.93 83.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.688 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -60.05 -55.62 43.62 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-O 118.137 -0.935 . . . . 0.0 112.942 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -67.38 -35.63 23.12 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.739 1.626 . . . . 0.0 109.97 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.695 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 19.2 m -56.73 -64.76 0.77 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -47.59 81.72 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.017 0.823 . . . . 0.0 109.665 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.0 -23.19 53.04 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 126.098 2.124 . . . . 0.0 112.022 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.14 -5.32 33.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.057 0.848 . . . . 0.0 110.758 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.79 38.87 1.02 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.422 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 11.1 mmm -127.13 -162.36 1.15 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -116.67 -64.67 1.28 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.85 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -124.66 179.4 4.99 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.499 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -127.75 160.74 21.75 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 112.701 -2.045 . . . . 0.0 113.56 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.444 ' HE3' ' H ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -156.24 135.84 12.45 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.444 ' H ' ' HE3' ' A' ' 26' ' ' LYS . 11.0 t -99.28 141.24 32.31 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 105.518 -2.031 . . . . 0.0 105.518 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.2 mt -115.21 -79.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.35 35.69 3.34 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 124.486 1.116 . . . . 0.0 111.343 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.63 -22.15 39.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -100.71 166.82 10.69 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.695 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.4 t -88.28 147.68 24.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.419 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 37.3 t70 -131.02 132.35 44.92 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.9 m -109.48 166.16 11.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.62 1.1 . . . . 0.0 113.675 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.9 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.646 179.823 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.6 t30 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.18 164.96 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HZ3' ' HB2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -99.62 145.97 26.98 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 124.875 1.359 . . . . 0.0 108.535 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 p -126.15 168.38 14.11 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.193 -1.821 . . . . 0.0 113.846 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -121.31 -43.07 2.43 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 110.047 -3.251 . . . . 0.0 105.554 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -131.72 179.2 6.21 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.545 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.3 m -89.44 34.61 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.977 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.77 -51.28 0.18 Allowed Glycine 0 N--CA 1.494 2.545 1 N-CA-C 102.998 -4.041 . . . . 0.0 102.998 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -23.04 1.9 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 112.668 -1.766 . . . . 0.0 109.934 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 39.4 t -98.7 -44.2 6.51 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.399 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.512 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.6 tt -54.3 -45.09 72.48 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.585 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.04 -56.86 31.31 Favored Pre-proline 0 C--N 1.306 -1.324 0 O-C-N 124.294 0.997 . . . . 0.0 113.032 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -67.62 -33.33 28.59 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.973 1.782 . . . . 0.0 110.418 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 16.9 m -59.58 -64.05 1.08 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -56.95 -47.78 79.87 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.238 0.961 . . . . 0.0 108.975 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -58.1 -24.53 59.02 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 126.119 2.137 . . . . 0.0 111.944 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.3 -2.36 39.65 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 124.039 0.837 . . . . 0.0 110.842 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.2 40.32 1.17 Allowed Glycine 0 N--CA 1.483 1.794 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.439 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 14.8 mmm -128.44 -163.02 1.24 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -114.56 -66.1 1.12 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.452 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -125.79 177.74 6.11 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.613 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.512 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -142.38 145.01 14.85 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 112.634 -2.076 . . . . 0.0 114.624 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 25' ' ' GLY . 12.6 mptt -138.51 153.47 48.77 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.5 t -99.97 132.41 45.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.24 -73.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -110.15 34.1 4.08 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.046 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.88 -25.16 29.36 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -100.92 168.11 9.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 21.3 t -86.77 145.58 26.58 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.465 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 36.6 t70 -131.59 136.46 47.81 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.3 m -108.56 166.94 10.4 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.872 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.486 1.335 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.831 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.88 165.37 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -99.86 140.58 33.86 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 124.556 1.16 . . . . 0.0 109.471 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 p -124.7 168.26 13.43 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.023 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -120.24 -43.92 2.51 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 109.977 -3.283 . . . . 0.0 104.96 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.412 ' C ' ' H ' ' A' ' 11' ' ' GLY . 43.1 m170 -128.06 177.26 7.01 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 124.968 1.417 . . . . 0.0 111.476 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.4 t -84.74 23.07 1.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.295 -1.775 . . . . 0.0 108.81 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.15 -49.89 0.29 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 103.475 -3.85 . . . . 0.0 103.475 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 -24.96 3.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 112.869 -1.666 . . . . 0.0 109.835 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 21.7 t -98.07 -38.79 9.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 112.578 -2.101 . . . . 0.0 111.748 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.438 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.7 tt -56.44 -44.55 80.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.78 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -59.76 -56.5 35.12 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 124.102 0.876 . . . . 0.0 112.611 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.61 -34.01 26.67 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.808 1.672 . . . . 0.0 110.32 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 9.9 m -59.01 -63.65 1.23 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.19 -47.67 80.68 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 124.088 0.868 . . . . 0.0 109.16 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.76 -25.32 60.29 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 125.976 2.048 . . . . 0.0 111.33 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.15 -1.94 41.06 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 123.876 0.735 . . . . 0.0 111.422 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.75 38.42 1.18 Allowed Glycine 0 N--CA 1.481 1.682 0 N-CA-C 116.929 1.531 . . . . 0.0 116.929 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.45 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 27.3 mmt -125.98 -164.34 1.31 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -114.29 -62.99 1.52 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -127.25 179.69 5.32 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 123.887 0.742 . . . . 0.0 110.734 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.438 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -128.24 156.75 20.98 Favored Glycine 0 C--O 1.216 -1.013 0 CA-C-N 113.064 -1.88 . . . . 0.0 114.295 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -149.25 138.1 21.19 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -99.43 132.95 44.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.2 mt -112.08 -74.15 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -110.08 35.22 3.48 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.905 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.79 -22.84 38.74 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 107.356 -2.298 . . . . 0.0 107.356 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 32' ' ' CYS . 19.8 ttpp -99.94 168.35 9.92 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 43.1 t -86.37 146.19 26.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.528 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 36.6 t70 -130.85 141.37 50.32 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 22' ' ' MET . 33.6 m -115.12 162.56 16.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 119.147 0.885 . . . . 0.0 112.076 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.5 m . . . . . 0 N--CA 1.487 1.423 0 CA-C-N 113.967 -1.47 . . . . 0.0 108.128 179.849 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.8 t30 . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.5 165.45 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -99.78 138.51 36.77 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 124.427 1.08 . . . . 0.0 109.906 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 p -121.86 167.45 13.02 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 112.693 -2.049 . . . . 0.0 112.212 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -117.87 -41.61 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.47 -3.059 . . . . 0.0 105.275 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' ' 11' ' ' GLY . 82.7 m-70 -131.8 177.2 7.71 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.985 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.3 m -86.58 26.63 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.17 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.12 -51.26 0.27 Allowed Glycine 0 N--CA 1.495 2.61 1 N-CA-C 102.636 -4.186 . . . . 0.0 102.636 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -24.07 3.73 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.623 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 14.9 t -98.19 -36.97 9.88 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.442 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.41 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.5 tt -57.62 -44.7 85.73 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.863 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.08 -54.37 54.63 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.245 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -67.01 -35.67 24.93 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.576 1.518 . . . . 0.0 110.335 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.625 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 6.5 m -57.62 -63.18 1.32 Allowed 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.37 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.8 -47.84 81.44 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 124.077 0.86 . . . . 0.0 109.365 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.49 -23.16 57.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 125.925 2.016 . . . . 0.0 112.048 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.33 -4.61 34.63 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 124.023 0.827 . . . . 0.0 110.521 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.25 39.94 1.0 Allowed Glycine 0 N--CA 1.483 1.786 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.422 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 19.2 mmm -128.27 -164.01 1.33 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -111.43 -65.87 1.13 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.444 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -127.09 -178.93 4.61 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 123.838 0.711 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.41 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -123.83 157.47 18.25 Favored Glycine 0 C--O 1.216 -1.003 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.846 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -150.7 133.46 15.83 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.1 t -99.43 140.33 33.76 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.55 -82.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -110.24 34.73 3.74 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.192 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.63 -23.41 31.42 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -101.04 165.6 11.23 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.625 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 39.4 t -88.52 150.12 23.26 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.521 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 31.5 t70 -134.46 143.4 47.5 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.7 m -112.91 166.28 11.54 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.682 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.5 m . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.712 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.1 t30 . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.52 162.96 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -99.78 140.06 34.54 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 124.608 1.192 . . . . 0.0 110.549 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.6 p -121.64 167.84 12.45 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.459 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.494 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 7.2 mmpt? -118.78 -42.66 2.71 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.3 -3.137 . . . . 0.0 104.463 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.407 ' C ' ' H ' ' A' ' 11' ' ' GLY . 26.7 m80 -128.41 176.19 7.91 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.179 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.1 m -87.49 25.75 1.38 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.922 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.82 -49.92 0.33 Allowed Glycine 0 N--CA 1.493 2.488 1 N-CA-C 102.353 -4.299 . . . . 0.0 102.353 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -23.83 4.55 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 113.18 -1.51 . . . . 0.0 109.587 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 26.3 t -97.45 -38.57 9.55 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 112.918 -1.946 . . . . 0.0 111.047 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.44 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.6 tt -59.54 -41.88 91.06 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.123 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -58.21 -58.92 15.32 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-O 117.871 -1.061 . . . . 0.0 111.301 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -68.42 -39.08 10.25 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.185 1.923 . . . . 0.0 111.055 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.712 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 14.4 m -55.39 -58.39 7.93 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -56.36 -52.77 63.35 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.385 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -62.45 -17.88 60.45 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 126.037 2.086 . . . . 0.0 112.303 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.46 -5.67 31.96 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 124.056 0.847 . . . . 0.0 109.659 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.76 37.21 1.31 Allowed Glycine 0 N--CA 1.481 1.665 0 N-CA-C 116.596 1.399 . . . . 0.0 116.596 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 14.3 mmm -127.32 -164.81 1.39 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -112.3 -64.54 1.28 Allowed 'General case' 0 C--N 1.309 -1.169 0 O-C-N 123.993 0.808 . . . . 0.0 110.389 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -124.35 -179.68 4.56 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.088 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.17 153.99 20.09 Favored Glycine 0 C--O 1.216 -0.98 0 CA-C-N 113.218 -1.81 . . . . 0.0 114.43 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -144.39 135.99 25.76 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -99.69 136.38 39.7 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 103.679 -2.711 . . . . 0.0 103.679 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.2 mm -113.26 -81.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 116.917 2.192 . . . . 0.0 116.917 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.22 34.38 3.93 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.426 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.27 -22.77 33.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -102.25 166.98 10.28 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.629 0.841 . . . . 0.0 109.269 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.712 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 37.3 t -90.09 148.78 22.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.459 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 39.2 t70 -132.63 137.12 46.9 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.0 m -108.74 162.77 13.86 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 119.796 1.18 . . . . 0.0 112.517 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.486 1.34 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.363 179.762 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.4 t30 . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 6' ' ' LYS . 44.2 t -126.72 166.51 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' N ' HG12 ' A' ' 5' ' ' VAL . 35.3 ttmt -99.96 138.01 37.63 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 124.841 1.338 . . . . 0.0 108.993 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 p -123.22 164.36 18.88 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.497 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 10.2 mmpt? -115.61 -41.11 3.28 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 111.168 -2.742 . . . . 0.0 104.108 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -126.1 175.31 7.84 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.308 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.1 p -91.37 24.73 2.84 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.525 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 13' ' ' CYS . . . -121.68 -43.02 0.43 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 105.63 -2.988 . . . . 0.0 105.63 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -74.4 5.4 4.67 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.28 -0.96 . . . . 0.0 109.762 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 14.3 t -114.53 -38.26 4.08 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 113.218 -1.81 . . . . 0.0 106.381 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tt -63.61 -39.36 94.18 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.748 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.493 ' N ' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -55.75 -61.51 6.17 Favored Pre-proline 0 N--CA 1.48 1.053 0 O-C-N 124.028 0.83 . . . . 0.0 109.594 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -66.96 -37.02 20.65 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.982 1.788 . . . . 0.0 110.634 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 7.7 m -55.54 -64.73 0.75 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.319 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -45.63 91.86 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.339 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.41 -22.66 54.89 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 125.504 1.753 . . . . 0.0 111.749 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.08 -6.67 31.23 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 123.994 0.809 . . . . 0.0 110.64 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.3 40.46 0.8 Allowed Glycine 0 N--CA 1.479 1.506 0 N-CA-C 116.466 1.347 . . . . 0.0 116.466 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.415 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 15.0 mmm -127.62 -166.01 1.55 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -111.27 -64.16 1.32 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.825 0.703 . . . . 0.0 109.531 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.34 179.91 4.89 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.934 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -124.57 154.32 17.97 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-N 113.166 -1.834 . . . . 0.0 114.748 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.23 134.46 15.09 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.4 t -99.52 139.63 34.89 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.27 -79.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 116.879 2.178 . . . . 0.0 116.879 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.16 34.61 3.8 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.47 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.97 -22.56 37.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -100.22 165.82 11.3 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 44.2 t -90.15 151.09 21.74 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.479 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.456 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.4 t70 -133.46 146.98 51.64 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.4 m -117.94 162.39 18.22 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.681 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.0 m . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.772 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.66 163.95 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.41 145.61 28.7 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 124.526 1.141 . . . . 0.0 110.266 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.3 p -128.38 167.21 17.31 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.808 -1.996 . . . . 0.0 112.991 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -121.17 -42.74 2.46 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 110.097 -3.228 . . . . 0.0 104.928 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.423 ' C ' ' H ' ' A' ' 11' ' ' GLY . 22.5 m80 -128.55 176.31 7.86 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.667 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.1 m -87.9 28.76 0.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.088 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.94 -50.93 0.26 Allowed Glycine 0 N--CA 1.495 2.567 1 N-CA-C 102.075 -4.41 . . . . 0.0 102.075 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.58 -25.93 1.96 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 113.239 -1.48 . . . . 0.0 109.384 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 31.0 t -96.75 -38.83 9.73 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.469 -2.15 . . . . 0.0 111.094 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.441 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -56.84 -45.64 82.24 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.514 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -57.65 -59.58 12.57 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.42 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.12 -33.39 40.71 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.428 1.419 . . . . 0.0 109.417 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.696 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.8 m -58.18 -64.29 0.97 Allowed 'General case' 0 C--N 1.307 -1.239 0 O-C-N 123.739 0.649 . . . . 0.0 109.932 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.515 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -57.97 -45.36 86.84 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.121 0.888 . . . . 0.0 109.553 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.515 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 40.4 m-20 -64.74 -18.53 65.13 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 125.59 1.806 . . . . 0.0 112.092 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.14 -3.89 36.79 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.24 41.08 1.31 Allowed Glycine 0 N--CA 1.483 1.811 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.423 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 13.1 mmm -128.49 -163.51 1.29 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -113.51 -64.12 1.35 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.611 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -125.79 179.15 5.32 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.469 0.652 . . . . 0.0 111.506 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.441 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -130.01 150.86 19.2 Favored Glycine 0 C--O 1.215 -1.076 0 CA-C-N 113.152 -1.84 . . . . 0.0 114.737 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -143.49 138.36 29.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.4 t -99.89 133.5 44.17 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.3 mm -114.33 -77.45 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -110.26 34.94 3.62 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.855 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.05 -19.69 52.04 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 32' ' ' CYS . 19.2 ttpp -106.41 168.54 9.09 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.696 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 35.0 t -88.28 149.7 23.66 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.507 -1.224 . . . . 0.0 114.186 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -134.94 123.61 23.65 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -99.94 162.18 13.15 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.153 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.488 1.441 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.144 179.893 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -126.92 165.56 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -99.88 147.58 25.38 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 124.595 1.184 . . . . 0.0 110.499 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p -127.67 168.14 15.46 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 112.547 -2.115 . . . . 0.0 113.114 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -119.95 -43.04 2.57 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 110.098 -3.228 . . . . 0.0 105.003 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.431 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.5 m-70 -132.88 176.88 8.09 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.536 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -85.63 28.89 0.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.455 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.37 -50.62 0.28 Allowed Glycine 0 N--CA 1.495 2.61 1 N-CA-C 102.551 -4.219 . . . . 0.0 102.551 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -25.68 3.87 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 112.962 -1.619 . . . . 0.0 109.593 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 25.7 t -97.01 -39.27 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 112.691 -2.05 . . . . 0.0 111.29 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.433 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.2 tt -57.28 -43.65 83.31 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.545 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -58.89 -57.45 26.87 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.605 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -68.09 -34.41 22.65 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.199 1.933 . . . . 0.0 109.985 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 14.8 m -58.06 -63.99 1.07 Allowed 'General case' 0 C--N 1.31 -1.127 0 O-C-N 123.837 0.711 . . . . 0.0 109.398 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -57.78 -47.3 82.93 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.265 0.978 . . . . 0.0 109.231 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -57.82 -24.37 57.05 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 126.02 2.075 . . . . 0.0 111.597 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.25 -3.41 37.46 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.137 0.898 . . . . 0.0 110.929 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.0 38.44 1.15 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.474 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.7 mmt -124.44 -164.71 1.29 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -115.43 -62.0 1.66 Allowed 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -126.92 179.44 5.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 123.883 0.739 . . . . 0.0 111.223 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.33 154.86 20.53 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-N 113.136 -1.847 . . . . 0.0 114.41 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -144.65 137.2 26.48 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -99.78 130.85 46.02 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.28 -78.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.23 34.53 3.85 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.831 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.46 -19.2 53.64 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 32' ' ' CYS . 18.4 ttpp -107.0 169.55 8.48 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 38.3 t -90.19 148.27 23.05 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.421 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 65.5 t0 -133.84 135.06 43.51 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.1 m -109.87 163.16 13.8 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 119.851 1.205 . . . . 0.0 113.421 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 N--CA 1.488 1.434 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.689 179.79 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.12 165.65 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -99.8 142.17 31.64 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 124.602 1.189 . . . . 0.0 109.027 -179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 p -123.59 166.53 15.31 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 112.43 -2.168 . . . . 0.0 112.041 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -121.79 -40.54 2.53 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 110.359 -3.109 . . . . 0.0 106.034 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.417 ' C ' ' H ' ' A' ' 11' ' ' GLY . 85.6 m-70 -134.13 179.82 6.02 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.05 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 t -84.71 29.42 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.167 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -125.93 -50.86 0.18 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 103.768 -3.733 . . . . 0.0 103.768 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -48.52 -24.87 1.44 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 112.958 -1.621 . . . . 0.0 110.069 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 33' ' ' ASP . 40.9 t -97.01 -42.05 8.08 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.64 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.51 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.6 tt -55.51 -45.89 77.06 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.394 0.677 . . . . 0.0 112.395 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -56.77 -58.92 14.23 Favored Pre-proline 0 C--N 1.309 -1.17 0 O-C-N 123.888 0.743 . . . . 0.0 112.379 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -68.25 -33.03 25.36 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.992 1.794 . . . . 0.0 110.458 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.6 m -59.87 -65.16 0.72 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.71 0.631 . . . . 0.0 109.305 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.499 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -56.56 -45.2 81.41 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.425 1.078 . . . . 0.0 108.952 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.499 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 52.8 t0 -60.85 -24.77 66.15 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 125.934 2.021 . . . . 0.0 110.752 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 -0.01 45.54 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.582 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.48 39.32 1.49 Allowed Glycine 0 N--CA 1.484 1.878 0 N-CA-C 116.691 1.436 . . . . 0.0 116.691 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.467 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.6 mmt -124.49 -163.74 1.19 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -118.49 -60.96 1.72 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.16 176.54 6.98 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.37 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -139.37 145.16 16.2 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.818 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HD2' ' C ' ' A' ' 25' ' ' GLY . 12.7 mptt -139.65 149.21 43.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.5 t -99.83 137.82 37.76 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.3 mt -115.12 -78.49 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -110.29 35.0 3.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.368 1.043 . . . . 0.0 111.282 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.3 -23.21 35.08 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -103.97 163.21 12.52 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 124.397 0.704 . . . . 0.0 109.151 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 25.3 t -82.14 148.46 28.49 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.346 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.416 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 36.8 t70 -131.94 129.22 39.95 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.4 m -106.84 164.15 12.35 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.977 1.262 . . . . 0.0 113.493 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.488 1.454 0 CA-C-N 113.329 -1.759 . . . . 0.0 108.942 179.827 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.8 t30 . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.57 164.83 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.441 ' C ' ' HD3' ' A' ' 6' ' ' LYS . 1.6 tmtm? -99.76 144.04 29.29 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 124.515 1.135 . . . . 0.0 109.783 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.4 p -125.09 167.41 14.82 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.613 -2.085 . . . . 0.0 112.898 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -119.43 -41.95 2.68 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 110.163 -3.199 . . . . 0.0 105.21 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.422 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.1 m-70 -132.23 176.2 8.6 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.521 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.7 p -85.37 26.42 0.91 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.564 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -119.39 -51.27 0.29 Allowed Glycine 0 N--CA 1.494 2.556 1 N-CA-C 102.832 -4.107 . . . . 0.0 102.832 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.66 -27.84 2.11 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.234 -1.483 . . . . 0.0 109.479 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 23.6 t -96.04 -35.84 11.24 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.116 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tt -59.24 -44.99 92.33 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.431 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 5.7 mptp? -56.1 -57.57 21.57 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.146 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 94.6 Cg_endo -68.35 -37.48 13.54 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.353 2.035 . . . . 0.0 111.845 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 7.4 m -57.78 -59.11 5.72 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -53.37 -54.65 33.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.585 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.18 -23.19 54.59 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 126.701 2.5 . . . . 0.0 112.402 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.38 -2.51 39.04 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 124.159 0.912 . . . . 0.0 111.282 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.84 38.31 1.44 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.442 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.1 mmt -123.82 -165.74 1.39 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -112.88 -62.86 1.52 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.45 -179.87 4.97 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.036 0.835 . . . . 0.0 110.433 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.13 157.04 16.14 Favored Glycine 0 C--O 1.216 -1.011 0 CA-C-N 113.147 -1.842 . . . . 0.0 113.53 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -149.46 132.77 16.5 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.2 t -99.5 132.28 44.93 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.0 mt -112.59 -78.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.37 34.91 3.66 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.364 1.04 . . . . 0.0 111.708 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.77 -17.05 58.85 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -105.01 168.22 9.2 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 43.2 t -90.75 147.62 23.11 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.535 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 13.3 t70 -132.29 144.01 50.29 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 22' ' ' MET . 29.8 m -114.5 160.39 19.28 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.449 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.0 m . . . . . 0 N--CA 1.488 1.446 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.172 179.792 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.73 165.5 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.93 143.31 30.3 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.256 1.027 . . . . 0.0 110.276 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 p -126.71 166.46 17.34 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 112.37 -2.196 . . . . 0.0 112.705 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -120.08 -40.68 2.7 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 110.44 -3.073 . . . . 0.0 105.847 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 11' ' ' GLY . 84.2 m-70 -131.87 178.5 6.72 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.386 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.4 m -85.1 23.14 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.329 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.34 -50.32 0.34 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 103.272 -3.931 . . . . 0.0 103.272 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.411 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -48.76 -25.79 2.02 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.3 -1.45 . . . . 0.0 109.595 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 34.6 t -97.28 -37.44 10.06 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 112.335 -2.211 . . . . 0.0 111.551 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.43 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -58.67 -43.98 90.06 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.063 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.403 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 2.1 mptm? -56.95 -58.2 19.3 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-O 118.24 -0.886 . . . . 0.0 112.036 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 91.2 Cg_endo -67.83 -36.61 17.89 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.396 2.064 . . . . 0.0 111.376 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 19.1 m -58.3 -60.54 3.62 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -52.26 -54.69 28.01 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.055 -1.43 . . . . 0.0 108.63 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.34 -23.11 55.73 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 126.954 2.659 . . . . 0.0 112.665 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.21 -2.37 39.88 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.131 0.894 . . . . 0.0 110.82 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.34 39.87 1.58 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 116.005 1.162 . . . . 0.0 116.005 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.4 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 12.4 mmm -126.73 -165.24 1.43 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -111.65 -67.42 1.0 Allowed 'General case' 0 C--N 1.31 -1.143 0 O-C-N 123.98 0.8 . . . . 0.0 109.474 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -123.47 179.53 4.71 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.739 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.43 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.77 156.27 20.02 Favored Glycine 0 C--O 1.215 -1.079 0 CA-C-N 112.918 -1.947 . . . . 0.0 114.099 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -151.4 138.32 19.02 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.3 t -99.6 138.71 36.3 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.2 mt -116.12 -79.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -110.38 35.34 3.48 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.413 1.07 . . . . 0.0 111.859 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.39 -22.08 38.9 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -103.93 166.36 10.46 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.594 0.82 . . . . 0.0 108.831 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 32.4 t -85.79 149.13 25.48 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.479 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 37.1 t70 -132.34 134.8 45.63 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.3 m -108.45 163.61 13.06 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 119.726 1.148 . . . . 0.0 112.537 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.838 179.856 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.2 t30 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.06 163.14 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -102.27 141.19 35.5 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 124.517 1.135 . . . . 0.0 109.711 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 p -118.52 168.73 10.4 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.064 -1.88 . . . . 0.0 112.938 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -118.17 -42.52 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 110.001 -3.272 . . . . 0.0 104.896 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.438 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.6 m-70 -132.9 175.7 9.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.627 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.0 m -85.6 28.9 0.73 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.255 -1.338 . . . . 0.0 109.296 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -121.28 -49.95 0.26 Allowed Glycine 0 N--CA 1.495 2.597 1 N-CA-C 102.916 -4.074 . . . . 0.0 102.916 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -23.07 4.88 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.109 -1.545 . . . . 0.0 109.753 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 33.8 t -97.72 -37.69 9.79 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 112.997 -1.911 . . . . 0.0 110.863 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.485 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.3 tt -59.21 -42.56 91.25 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.23 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -58.67 -57.17 28.65 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.251 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.9 -37.12 11.9 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.567 2.178 . . . . 0.0 111.855 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.692 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 12.8 m -58.82 -58.6 7.91 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -53.28 -54.81 30.88 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.242 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -57.81 -23.77 54.14 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 126.809 2.568 . . . . 0.0 112.34 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.38 -1.3 41.89 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 124.078 0.861 . . . . 0.0 111.301 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.12 38.61 1.65 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.447 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.6 mmt -124.25 -165.44 1.37 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -113.44 -62.7 1.55 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -126.25 178.57 5.74 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.045 0.84 . . . . 0.0 110.84 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.485 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -127.98 145.28 15.86 Favored Glycine 0 C--O 1.215 -1.083 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.571 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.22 136.58 45.69 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.8 t -99.6 132.29 45.04 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.1 mm -109.72 -83.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.35 33.94 4.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.439 1.087 . . . . 0.0 111.436 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.36 -19.08 46.65 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.015 -2.434 . . . . 0.0 107.015 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -103.01 165.42 11.03 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.757 0.916 . . . . 0.0 109.708 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.692 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 36.7 t -92.74 145.76 24.17 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.454 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 38.5 t70 -131.57 141.41 49.68 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.6 m -110.48 159.91 17.09 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 119.822 1.192 . . . . 0.0 112.553 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.2 m . . . . . 0 N--CA 1.489 1.495 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.476 179.88 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -126.87 158.26 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 8.0 mtpm? -102.89 133.85 47.28 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 124.503 1.127 . . . . 0.0 110.764 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 p -126.57 166.66 16.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.613 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -117.98 -35.63 3.82 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 111.659 -2.519 . . . . 0.0 105.705 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -123.56 173.32 8.13 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.07 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.6 p -91.26 35.22 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.059 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.57 -47.92 0.24 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 105.405 -3.078 . . . . 0.0 105.405 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -61.94 -8.41 5.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.618 1.567 . . . . 0.0 111.116 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 37.4 t -106.51 -41.76 5.19 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.671 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.48 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.8 tt -58.28 -41.09 83.61 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.995 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -62.81 -57.09 23.54 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-O 118.128 -0.939 . . . . 0.0 112.138 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -67.68 -32.59 30.1 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.467 2.111 . . . . 0.0 110.99 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.5 m -61.4 -60.71 3.31 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -51.28 -54.97 20.89 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.792 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -58.3 -23.75 57.36 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 127.09 2.744 . . . . 0.0 112.769 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.22 0.11 45.17 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 124.011 0.819 . . . . 0.0 110.833 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.53 40.57 2.02 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.401 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 12.6 mmm -127.15 -165.5 1.48 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -112.96 -65.51 1.18 Allowed 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.982 0.801 . . . . 0.0 109.16 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -123.83 -179.77 4.51 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.662 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.48 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -134.54 152.39 20.65 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-N 113.246 -1.797 . . . . 0.0 114.377 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -148.47 140.26 23.76 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -99.62 142.19 31.44 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 105.15 -2.166 . . . . 0.0 105.15 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.1 mm -115.11 -78.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.27 35.27 3.49 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.45 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.53 -24.51 29.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.223 -2.351 . . . . 0.0 107.223 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -99.95 167.92 10.19 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 124.761 0.918 . . . . 0.0 109.294 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 32.0 t -89.69 151.09 22.04 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -136.75 124.87 22.97 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.8 m -99.8 164.9 11.83 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 118.981 0.81 . . . . 0.0 112.367 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.7 m . . . . . 0 N--CA 1.487 1.418 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.075 179.874 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.5 t30 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.57 164.54 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -99.74 137.94 37.51 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 124.583 1.177 . . . . 0.0 110.432 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 p -121.7 167.88 12.44 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 112.387 -2.188 . . . . 0.0 111.778 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -120.18 -40.35 2.72 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 110.387 -3.097 . . . . 0.0 105.643 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.421 ' H ' ' HB2' ' A' ' 12' ' ' GLN . 20.3 m80 -128.89 177.9 6.77 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.946 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.5 t -85.8 21.99 1.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 113.24 -1.8 . . . . 0.0 108.758 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.91 -49.07 0.29 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 103.571 -3.812 . . . . 0.0 103.571 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.421 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -52.13 -21.99 3.8 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 113.004 -1.598 . . . . 0.0 110.067 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 32.8 t -99.95 -38.9 8.41 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 112.98 -1.918 . . . . 0.0 110.939 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.484 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.9 tt -58.98 -38.42 79.1 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.776 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.97 -56.67 22.91 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.997 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.14 -31.8 35.51 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.137 1.891 . . . . 0.0 110.824 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.5 m -62.26 -58.22 8.55 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HZ2' ' HB3' ' A' ' 18' ' ' LYS . 2.3 mmmp? -48.89 -57.51 6.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.617 1.198 . . . . 0.0 108.171 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -55.62 -27.17 48.11 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 128.186 3.429 . . . . 0.0 112.455 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 1.97 48.45 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 124.264 0.978 . . . . 0.0 111.458 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.86 43.72 2.05 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 115.241 0.856 . . . . 0.0 115.241 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.425 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 27.0 mmt -124.85 -166.57 1.54 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 116.972 0.386 . . . . 0.0 109.974 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -113.87 -62.94 1.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.19 177.27 6.79 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.971 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -132.01 150.91 19.68 Favored Glycine 0 C--O 1.216 -0.986 0 CA-C-N 112.504 -2.135 . . . . 0.0 112.98 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -146.98 140.93 25.94 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.64 141.08 32.91 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.96 -81.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -110.32 34.41 3.93 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.226 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.56 -24.15 29.48 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.401 -2.279 . . . . 0.0 107.401 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -100.7 165.65 11.28 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.694 0.879 . . . . 0.0 109.157 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 25.7 t -89.48 149.6 22.85 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.44 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.6 t70 -133.11 134.75 44.66 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.4 m -110.46 163.82 13.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 119.079 0.854 . . . . 0.0 111.489 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.49 1.541 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.639 179.812 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.4 t30 . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.21 166.06 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -100.47 140.71 34.33 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 124.906 1.379 . . . . 0.0 108.638 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.3 p -125.27 166.83 15.81 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 113.266 -1.788 . . . . 0.0 112.532 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -120.97 -40.95 2.57 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 110.635 -2.984 . . . . 0.0 104.973 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -124.11 175.02 7.26 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.546 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.1 p -94.67 34.14 1.37 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.552 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 13' ' ' CYS . . . -126.7 -44.69 0.24 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -73.17 7.51 2.12 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.95 1.3 . . . . 0.0 110.604 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 37.6 t -114.19 -41.04 3.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.117 -1.856 . . . . 0.0 106.204 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.493 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 7.6 tt -61.94 -35.45 78.47 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.794 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -66.82 -56.23 14.87 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.815 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.13 -31.96 44.15 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.047 1.831 . . . . 0.0 111.327 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.6 m -63.51 -56.3 17.14 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -48.67 -58.69 4.37 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -56.09 -25.84 47.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 128.245 3.466 . . . . 0.0 113.241 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.12 1.67 47.79 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 124.522 1.139 . . . . 0.0 111.133 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.96 43.08 2.3 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 115.166 0.826 . . . . 0.0 115.166 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.403 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 21.5 mmm -128.57 -167.32 1.75 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -112.85 -66.46 1.08 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.066 0.854 . . . . 0.0 109.442 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -121.27 179.26 4.47 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.987 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.493 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -137.59 148.12 19.64 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-N 112.81 -1.995 . . . . 0.0 114.676 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.405 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -147.36 148.79 31.72 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -99.58 140.12 34.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.22 -77.65 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.37 33.72 4.33 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.656 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.57 -21.88 40.87 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -102.62 165.41 11.09 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 15.6 t -90.16 148.36 23.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.511 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 29.0 t70 -131.18 146.41 52.32 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 103.366 -2.828 . . . . 0.0 103.366 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.5 m -111.6 173.75 6.2 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.685 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.8 m . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.827 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 6' ' ' LYS . 46.3 t -131.52 165.71 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' N ' HG12 ' A' ' 5' ' ' VAL . 38.3 mtpt -103.6 140.86 36.98 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 125.016 1.448 . . . . 0.0 108.956 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 p -122.98 166.4 15.14 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.485 -1.689 . . . . 0.0 112.511 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -40.5 2.91 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 110.764 -2.925 . . . . 0.0 105.775 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -131.87 179.59 5.99 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.67 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.0 t -86.69 28.91 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.188 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.87 -51.16 0.19 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 103.294 -3.922 . . . . 0.0 103.294 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -22.6 2.03 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.506 -1.847 . . . . 0.0 110.077 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 44.3 t -99.24 -43.23 6.69 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.937 -1.938 . . . . 0.0 111.478 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.508 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.3 tt -53.73 -43.97 69.5 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.859 0.863 . . . . 0.0 112.329 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -61.46 -56.51 32.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 124.189 0.931 . . . . 0.0 112.707 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -67.57 -31.3 33.75 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.837 1.691 . . . . 0.0 110.323 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 9.2 m -61.44 -63.52 1.25 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -56.52 -47.82 78.53 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -59.03 -23.77 62.25 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 126.126 2.142 . . . . 0.0 111.486 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.91 -1.19 43.49 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 123.703 0.627 . . . . 0.0 110.391 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.67 40.8 1.54 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 116.112 1.205 . . . . 0.0 116.112 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.409 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 14.8 mmm -128.22 -164.04 1.34 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.3 mtm180 -111.57 -66.53 1.07 Allowed 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.14 178.86 5.33 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.234 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -140.6 149.0 20.63 Favored Glycine 0 C--O 1.215 -1.087 0 CA-C-N 113.101 -1.863 . . . . 0.0 114.502 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 21.5 ptmt -144.73 152.15 39.96 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -99.61 143.38 29.92 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.122 -1.431 . . . . 0.0 107.359 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.8 mm -114.68 -81.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.45 33.6 4.41 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.453 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.76 -22.57 35.13 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.103 -2.399 . . . . 0.0 107.103 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -99.97 163.81 12.28 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 11.4 t -90.44 150.78 21.69 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.557 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 32.5 t70 -135.01 144.23 47.24 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.9 m -112.37 167.48 10.4 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 119.317 0.962 . . . . 0.0 113.34 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.487 1.421 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.072 179.825 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.83 163.27 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.26 143.61 31.12 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 122.111 0.958 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.6 p -128.85 167.49 17.28 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 112.52 -2.127 . . . . 0.0 113.159 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -121.93 -42.64 2.38 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 110.216 -3.175 . . . . 0.0 105.272 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.0 m80 -127.13 177.37 6.7 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.293 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.2 m -88.64 28.16 1.18 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.902 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -121.22 -50.54 0.26 Allowed Glycine 0 N--CA 1.494 2.53 1 N-CA-C 102.504 -4.239 . . . . 0.0 102.504 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -24.96 2.05 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 113.053 -1.574 . . . . 0.0 109.523 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 35.6 t -97.58 -39.33 9.17 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 112.559 -2.109 . . . . 0.0 110.77 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.457 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -56.17 -45.3 79.77 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.198 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -58.05 -58.96 14.96 Favored Pre-proline 0 C--N 1.308 -1.196 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.829 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -66.97 -31.62 37.12 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.335 2.023 . . . . 0.0 110.888 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.748 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 32.8 m -61.38 -62.3 1.93 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -50.47 -54.42 22.28 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 113.82 -1.537 . . . . 0.0 107.997 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.19 -26.6 60.91 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 127.196 2.81 . . . . 0.0 112.072 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.08 2.19 48.43 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 124.004 0.815 . . . . 0.0 111.529 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.98 39.65 2.11 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.426 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 26.6 mmt -125.15 -164.27 1.27 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -117.43 -62.04 1.62 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.19 178.82 5.36 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.167 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.457 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -131.9 150.74 19.63 Favored Glycine 0 C--O 1.216 -1.023 0 CA-C-N 113.15 -1.841 . . . . 0.0 113.792 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -145.15 140.72 28.17 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t -99.89 139.38 35.64 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 mt -116.91 -78.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 117.171 2.285 . . . . 0.0 117.171 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.38 35.36 3.47 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.353 1.033 . . . . 0.0 111.945 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.05 -21.38 41.97 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -105.11 166.37 10.44 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.748 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 37.9 t -84.97 149.54 25.54 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.877 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -134.71 120.91 20.06 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.8 m -99.66 166.06 11.3 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.646 1.112 . . . . 0.0 113.044 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.6 m . . . . . 0 N--CA 1.488 1.469 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.495 179.86 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.65 164.0 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.471 ' C ' ' HD2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -99.96 139.38 35.71 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 124.732 1.27 . . . . 0.0 109.059 -179.723 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 p -123.36 166.75 14.8 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 112.616 -2.084 . . . . 0.0 111.525 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -42.79 2.21 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 110.513 -3.04 . . . . 0.0 103.953 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.405 ' C ' ' H ' ' A' ' 11' ' ' GLY . 18.7 m80 -124.32 179.0 5.08 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.081 0.944 . . . . 0.0 111.745 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.4 t -89.04 28.62 1.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.211 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -124.63 -50.59 0.2 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 103.301 -3.92 . . . . 0.0 103.301 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.95 -22.84 1.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.718 -1.741 . . . . 0.0 109.788 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 43.0 t -99.4 -43.89 6.39 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.493 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.5 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.4 tt -54.8 -44.09 73.49 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.616 0.766 . . . . 0.0 112.499 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -60.85 -56.44 35.02 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.877 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.53 -32.93 23.75 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.336 2.024 . . . . 0.0 111.287 178.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.728 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.1 m -61.07 -61.07 2.84 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -52.72 -52.79 54.77 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.888 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.82 -24.66 62.29 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 126.431 2.332 . . . . 0.0 111.817 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.28 1.71 47.45 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.077 0.861 . . . . 0.0 111.073 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.69 38.31 2.07 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 116.592 1.397 . . . . 0.0 116.592 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.421 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 25.7 mmt -125.64 -164.85 1.34 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -113.27 -63.78 1.4 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.75 178.37 5.73 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 123.954 0.784 . . . . 0.0 111.036 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.5 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -143.91 150.93 22.94 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-N 113.154 -1.839 . . . . 0.0 114.145 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.72 153.14 41.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.84 141.96 31.96 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.08 -78.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 116.509 2.041 . . . . 0.0 116.509 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -110.28 34.84 3.68 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 124.526 1.141 . . . . 0.0 111.223 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.6 -24.2 31.59 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -103.58 163.07 12.54 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.443 0.731 . . . . 0.0 109.138 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.728 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 12.7 t -84.13 146.97 27.59 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.9 t70 -129.8 130.48 45.38 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.4 m -103.8 161.22 14.13 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 119.745 1.157 . . . . 0.0 112.439 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.2 m . . . . . 0 N--CA 1.488 1.442 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.831 179.807 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.25 155.01 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -99.96 133.22 44.66 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 125.06 1.475 . . . . 0.0 111.226 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -123.61 167.13 14.35 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 112.458 -2.156 . . . . 0.0 111.959 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.466 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 6.9 mmpt? -117.79 -38.26 3.29 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 111.081 -2.781 . . . . 0.0 105.206 179.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -126.31 174.22 8.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.604 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -88.59 35.54 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.758 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.46 -50.63 0.21 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 104.531 -3.428 . . . . 0.0 104.531 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -56.15 -16.59 5.44 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 113.593 -1.304 . . . . 0.0 110.526 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.461 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 39.4 t -100.83 -41.31 6.91 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.255 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.428 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.9 tt -55.91 -46.13 78.51 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.023 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -57.93 -60.19 10.79 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.651 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -66.43 -32.75 39.65 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.102 1.868 . . . . 0.0 110.314 -177.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 33.5 m -59.84 -58.96 6.32 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -52.09 -56.0 17.19 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 124.888 1.367 . . . . 0.0 108.417 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -20.18 61.07 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 126.891 2.619 . . . . 0.0 113.268 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.3 -1.96 40.57 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 124.037 0.836 . . . . 0.0 109.841 179.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.93 38.19 2.06 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 115.735 1.054 . . . . 0.0 115.735 179.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.403 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 22.1 mmt -125.15 -165.71 1.44 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.21 -61.37 1.76 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.82 -178.21 4.2 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.195 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -131.05 154.17 20.68 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 112.267 -2.242 . . . . 0.0 113.361 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -151.83 136.13 16.75 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 t -99.74 143.06 30.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.6 -82.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.34 34.61 3.82 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.409 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.66 -20.99 40.09 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.082 -2.407 . . . . 0.0 107.082 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -100.02 166.61 10.96 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 36.4 t -91.6 150.95 20.93 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -137.01 124.04 21.54 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 28.5 m -99.75 176.5 5.43 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.466 1.03 . . . . 0.0 112.444 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.7 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-N 112.917 -1.947 . . . . 0.0 106.877 179.771 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.48 158.53 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -100.82 138.47 37.83 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.305 1.003 . . . . 0.0 111.131 -179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 p -126.85 167.28 16.02 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.595 -2.093 . . . . 0.0 112.328 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -118.35 -39.0 3.08 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 110.955 -2.839 . . . . 0.0 105.645 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -126.32 175.09 8.08 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.956 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.4 m -89.5 34.16 0.82 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.511 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.9 -48.38 0.25 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 104.959 -3.256 . . . . 0.0 104.959 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.86 -11.88 6.38 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 113.536 -1.332 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 38.7 t -103.24 -41.6 6.01 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.775 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.501 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.4 tt -57.31 -43.04 82.92 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.353 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -60.85 -57.23 27.97 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.203 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.29 -32.22 26.91 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.531 2.154 . . . . 0.0 111.065 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 22.4 m -61.54 -60.92 2.97 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.36 -54.51 30.91 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -57.75 -23.81 53.93 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 126.577 2.423 . . . . 0.0 112.601 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.25 0.76 46.32 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 124.098 0.874 . . . . 0.0 111.013 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.7 39.07 2.26 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.415 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 25.7 mmt -124.82 -165.95 1.46 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -112.36 -64.93 1.23 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -124.87 179.08 5.16 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.692 0.758 . . . . 0.0 110.62 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.501 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -132.92 149.56 19.6 Favored Glycine 0 C--O 1.216 -0.992 0 CA-C-N 112.802 -1.999 . . . . 0.0 113.252 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -144.25 141.63 29.96 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 104.47 -2.418 . . . . 0.0 104.47 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.3 t -99.65 141.03 32.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.6 mt -117.13 -78.45 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.26 35.58 3.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.57 1.169 . . . . 0.0 111.465 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.23 -23.35 34.69 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -101.93 167.82 9.81 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.75 0.912 . . . . 0.0 109.055 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.1 t -88.38 148.84 24.04 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.667 -1.151 . . . . 0.0 113.946 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -132.97 124.14 27.2 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.0 m -99.83 162.45 12.99 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 119.605 1.093 . . . . 0.0 111.946 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.489 1.496 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.536 179.891 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.2 t30 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.25 163.22 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -99.98 136.87 39.23 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 124.457 1.098 . . . . 0.0 111.609 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 p -122.0 167.12 13.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.73 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -118.8 -41.12 2.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 110.598 -3.001 . . . . 0.0 105.405 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -126.21 177.22 6.53 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.607 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.5 p -87.33 21.05 2.56 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.904 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.58 -48.93 0.4 Allowed Glycine 0 N--CA 1.495 2.567 1 N-CA-C 103.088 -4.005 . . . . 0.0 103.088 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -23.91 4.37 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 113.071 -1.565 . . . . 0.0 109.522 179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 23.1 t -98.42 -36.01 10.1 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.827 -1.988 . . . . 0.0 111.035 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.428 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.0 tt -59.14 -42.3 90.34 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.288 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -60.17 -55.84 41.34 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-O 117.796 -1.097 . . . . 0.0 112.538 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -68.49 -36.81 14.36 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.289 1.992 . . . . 0.0 111.374 178.156 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 15.6 m -58.45 -59.43 5.36 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -52.85 -54.77 29.66 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.37 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.47 -24.74 57.53 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 126.764 2.54 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.41 -0.72 43.07 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 124.167 0.917 . . . . 0.0 111.541 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.38 38.78 1.58 Allowed Glycine 0 N--CA 1.483 1.809 0 N-CA-C 116.831 1.493 . . . . 0.0 116.831 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.445 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.8 mmt -124.18 -165.62 1.39 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -114.09 -62.41 1.6 Allowed 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -126.28 179.59 5.2 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.048 0.842 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.57 158.1 20.54 Favored Glycine 0 C--O 1.217 -0.913 0 CA-C-N 113.001 -1.909 . . . . 0.0 113.247 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.38 137.03 15.17 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 102.138 -3.282 . . . . 0.0 102.138 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t -99.62 142.39 31.17 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 117.928 -1.509 . . . . 0.0 107.601 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 33' ' ' ASP . 33.0 mt -109.63 -85.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -179.361 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 28' ' ' ILE . 22.9 p30 -110.38 35.35 3.48 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.272 0.982 . . . . 0.0 111.329 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.22 -22.06 33.94 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 106.382 -2.687 . . . . 0.0 106.382 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -99.68 166.4 11.13 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 39.1 t -89.9 146.3 24.51 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -179.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.49 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 37.6 t70 -129.64 137.35 50.62 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 m -110.66 160.17 16.93 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.276 -0.969 . . . . 0.0 112.39 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 N--CA 1.488 1.434 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.409 179.791 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.92 161.27 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 8.7 mtpm? -99.98 139.0 36.28 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 122.213 1.006 . . . . 0.0 111.244 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.0 p -125.44 167.37 15.08 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.709 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -117.51 -38.76 3.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 110.884 -2.871 . . . . 0.0 105.342 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -129.61 175.48 8.77 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.653 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.5 t -85.46 34.52 0.58 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.08 -48.47 0.19 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 106.598 -2.601 . . . . 0.0 106.598 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -62.65 -7.59 5.07 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.753 -1.224 . . . . 0.0 110.864 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 35.4 t -105.85 -40.6 5.66 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.301 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.448 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.0 tt -57.46 -45.11 85.13 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.341 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -60.36 -56.15 38.18 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-O 117.995 -1.002 . . . . 0.0 112.846 -179.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -67.23 -34.7 26.91 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.694 1.596 . . . . 0.0 110.928 178.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 11.9 m -60.39 -63.97 1.11 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -56.3 -45.08 80.37 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.122 0.889 . . . . 0.0 109.347 -179.73 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 10.7 t70 -61.3 -25.19 66.95 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 125.832 1.958 . . . . 0.0 111.091 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.99 0.57 46.59 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 123.929 0.768 . . . . 0.0 110.858 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.35 39.43 1.36 Allowed Glycine 0 N--CA 1.483 1.81 0 N-CA-C 117.008 1.563 . . . . 0.0 117.008 179.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.442 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 26.1 mmt -126.14 -164.56 1.33 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.9 mtm180 -114.01 -64.59 1.29 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -126.07 179.95 4.99 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.384 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.448 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -128.27 153.47 19.51 Favored Glycine 0 C--O 1.216 -1.013 0 CA-C-N 113.05 -1.886 . . . . 0.0 113.576 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -145.52 137.69 25.59 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -99.31 138.83 35.86 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 179.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.3 mt -116.45 -79.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 117.667 2.469 . . . . 0.0 117.667 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.31 35.29 3.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.468 1.105 . . . . 0.0 111.36 -179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.36 -22.82 36.33 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 106.922 -2.471 . . . . 0.0 106.922 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -102.46 168.26 9.42 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.815 0.95 . . . . 0.0 109.064 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 35.2 t -90.43 147.57 23.34 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 12.1 t70 -131.04 141.55 50.22 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.434 ' SG ' ' HG3' ' A' ' 22' ' ' MET . 29.8 m -112.33 164.24 13.47 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 119.088 0.858 . . . . 0.0 112.315 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.3 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.781 179.82 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 34' ' ' CYS . 35.8 m . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.815 0.34 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -21.54 148.15 0.0 OUTLIER Glycine 0 N--CA 1.503 3.133 0 N-CA-C 119.478 2.551 . . . . 0.0 119.478 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.625 HG13 ' H ' ' A' ' 4' ' ' ASN . 14.6 pt -115.06 -103.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.625 ' H ' HG13 ' A' ' 3' ' ' ILE . 15.3 t-20 -173.26 38.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.01 158.71 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -102.27 125.71 49.06 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 125.432 1.707 . . . . 0.0 107.635 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.7 p -114.14 167.56 10.58 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.773 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -119.5 -40.04 2.82 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 110.402 -3.09 . . . . 0.0 105.847 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.4 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.7 m-70 -129.84 176.82 7.73 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.645 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.1 m -87.46 25.52 1.42 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.815 -1.538 . . . . 0.0 109.301 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.01 -50.75 0.28 Allowed Glycine 0 N--CA 1.495 2.6 1 N-CA-C 102.48 -4.248 . . . . 0.0 102.48 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.39 -24.74 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.861 -1.669 . . . . 0.0 109.577 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 29.5 t -98.67 -37.41 9.52 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 112.551 -2.113 . . . . 0.0 111.527 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.434 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.8 tt -58.23 -43.57 87.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.432 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -60.24 -56.12 38.6 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-O 117.898 -1.049 . . . . 0.0 112.059 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.23 -34.25 28.29 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.248 1.965 . . . . 0.0 111.24 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 10.6 m -59.79 -59.96 4.6 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -52.17 -55.11 23.09 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.936 -1.483 . . . . 0.0 108.178 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.22 -23.36 55.53 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 127.089 2.743 . . . . 0.0 112.307 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 -1.4 42.79 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 123.915 0.759 . . . . 0.0 110.927 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.68 39.93 1.81 Allowed Glycine 0 N--CA 1.483 1.793 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.0 mmm -127.24 -165.74 1.51 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -111.29 -65.98 1.12 Allowed 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -123.88 -179.94 4.59 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.399 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.434 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.11 154.63 18.94 Favored Glycine 0 C--O 1.216 -1.031 0 CA-C-N 113.041 -1.89 . . . . 0.0 114.494 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -150.0 136.17 18.8 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.48 139.74 34.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -112.17 -80.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.41 34.53 3.88 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.982 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.34 -23.34 33.45 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 107.073 -2.411 . . . . 0.0 107.073 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -99.42 165.05 11.84 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.5 t -88.06 153.99 20.83 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.529 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 33.9 t70 -139.92 143.8 36.8 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.604 ' SG ' HG23 ' A' ' 3' ' ' ILE . 38.4 m -113.91 167.18 10.87 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 119.446 1.021 . . . . 0.0 112.812 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.6 m -121.38 58.75 8.28 Favored Pre-proline 0 N--CA 1.489 1.486 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.195 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.05 174.26 8.17 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.25 2.633 . . . . 0.0 111.508 -168.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -29.39 -50.53 0.1 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 125.701 1.876 . . . . 0.0 115.2 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 119.002 -2.311 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 123.355 1.55 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.583 ' N ' ' H ' ' A' ' 34' ' ' CYS . . . 124.69 176.0 14.47 Favored Glycine 0 C--N 1.301 -1.399 0 CA-C-N 112.175 -2.284 . . . . 0.0 113.258 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.622 HG13 ' H ' ' A' ' 4' ' ' ASN . 11.0 pt -121.61 -106.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.622 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.7 t30 -176.01 37.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 125.409 1.484 . . . . 0.0 107.812 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.464 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.2 t -125.88 162.28 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -99.63 135.47 41.0 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.821 1.326 . . . . 0.0 109.122 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 p -119.47 167.93 11.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.607 -2.088 . . . . 0.0 112.384 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -120.89 -43.59 2.45 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 110.023 -3.262 . . . . 0.0 105.404 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -124.13 177.34 5.87 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.678 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.4 p -89.38 26.84 1.57 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.875 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.92 -50.87 0.26 Allowed Glycine 0 N--CA 1.493 2.496 1 N-CA-C 102.544 -4.222 . . . . 0.0 102.544 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -24.06 1.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 112.803 -1.698 . . . . 0.0 109.628 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 39.6 t -98.97 -43.04 6.85 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.757 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.478 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.0 tt -55.09 -46.15 75.46 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.832 0.853 . . . . 0.0 112.104 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -56.38 -60.84 7.91 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 124.12 0.888 . . . . 0.0 111.521 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -66.11 -33.37 40.88 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.412 1.408 . . . . 0.0 109.965 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 13.2 m -58.67 -63.66 1.21 Allowed 'General case' 0 C--N 1.31 -1.15 0 O-C-N 123.599 0.562 . . . . 0.0 109.756 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -58.81 -47.28 85.32 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.284 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.11 -22.89 61.57 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 125.708 1.88 . . . . 0.0 111.695 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.27 -3.25 37.73 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 123.889 0.743 . . . . 0.0 110.594 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.67 38.1 1.11 Allowed Glycine 0 N--CA 1.482 1.727 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.449 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 25.4 mmt -126.41 -163.48 1.23 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -115.05 -63.09 1.51 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -128.16 -179.91 5.25 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.059 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.478 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -137.65 151.99 21.46 Favored Glycine 0 N--CA 1.472 1.043 0 CA-C-N 112.633 -2.076 . . . . 0.0 115.074 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -149.57 147.76 28.54 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -99.85 140.83 33.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.54 -80.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -110.33 33.67 4.36 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.141 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.47 -22.06 38.86 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -99.91 164.42 12.02 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.1 t -89.43 147.82 23.81 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.546 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 68.5 t0 -132.17 141.78 49.22 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.583 ' H ' ' N ' ' A' ' 2' ' ' GLY . 33.8 m -113.37 171.35 7.61 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 119.112 0.869 . . . . 0.0 111.916 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.0 m -118.72 64.42 6.2 Favored Pre-proline 0 N--CA 1.484 1.259 0 O-C-N 125.068 1.48 . . . . 0.0 107.496 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 73.8 Cg_endo -59.18 176.79 0.45 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 123.484 2.79 . . . . 0.0 112.677 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.18 60.29 0.6 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.918 -1.946 . . . . 0.0 107.338 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.325 0 O-C-N 119.278 -2.139 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.4 m . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.747 0.784 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.12 -163.35 28.89 Favored Glycine 0 C--N 1.306 -1.102 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.696 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.624 HG13 ' H ' ' A' ' 4' ' ' ASN . 11.8 pt -116.35 -107.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.624 ' H ' HG13 ' A' ' 3' ' ' ILE . 15.8 t-20 -176.45 40.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.7 t -126.29 164.4 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -99.84 138.2 37.25 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 124.7 1.25 . . . . 0.0 108.517 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 p -123.92 167.16 14.49 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.377 -1.738 . . . . 0.0 112.563 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -119.25 -41.26 2.74 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 110.522 -3.035 . . . . 0.0 105.359 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 11' ' ' GLY . 87.2 m-70 -130.03 177.79 7.02 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.58 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 m -87.09 25.89 1.27 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 113.6 -1.636 . . . . 0.0 108.982 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -119.69 -50.26 0.3 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 103.205 -3.958 . . . . 0.0 103.205 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -24.87 3.21 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 113.012 -1.594 . . . . 0.0 109.763 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 27.3 t -97.92 -38.22 9.5 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.438 -2.165 . . . . 0.0 111.439 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.453 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.6 tt -58.06 -44.21 87.36 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.526 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -59.24 -56.85 31.85 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-O 117.877 -1.059 . . . . 0.0 112.079 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -67.55 -36.1 20.77 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.214 1.942 . . . . 0.0 111.418 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.64 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 12.5 m -58.96 -59.59 5.22 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -52.37 -55.33 22.36 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.658 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -57.38 -24.49 55.67 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 127.165 2.791 . . . . 0.0 112.086 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.21 -1.28 42.42 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.596 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.76 39.62 1.56 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 116.343 1.297 . . . . 0.0 116.343 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.44 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 13.5 mmm -127.51 -165.83 1.53 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -111.32 -66.21 1.1 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -123.84 -178.23 3.99 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.488 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.453 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.6 154.4 20.39 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 113.352 -1.749 . . . . 0.0 114.214 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -149.56 137.97 20.74 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -99.44 138.51 36.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.9 mm -112.82 -78.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -110.17 34.45 3.89 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.381 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.94 -26.21 23.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -99.77 165.06 11.76 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.375 0.691 . . . . 0.0 109.395 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.64 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 38.6 t -84.89 150.78 24.74 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.53 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.0 t70 -135.69 141.69 44.99 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.519 ' SG ' HG23 ' A' ' 3' ' ' ILE . 38.4 m -110.6 170.38 8.13 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 119.462 1.028 . . . . 0.0 112.819 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.1 m -121.51 56.83 6.61 Favored Pre-proline 0 N--CA 1.49 1.533 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.208 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.44 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 98.1 Cg_endo -64.93 178.29 1.93 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.609 2.873 . . . . 0.0 113.233 -165.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -94.31 173.02 7.85 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.067 -1.879 . . . . 0.0 107.3 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.363 0 O-C-N 118.38 -2.7 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -33.99 172.04 0.01 OUTLIER Glycine 0 N--CA 1.499 2.862 0 N-CA-C 120.674 3.03 . . . . 0.0 120.674 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.626 HG23 ' SG ' ' A' ' 34' ' ' CYS . 12.1 pt -113.99 -104.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 112.11 -2.045 . . . . 0.0 106.893 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.62 ' H ' HG13 ' A' ' 3' ' ' ILE . 13.3 t-20 -174.48 34.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 124.511 1.132 . . . . 0.0 108.213 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.428 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.6 t -124.77 162.1 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -99.83 137.08 38.8 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.225 0.953 . . . . 0.0 110.77 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 p -123.06 167.58 13.46 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.834 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -119.71 -40.36 2.77 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 110.472 -3.058 . . . . 0.0 105.756 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.428 ' H ' ' HB2' ' A' ' 12' ' ' GLN . 21.9 m80 -128.34 177.69 6.78 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.902 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.9 t -84.2 19.26 1.88 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.961 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.29 -49.17 0.37 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 103.639 -3.784 . . . . 0.0 103.639 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.428 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -51.35 -24.16 4.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.905 -1.647 . . . . 0.0 109.882 179.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 25.4 t -98.96 -38.5 8.97 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 112.888 -1.96 . . . . 0.0 111.013 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.428 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.8 tt -57.34 -43.93 83.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.688 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -60.05 -55.62 43.62 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-O 118.137 -0.935 . . . . 0.0 112.942 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -67.38 -35.63 23.12 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.739 1.626 . . . . 0.0 109.97 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.695 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 19.2 m -56.73 -64.76 0.77 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -47.59 81.72 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.017 0.823 . . . . 0.0 109.665 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.0 -23.19 53.04 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 126.098 2.124 . . . . 0.0 112.022 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.14 -5.32 33.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.057 0.848 . . . . 0.0 110.758 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.79 38.87 1.02 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.533 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 11.1 mmm -127.13 -162.36 1.15 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -116.67 -64.67 1.28 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.85 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -124.66 179.4 4.99 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.499 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -127.75 160.74 21.75 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 112.701 -2.045 . . . . 0.0 113.56 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.444 ' HE3' ' H ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -156.24 135.84 12.45 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.444 ' H ' ' HE3' ' A' ' 26' ' ' LYS . 11.0 t -99.28 141.24 32.31 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 105.518 -2.031 . . . . 0.0 105.518 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.2 mt -115.21 -79.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.35 35.69 3.34 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 124.486 1.116 . . . . 0.0 111.343 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.63 -22.15 39.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -100.71 166.82 10.69 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.695 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.4 t -88.28 147.68 24.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.523 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 37.3 t70 -131.02 132.35 44.92 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.626 ' SG ' HG23 ' A' ' 3' ' ' ILE . 27.9 m -109.48 166.16 11.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.62 1.1 . . . . 0.0 113.675 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.9 m -121.24 60.82 9.98 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.646 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.533 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 76.7 Cg_endo -66.44 177.59 3.18 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 123.529 2.819 . . . . 0.0 113.442 -166.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.419 ' HG2' ' H ' ' A' ' 37' ' ' LYS . 69.9 mmtt -29.81 156.35 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 126.131 2.145 . . . . 0.0 116.123 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.343 0 O-C-N 119.046 -2.284 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.941 0.877 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.812 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 54.11 -179.46 0.18 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 113.093 -1.867 . . . . 0.0 115.214 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.611 HG13 ' H ' ' A' ' 4' ' ' ASN . 12.4 pt -121.58 -107.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.611 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.6 t30 -175.63 38.29 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 O-C-N 124.959 1.412 . . . . 0.0 107.868 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.462 ' H ' HG13 ' A' ' 3' ' ' ILE . 44.8 t -125.18 164.96 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HZ3' ' HB2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -99.62 145.97 26.98 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 124.875 1.359 . . . . 0.0 108.535 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 p -126.15 168.38 14.11 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.193 -1.821 . . . . 0.0 113.846 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -121.31 -43.07 2.43 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 110.047 -3.251 . . . . 0.0 105.554 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -131.72 179.2 6.21 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.545 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.3 m -89.44 34.61 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.977 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.77 -51.28 0.18 Allowed Glycine 0 N--CA 1.494 2.545 1 N-CA-C 102.998 -4.041 . . . . 0.0 102.998 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -23.04 1.9 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 112.668 -1.766 . . . . 0.0 109.934 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 39.4 t -98.7 -44.2 6.51 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.399 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.512 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.6 tt -54.3 -45.09 72.48 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.585 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.04 -56.86 31.31 Favored Pre-proline 0 C--N 1.306 -1.324 0 O-C-N 124.294 0.997 . . . . 0.0 113.032 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -67.62 -33.33 28.59 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.973 1.782 . . . . 0.0 110.418 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 16.9 m -59.58 -64.05 1.08 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -56.95 -47.78 79.87 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.238 0.961 . . . . 0.0 108.975 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -58.1 -24.53 59.02 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 126.119 2.137 . . . . 0.0 111.944 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.3 -2.36 39.65 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 124.039 0.837 . . . . 0.0 110.842 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.2 40.32 1.17 Allowed Glycine 0 N--CA 1.483 1.794 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.439 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 14.8 mmm -128.44 -163.02 1.24 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.529 ' HE ' ' C ' ' A' ' 36' ' ' PRO . 49.0 mtm180 -114.56 -66.1 1.12 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.452 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -125.79 177.74 6.11 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.613 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.512 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -142.38 145.01 14.85 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 112.634 -2.076 . . . . 0.0 114.624 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 25' ' ' GLY . 12.6 mptt -138.51 153.47 48.77 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.5 t -99.97 132.41 45.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.24 -73.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -110.15 34.1 4.08 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.046 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.88 -25.16 29.36 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -100.92 168.11 9.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 21.3 t -86.77 145.58 26.58 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.465 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 36.6 t70 -131.59 136.46 47.81 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.812 ' H ' ' H ' ' A' ' 2' ' ' GLY . 29.3 m -108.56 166.94 10.4 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.872 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.3 m -120.36 66.31 12.13 Favored Pre-proline 0 N--CA 1.486 1.335 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.831 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' C ' ' HE ' ' A' ' 23' ' ' ARG . 70.2 Cg_endo -68.4 174.96 7.49 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 123.243 2.629 . . . . 0.0 111.457 -175.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' N ' ' HE ' ' A' ' 23' ' ' ARG . 16.9 tppt? -29.57 -58.57 0.16 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 113.163 -1.835 . . . . 0.0 114.003 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.348 0 O-C-N 119.422 -2.049 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.845 0.831 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.717 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 63.73 177.16 4.39 Favored Glycine 0 C--N 1.306 -1.118 0 CA-C-N 113.46 -1.7 . . . . 0.0 114.115 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.621 HG13 ' H ' ' A' ' 4' ' ' ASN . 11.8 pt -121.32 -107.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.621 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.7 t30 -175.71 38.47 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 124.972 1.42 . . . . 0.0 108.085 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.7 t -124.88 165.37 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -99.86 140.58 33.86 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 124.556 1.16 . . . . 0.0 109.471 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 p -124.7 168.26 13.43 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.023 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -120.24 -43.92 2.51 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 109.977 -3.283 . . . . 0.0 104.96 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.412 ' C ' ' H ' ' A' ' 11' ' ' GLY . 43.1 m170 -128.06 177.26 7.01 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 124.968 1.417 . . . . 0.0 111.476 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.4 t -84.74 23.07 1.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.295 -1.775 . . . . 0.0 108.81 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.15 -49.89 0.29 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 103.475 -3.85 . . . . 0.0 103.475 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 -24.96 3.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 112.869 -1.666 . . . . 0.0 109.835 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 21.7 t -98.07 -38.79 9.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 112.578 -2.101 . . . . 0.0 111.748 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.438 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.7 tt -56.44 -44.55 80.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.78 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -59.76 -56.5 35.12 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 124.102 0.876 . . . . 0.0 112.611 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.61 -34.01 26.67 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.808 1.672 . . . . 0.0 110.32 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 9.9 m -59.01 -63.65 1.23 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.19 -47.67 80.68 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 124.088 0.868 . . . . 0.0 109.16 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.76 -25.32 60.29 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 125.976 2.048 . . . . 0.0 111.33 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.15 -1.94 41.06 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 123.876 0.735 . . . . 0.0 111.422 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.75 38.42 1.18 Allowed Glycine 0 N--CA 1.481 1.682 0 N-CA-C 116.929 1.531 . . . . 0.0 116.929 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.45 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 27.3 mmt -125.98 -164.34 1.31 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -114.29 -62.99 1.52 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -127.25 179.69 5.32 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 123.887 0.742 . . . . 0.0 110.734 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -128.24 156.75 20.98 Favored Glycine 0 C--O 1.216 -1.013 0 CA-C-N 113.064 -1.88 . . . . 0.0 114.295 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -149.25 138.1 21.19 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -99.43 132.95 44.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.2 mt -112.08 -74.15 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -110.08 35.22 3.48 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.905 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.79 -22.84 38.74 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 107.356 -2.298 . . . . 0.0 107.356 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 32' ' ' CYS . 19.8 ttpp -99.94 168.35 9.92 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 43.1 t -86.37 146.19 26.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.528 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 36.6 t70 -130.85 141.37 50.32 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.717 ' H ' ' H ' ' A' ' 2' ' ' GLY . 33.6 m -115.12 162.56 16.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 119.147 0.885 . . . . 0.0 112.076 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.5 m -122.27 60.61 13.24 Favored Pre-proline 0 N--CA 1.487 1.423 0 CA-C-N 113.967 -1.47 . . . . 0.0 108.128 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.45 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 78.3 Cg_endo -67.15 175.61 5.52 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 123.236 2.624 . . . . 0.0 111.58 -172.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -29.37 -53.59 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 125.762 1.914 . . . . 0.0 113.444 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.37 0 O-C-N 119.346 -2.096 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.622 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 53.4 -174.75 0.33 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-N 115.27 -0.877 . . . . 0.0 114.544 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.617 HG13 ' H ' ' A' ' 4' ' ' ASN . 12.4 pt -122.48 -107.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.617 ' H ' HG13 ' A' ' 3' ' ' ILE . 49.8 t30 -176.65 37.5 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 125.439 1.496 . . . . 0.0 108.171 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.462 ' H ' HG13 ' A' ' 3' ' ' ILE . 45.1 t -124.5 165.45 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -99.78 138.51 36.77 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 124.427 1.08 . . . . 0.0 109.906 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 p -121.86 167.45 13.02 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 112.693 -2.049 . . . . 0.0 112.212 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -117.87 -41.61 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.47 -3.059 . . . . 0.0 105.275 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' ' 11' ' ' GLY . 82.7 m-70 -131.8 177.2 7.71 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.985 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.3 m -86.58 26.63 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.17 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.12 -51.26 0.27 Allowed Glycine 0 N--CA 1.495 2.61 1 N-CA-C 102.636 -4.186 . . . . 0.0 102.636 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -24.07 3.73 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.623 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 14.9 t -98.19 -36.97 9.88 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.442 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.41 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.5 tt -57.62 -44.7 85.73 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.863 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.08 -54.37 54.63 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.245 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -67.01 -35.67 24.93 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.576 1.518 . . . . 0.0 110.335 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.625 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 6.5 m -57.62 -63.18 1.32 Allowed 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.37 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.8 -47.84 81.44 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 124.077 0.86 . . . . 0.0 109.365 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.49 -23.16 57.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 125.925 2.016 . . . . 0.0 112.048 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.33 -4.61 34.63 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 124.023 0.827 . . . . 0.0 110.521 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.25 39.94 1.0 Allowed Glycine 0 N--CA 1.483 1.786 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.422 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 19.2 mmm -128.27 -164.01 1.33 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -111.43 -65.87 1.13 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.444 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -127.09 -178.93 4.61 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 123.838 0.711 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.41 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -123.83 157.47 18.25 Favored Glycine 0 C--O 1.216 -1.003 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.846 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -150.7 133.46 15.83 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.1 t -99.43 140.33 33.76 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.55 -82.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -110.24 34.73 3.74 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.192 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.63 -23.41 31.42 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -101.04 165.6 11.23 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.625 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 39.4 t -88.52 150.12 23.26 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.521 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 31.5 t70 -134.46 143.4 47.5 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.622 ' H ' ' H ' ' A' ' 2' ' ' GLY . 55.7 m -112.91 166.28 11.54 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.682 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.5 m -123.3 60.67 17.79 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -74.83 173.4 14.5 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 123.348 2.699 . . . . 0.0 111.688 -168.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -29.6 83.6 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 125.898 1.999 . . . . 0.0 115.277 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.401 0 O-C-N 118.656 -2.528 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 34' ' ' CYS . 35.6 m . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.872 0.367 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -30.69 170.61 0.0 OUTLIER Glycine 0 N--CA 1.501 2.993 0 N-CA-C 121.093 3.197 . . . . 0.0 121.093 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.624 HG13 ' H ' ' A' ' 4' ' ' ASN . 12.9 pt -114.27 -105.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 111.721 -2.24 . . . . 0.0 105.682 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.624 ' H ' HG13 ' A' ' 3' ' ' ILE . 50.1 t30 -175.22 34.92 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 124.792 1.237 . . . . 0.0 108.635 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' H ' HG13 ' A' ' 3' ' ' ILE . 46.6 t -125.52 162.96 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -99.78 140.06 34.54 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 124.608 1.192 . . . . 0.0 110.549 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.6 p -121.64 167.84 12.45 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.459 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.494 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 7.2 mmpt? -118.78 -42.66 2.71 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.3 -3.137 . . . . 0.0 104.463 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.407 ' C ' ' H ' ' A' ' 11' ' ' GLY . 26.7 m80 -128.41 176.19 7.91 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.179 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.1 m -87.49 25.75 1.38 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.922 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.82 -49.92 0.33 Allowed Glycine 0 N--CA 1.493 2.488 1 N-CA-C 102.353 -4.299 . . . . 0.0 102.353 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -23.83 4.55 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 113.18 -1.51 . . . . 0.0 109.587 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 26.3 t -97.45 -38.57 9.55 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 112.918 -1.946 . . . . 0.0 111.047 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.44 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.6 tt -59.54 -41.88 91.06 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.123 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -58.21 -58.92 15.32 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-O 117.871 -1.061 . . . . 0.0 111.301 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -68.42 -39.08 10.25 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.185 1.923 . . . . 0.0 111.055 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.712 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 14.4 m -55.39 -58.39 7.93 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -56.36 -52.77 63.35 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.385 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -62.45 -17.88 60.45 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 126.037 2.086 . . . . 0.0 112.303 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.46 -5.67 31.96 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 124.056 0.847 . . . . 0.0 109.659 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.76 37.21 1.31 Allowed Glycine 0 N--CA 1.481 1.665 0 N-CA-C 116.596 1.399 . . . . 0.0 116.596 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 14.3 mmm -127.32 -164.81 1.39 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HE ' ' C ' ' A' ' 36' ' ' PRO . 42.0 mtm180 -112.3 -64.54 1.28 Allowed 'General case' 0 C--N 1.309 -1.169 0 O-C-N 123.993 0.808 . . . . 0.0 110.389 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -124.35 -179.68 4.56 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.088 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.17 153.99 20.09 Favored Glycine 0 C--O 1.216 -0.98 0 CA-C-N 113.218 -1.81 . . . . 0.0 114.43 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -144.39 135.99 25.76 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -99.69 136.38 39.7 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 103.679 -2.711 . . . . 0.0 103.679 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.2 mm -113.26 -81.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 116.917 2.192 . . . . 0.0 116.917 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.22 34.38 3.93 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.426 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.27 -22.77 33.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -102.25 166.98 10.28 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.629 0.841 . . . . 0.0 109.269 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.712 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 37.3 t -90.09 148.78 22.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.503 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 39.2 t70 -132.63 137.12 46.9 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.561 ' SG ' HG23 ' A' ' 3' ' ' ILE . 17.0 m -108.74 162.77 13.86 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 119.796 1.18 . . . . 0.0 112.517 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.1 m -121.62 65.93 18.48 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.363 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.504 ' C ' ' HE ' ' A' ' 23' ' ' ARG . 92.3 Cg_endo -65.2 178.26 2.09 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 123.486 2.791 . . . . 0.0 112.384 -174.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -29.12 83.75 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 O-C-N 125.829 1.956 . . . . 0.0 114.415 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.332 0 O-C-N 119.107 -2.246 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.731 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 41.87 -175.38 0.01 OUTLIER Glycine 0 N--CA 1.499 2.878 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.585 HG13 ' H ' ' A' ' 4' ' ' ASN . 12.4 pt -124.26 -106.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.585 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.4 t30 -176.69 36.49 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 125.444 1.498 . . . . 0.0 108.132 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' H ' HG13 ' A' ' 3' ' ' ILE . 44.2 t -126.72 166.51 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' N ' HG12 ' A' ' 5' ' ' VAL . 35.3 ttmt -99.96 138.01 37.63 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 124.841 1.338 . . . . 0.0 108.993 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 p -123.22 164.36 18.88 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.497 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 10.2 mmpt? -115.61 -41.11 3.28 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 111.168 -2.742 . . . . 0.0 104.108 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -126.1 175.31 7.84 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.308 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.1 p -91.37 24.73 2.84 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.525 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 13' ' ' CYS . . . -121.68 -43.02 0.43 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 105.63 -2.988 . . . . 0.0 105.63 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -74.4 5.4 4.67 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.28 -0.96 . . . . 0.0 109.762 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 14.3 t -114.53 -38.26 4.08 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 113.218 -1.81 . . . . 0.0 106.381 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tt -63.61 -39.36 94.18 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.748 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.493 ' N ' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -55.75 -61.51 6.17 Favored Pre-proline 0 N--CA 1.48 1.053 0 O-C-N 124.028 0.83 . . . . 0.0 109.594 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -66.96 -37.02 20.65 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.982 1.788 . . . . 0.0 110.634 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 7.7 m -55.54 -64.73 0.75 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.319 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -45.63 91.86 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.339 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.41 -22.66 54.89 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 125.504 1.753 . . . . 0.0 111.749 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.08 -6.67 31.23 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 123.994 0.809 . . . . 0.0 110.64 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.3 40.46 0.8 Allowed Glycine 0 N--CA 1.479 1.506 0 N-CA-C 116.466 1.347 . . . . 0.0 116.466 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.415 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 15.0 mmm -127.62 -166.01 1.55 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -111.27 -64.16 1.32 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.825 0.703 . . . . 0.0 109.531 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.34 179.91 4.89 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.934 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -124.57 154.32 17.97 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-N 113.166 -1.834 . . . . 0.0 114.748 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.23 134.46 15.09 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.4 t -99.52 139.63 34.89 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.27 -79.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 116.879 2.178 . . . . 0.0 116.879 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.16 34.61 3.8 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.47 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.97 -22.56 37.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -100.22 165.82 11.3 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 44.2 t -90.15 151.09 21.74 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.479 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.456 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.4 t70 -133.46 146.98 51.64 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.731 ' H ' ' H ' ' A' ' 2' ' ' GLY . 37.4 m -117.94 162.39 18.22 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.0 m -121.4 62.05 11.9 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.7 176.0 6.48 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 C-N-CA 123.393 2.728 . . . . 0.0 111.361 -169.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 38' ' ' NH2 . 2.4 pptp? -29.45 -46.8 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 125.695 1.872 . . . . 0.0 114.614 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . 0.413 ' N ' ' HD2' ' A' ' 37' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.326 0 O-C-N 119.023 -2.298 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 122.134 0.969 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -131.22 -171.19 12.83 Favored Glycine 0 C--O 1.215 -1.034 0 CA-C-N 113.517 -1.674 . . . . 0.0 112.865 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.62 HG13 ' H ' ' A' ' 4' ' ' ASN . 15.1 pt -111.69 -105.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.62 ' H ' HG13 ' A' ' 3' ' ' ILE . 14.4 t-20 -173.18 35.75 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 124.483 1.115 . . . . 0.0 108.126 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.66 163.95 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.41 145.61 28.7 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 124.526 1.141 . . . . 0.0 110.266 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.3 p -128.38 167.21 17.31 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.808 -1.996 . . . . 0.0 112.991 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -121.17 -42.74 2.46 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 110.097 -3.228 . . . . 0.0 104.928 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.423 ' C ' ' H ' ' A' ' 11' ' ' GLY . 22.5 m80 -128.55 176.31 7.86 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.667 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.1 m -87.9 28.76 0.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.088 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.94 -50.93 0.26 Allowed Glycine 0 N--CA 1.495 2.567 1 N-CA-C 102.075 -4.41 . . . . 0.0 102.075 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.58 -25.93 1.96 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 113.239 -1.48 . . . . 0.0 109.384 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 31.0 t -96.75 -38.83 9.73 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.469 -2.15 . . . . 0.0 111.094 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.441 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -56.84 -45.64 82.24 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.514 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -57.65 -59.58 12.57 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.42 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.12 -33.39 40.71 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.428 1.419 . . . . 0.0 109.417 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.696 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.8 m -58.18 -64.29 0.97 Allowed 'General case' 0 C--N 1.307 -1.239 0 O-C-N 123.739 0.649 . . . . 0.0 109.932 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.515 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -57.97 -45.36 86.84 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.121 0.888 . . . . 0.0 109.553 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.515 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 40.4 m-20 -64.74 -18.53 65.13 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 125.59 1.806 . . . . 0.0 112.092 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.14 -3.89 36.79 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.24 41.08 1.31 Allowed Glycine 0 N--CA 1.483 1.811 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.423 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 13.1 mmm -128.49 -163.51 1.29 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -113.51 -64.12 1.35 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.611 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -125.79 179.15 5.32 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.469 0.652 . . . . 0.0 111.506 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.441 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -130.01 150.86 19.2 Favored Glycine 0 C--O 1.215 -1.076 0 CA-C-N 113.152 -1.84 . . . . 0.0 114.737 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -143.49 138.36 29.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.4 t -99.89 133.5 44.17 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.3 mm -114.33 -77.45 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -110.26 34.94 3.62 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.855 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.05 -19.69 52.04 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 32' ' ' CYS . 19.2 ttpp -106.41 168.54 9.09 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.696 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 35.0 t -88.28 149.7 23.66 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.507 -1.224 . . . . 0.0 114.186 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.544 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 11.3 t70 -134.94 123.61 23.65 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.586 ' SG ' HG23 ' A' ' 3' ' ' ILE . 31.5 m -99.94 162.18 13.15 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.153 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.9 m -121.52 64.75 16.02 Favored Pre-proline 0 N--CA 1.488 1.441 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.144 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.19 176.02 7.66 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 123.343 2.696 . . . . 0.0 111.293 -171.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -29.36 -51.34 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 125.625 1.828 . . . . 0.0 115.148 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.391 0 O-C-N 119.095 -2.253 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.828 0.346 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -35.46 171.03 0.01 OUTLIER Glycine 0 N--CA 1.501 2.972 0 N-CA-C 119.411 2.524 . . . . 0.0 119.411 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.616 HG13 ' H ' ' A' ' 4' ' ' ASN . 13.2 pt -114.71 -106.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 112.639 -1.781 . . . . 0.0 106.399 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.616 ' H ' HG13 ' A' ' 3' ' ' ILE . 14.9 t-20 -174.38 36.63 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 124.667 1.229 . . . . 0.0 107.714 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.428 ' H ' HG13 ' A' ' 3' ' ' ILE . 46.5 t -126.92 165.56 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -99.88 147.58 25.38 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 124.595 1.184 . . . . 0.0 110.499 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p -127.67 168.14 15.46 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 112.547 -2.115 . . . . 0.0 113.114 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -119.95 -43.04 2.57 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 110.098 -3.228 . . . . 0.0 105.003 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.431 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.5 m-70 -132.88 176.88 8.09 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.536 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -85.63 28.89 0.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.455 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.37 -50.62 0.28 Allowed Glycine 0 N--CA 1.495 2.61 1 N-CA-C 102.551 -4.219 . . . . 0.0 102.551 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -25.68 3.87 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 112.962 -1.619 . . . . 0.0 109.593 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 25.7 t -97.01 -39.27 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 112.691 -2.05 . . . . 0.0 111.29 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.433 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.2 tt -57.28 -43.65 83.31 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.545 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -58.89 -57.45 26.87 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.605 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -68.09 -34.41 22.65 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.199 1.933 . . . . 0.0 109.985 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 14.8 m -58.06 -63.99 1.07 Allowed 'General case' 0 C--N 1.31 -1.127 0 O-C-N 123.837 0.711 . . . . 0.0 109.398 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -57.78 -47.3 82.93 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.265 0.978 . . . . 0.0 109.231 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -57.82 -24.37 57.05 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 126.02 2.075 . . . . 0.0 111.597 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.25 -3.41 37.46 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.137 0.898 . . . . 0.0 110.929 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.0 38.44 1.15 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.474 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.7 mmt -124.44 -164.71 1.29 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -115.43 -62.0 1.66 Allowed 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -126.92 179.44 5.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 123.883 0.739 . . . . 0.0 111.223 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -129.33 154.86 20.53 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-N 113.136 -1.847 . . . . 0.0 114.41 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -144.65 137.2 26.48 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -99.78 130.85 46.02 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.28 -78.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -110.23 34.53 3.85 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.831 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.46 -19.2 53.64 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 32' ' ' CYS . 18.4 ttpp -107.0 169.55 8.48 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 38.3 t -90.19 148.27 23.05 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.497 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 65.5 t0 -133.84 135.06 43.51 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.522 ' SG ' HG23 ' A' ' 3' ' ' ILE . 20.1 m -109.87 163.16 13.8 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 119.851 1.205 . . . . 0.0 113.421 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.6 m -122.29 62.57 16.24 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.689 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 81.4 Cg_endo -67.1 176.36 4.68 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 123.218 2.612 . . . . 0.0 111.551 -174.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -29.3 -41.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.36 0 O-C-N 118.0 -2.938 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.875 0.369 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -38.33 173.72 0.01 OUTLIER Glycine 0 N--CA 1.5 2.907 0 N-CA-C 119.228 2.451 . . . . 0.0 119.228 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.638 HG23 ' SG ' ' A' ' 34' ' ' CYS . 11.5 pt -113.62 -104.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 112.759 -1.721 . . . . 0.0 107.149 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.627 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.6 t30 -175.3 35.6 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 O-C-N 124.747 1.279 . . . . 0.0 108.496 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' H ' HG13 ' A' ' 3' ' ' ILE . 46.9 t -125.12 165.65 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -99.8 142.17 31.64 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 124.602 1.189 . . . . 0.0 109.027 -179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 p -123.59 166.53 15.31 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 112.43 -2.168 . . . . 0.0 112.041 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -121.79 -40.54 2.53 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 110.359 -3.109 . . . . 0.0 106.034 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.417 ' C ' ' H ' ' A' ' 11' ' ' GLY . 85.6 m-70 -134.13 179.82 6.02 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.05 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 t -84.71 29.42 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.167 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -125.93 -50.86 0.18 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 103.768 -3.733 . . . . 0.0 103.768 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -48.52 -24.87 1.44 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 112.958 -1.621 . . . . 0.0 110.069 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 33' ' ' ASP . 40.9 t -97.01 -42.05 8.08 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.64 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.51 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.6 tt -55.51 -45.89 77.06 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.394 0.677 . . . . 0.0 112.395 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -56.77 -58.92 14.23 Favored Pre-proline 0 C--N 1.309 -1.17 0 O-C-N 123.888 0.743 . . . . 0.0 112.379 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -68.25 -33.03 25.36 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.992 1.794 . . . . 0.0 110.458 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.6 m -59.87 -65.16 0.72 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.71 0.631 . . . . 0.0 109.305 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.499 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -56.56 -45.2 81.41 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.425 1.078 . . . . 0.0 108.952 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.499 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 52.8 t0 -60.85 -24.77 66.15 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 125.934 2.021 . . . . 0.0 110.752 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 -0.01 45.54 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.582 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.48 39.32 1.49 Allowed Glycine 0 N--CA 1.484 1.878 0 N-CA-C 116.691 1.436 . . . . 0.0 116.691 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.48 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 29.6 mmt -124.49 -163.74 1.19 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -118.49 -60.96 1.72 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.16 176.54 6.98 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.37 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -139.37 145.16 16.2 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.818 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HD2' ' C ' ' A' ' 25' ' ' GLY . 12.7 mptt -139.65 149.21 43.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.5 t -99.83 137.82 37.76 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.3 mt -115.12 -78.49 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -110.29 35.0 3.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.368 1.043 . . . . 0.0 111.282 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.3 -23.21 35.08 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -103.97 163.21 12.52 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 124.397 0.704 . . . . 0.0 109.151 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 25.3 t -82.14 148.46 28.49 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.346 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 36.8 t70 -131.94 129.22 39.95 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.638 ' SG ' HG23 ' A' ' 3' ' ' ILE . 13.4 m -106.84 164.15 12.35 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.977 1.262 . . . . 0.0 113.493 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.4 m -122.15 68.45 27.32 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-N 113.329 -1.759 . . . . 0.0 108.942 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 17.1 Cg_endo -79.73 177.68 8.15 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 123.554 2.836 . . . . 0.0 112.072 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -110.07 69.92 0.71 Allowed 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.119 -1.855 . . . . 0.0 106.237 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.356 0 O-C-N 119.194 -2.191 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.757 0.789 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.67 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 71.65 176.3 25.23 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 113.696 -1.593 . . . . 0.0 114.087 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.638 HG13 ' H ' ' A' ' 4' ' ' ASN . 11.6 pt -121.24 -105.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.638 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.8 t30 -175.7 36.6 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 125.242 1.417 . . . . 0.0 108.237 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 3' ' ' ILE . 46.6 t -125.57 164.83 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.441 ' C ' ' HD3' ' A' ' 6' ' ' LYS . 1.6 tmtm? -99.76 144.04 29.29 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 124.515 1.135 . . . . 0.0 109.783 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.4 p -125.09 167.41 14.82 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.613 -2.085 . . . . 0.0 112.898 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -119.43 -41.95 2.68 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 110.163 -3.199 . . . . 0.0 105.21 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.422 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.1 m-70 -132.23 176.2 8.6 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.521 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.7 p -85.37 26.42 0.91 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.564 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -119.39 -51.27 0.29 Allowed Glycine 0 N--CA 1.494 2.556 1 N-CA-C 102.832 -4.107 . . . . 0.0 102.832 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.66 -27.84 2.11 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.234 -1.483 . . . . 0.0 109.479 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 23.6 t -96.04 -35.84 11.24 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.116 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tt -59.24 -44.99 92.33 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.431 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 5.7 mptp? -56.1 -57.57 21.57 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.146 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 94.6 Cg_endo -68.35 -37.48 13.54 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.353 2.035 . . . . 0.0 111.845 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 7.4 m -57.78 -59.11 5.72 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -53.37 -54.65 33.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.585 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.18 -23.19 54.59 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 126.701 2.5 . . . . 0.0 112.402 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.38 -2.51 39.04 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 124.159 0.912 . . . . 0.0 111.282 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.84 38.31 1.44 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.442 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.1 mmt -123.82 -165.74 1.39 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -112.88 -62.86 1.52 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.45 -179.87 4.97 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.036 0.835 . . . . 0.0 110.433 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.13 157.04 16.14 Favored Glycine 0 C--O 1.216 -1.011 0 CA-C-N 113.147 -1.842 . . . . 0.0 113.53 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -149.46 132.77 16.5 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.2 t -99.5 132.28 44.93 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.0 mt -112.59 -78.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.37 34.91 3.66 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.364 1.04 . . . . 0.0 111.708 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.77 -17.05 58.85 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -105.01 168.22 9.2 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 43.2 t -90.75 147.62 23.11 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.535 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 13.3 t70 -132.29 144.01 50.29 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.67 ' H ' ' H ' ' A' ' 2' ' ' GLY . 29.8 m -114.5 160.39 19.28 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.449 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.0 m -121.9 61.38 13.0 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.172 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.8 175.81 6.82 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 123.375 2.717 . . . . 0.0 111.553 -172.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -29.32 -59.36 0.15 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 125.741 1.901 . . . . 0.0 113.823 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.327 0 O-C-N 119.377 -2.077 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -31.98 170.67 0.0 OUTLIER Glycine 0 N--CA 1.501 2.97 0 N-CA-C 120.898 3.119 . . . . 0.0 120.898 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.632 HG13 ' H ' ' A' ' 4' ' ' ASN . 12.6 pt -113.81 -105.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 111.877 -2.161 . . . . 0.0 106.168 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.632 ' H ' HG13 ' A' ' 3' ' ' ILE . 13.2 t-20 -174.67 36.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 124.641 1.213 . . . . 0.0 108.059 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.42 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.6 t -125.73 165.5 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.93 143.31 30.3 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.256 1.027 . . . . 0.0 110.276 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 p -126.71 166.46 17.34 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 112.37 -2.196 . . . . 0.0 112.705 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -120.08 -40.68 2.7 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 110.44 -3.073 . . . . 0.0 105.847 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 11' ' ' GLY . 84.2 m-70 -131.87 178.5 6.72 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.386 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.4 m -85.1 23.14 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.329 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -118.34 -50.32 0.34 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 103.272 -3.931 . . . . 0.0 103.272 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.411 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -48.76 -25.79 2.02 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.3 -1.45 . . . . 0.0 109.595 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 34.6 t -97.28 -37.44 10.06 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 112.335 -2.211 . . . . 0.0 111.551 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.43 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -58.67 -43.98 90.06 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.063 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.403 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 2.1 mptm? -56.95 -58.2 19.3 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-O 118.24 -0.886 . . . . 0.0 112.036 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 91.2 Cg_endo -67.83 -36.61 17.89 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.396 2.064 . . . . 0.0 111.376 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 19.1 m -58.3 -60.54 3.62 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -52.26 -54.69 28.01 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.055 -1.43 . . . . 0.0 108.63 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.34 -23.11 55.73 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 126.954 2.659 . . . . 0.0 112.665 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.21 -2.37 39.88 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.131 0.894 . . . . 0.0 110.82 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.34 39.87 1.58 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 116.005 1.162 . . . . 0.0 116.005 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.4 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 12.4 mmm -126.73 -165.24 1.43 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -111.65 -67.42 1.0 Allowed 'General case' 0 C--N 1.31 -1.143 0 O-C-N 123.98 0.8 . . . . 0.0 109.474 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -123.47 179.53 4.71 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.739 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.43 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.77 156.27 20.02 Favored Glycine 0 C--O 1.215 -1.079 0 CA-C-N 112.918 -1.947 . . . . 0.0 114.099 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -151.4 138.32 19.02 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.3 t -99.6 138.71 36.3 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.2 mt -116.12 -79.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -110.38 35.34 3.48 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.413 1.07 . . . . 0.0 111.859 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.39 -22.08 38.9 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -103.93 166.36 10.46 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.594 0.82 . . . . 0.0 108.831 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.679 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 32.4 t -85.79 149.13 25.48 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.516 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 37.1 t70 -132.34 134.8 45.63 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.578 ' SG ' HG23 ' A' ' 3' ' ' ILE . 27.3 m -108.45 163.61 13.06 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 119.726 1.148 . . . . 0.0 112.537 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.5 m -121.32 59.66 9.05 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.838 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -74.35 172.41 16.14 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 123.286 2.657 . . . . 0.0 111.866 -167.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -29.61 83.08 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 126.061 2.101 . . . . 0.0 115.217 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.442 0 O-C-N 118.455 -2.653 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.478 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -28.75 168.66 0.0 OUTLIER Glycine 0 N--CA 1.501 3.021 0 N-CA-C 121.023 3.169 . . . . 0.0 121.023 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.608 HG13 ' H ' ' A' ' 4' ' ' ASN . 13.1 pt -113.81 -104.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 112.092 -2.054 . . . . 0.0 107.077 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.608 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.2 t30 -174.67 34.8 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 124.641 1.213 . . . . 0.0 108.2 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.7 t -128.06 163.14 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -102.27 141.19 35.5 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 124.517 1.135 . . . . 0.0 109.711 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 p -118.52 168.73 10.4 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.064 -1.88 . . . . 0.0 112.938 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -118.17 -42.52 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 110.001 -3.272 . . . . 0.0 104.896 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.438 ' C ' ' H ' ' A' ' 11' ' ' GLY . 83.6 m-70 -132.9 175.7 9.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.627 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.0 m -85.6 28.9 0.73 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.255 -1.338 . . . . 0.0 109.296 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -121.28 -49.95 0.26 Allowed Glycine 0 N--CA 1.495 2.597 1 N-CA-C 102.916 -4.074 . . . . 0.0 102.916 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -23.07 4.88 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.109 -1.545 . . . . 0.0 109.753 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 33.8 t -97.72 -37.69 9.79 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 112.997 -1.911 . . . . 0.0 110.863 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.485 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.3 tt -59.21 -42.56 91.25 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.23 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -58.67 -57.17 28.65 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.251 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.9 -37.12 11.9 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.567 2.178 . . . . 0.0 111.855 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.692 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 12.8 m -58.82 -58.6 7.91 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -53.28 -54.81 30.88 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.242 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -57.81 -23.77 54.14 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 126.809 2.568 . . . . 0.0 112.34 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.38 -1.3 41.89 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 124.078 0.861 . . . . 0.0 111.301 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.12 38.61 1.65 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.447 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.6 mmt -124.25 -165.44 1.37 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -113.44 -62.7 1.55 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -126.25 178.57 5.74 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.045 0.84 . . . . 0.0 110.84 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.485 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -127.98 145.28 15.86 Favored Glycine 0 C--O 1.215 -1.083 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.571 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.22 136.58 45.69 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.8 t -99.6 132.29 45.04 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.1 mm -109.72 -83.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.35 33.94 4.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.439 1.087 . . . . 0.0 111.436 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.36 -19.08 46.65 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.015 -2.434 . . . . 0.0 107.015 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -103.01 165.42 11.03 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.757 0.916 . . . . 0.0 109.708 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.692 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 36.7 t -92.74 145.76 24.17 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.478 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 38.5 t70 -131.57 141.41 49.68 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.538 ' SG ' HG23 ' A' ' 3' ' ' ILE . 20.6 m -110.48 159.91 17.09 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 119.822 1.192 . . . . 0.0 112.553 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.2 m -121.56 62.02 12.48 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.476 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.406 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 66.2 Cg_endo -68.22 175.95 6.11 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 123.356 2.704 . . . . 0.0 111.652 -174.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -29.42 -59.31 0.15 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 125.751 1.907 . . . . 0.0 113.83 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.349 0 O-C-N 119.52 -1.988 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.955 0.883 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -129.78 -169.76 12.59 Favored Glycine 0 C--N 1.307 -1.044 0 CA-C-N 113.562 -1.654 . . . . 0.0 113.153 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.624 HG23 ' SG ' ' A' ' 34' ' ' CYS . 13.1 pt -110.3 -104.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.616 ' H ' HG13 ' A' ' 3' ' ' ILE . 13.6 t-20 -173.91 35.29 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 O-C-N 124.42 1.075 . . . . 0.0 108.347 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -126.87 158.26 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 8.0 mtpm? -102.89 133.85 47.28 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 124.503 1.127 . . . . 0.0 110.764 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 p -126.57 166.66 16.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.613 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -117.98 -35.63 3.82 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 111.659 -2.519 . . . . 0.0 105.705 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -123.56 173.32 8.13 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.07 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.6 p -91.26 35.22 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.059 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.57 -47.92 0.24 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 105.405 -3.078 . . . . 0.0 105.405 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -61.94 -8.41 5.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.618 1.567 . . . . 0.0 111.116 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 37.4 t -106.51 -41.76 5.19 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.671 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.48 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.8 tt -58.28 -41.09 83.61 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.995 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -62.81 -57.09 23.54 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-O 118.128 -0.939 . . . . 0.0 112.138 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -67.68 -32.59 30.1 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.467 2.111 . . . . 0.0 110.99 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.5 m -61.4 -60.71 3.31 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -51.28 -54.97 20.89 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.792 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -58.3 -23.75 57.36 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 127.09 2.744 . . . . 0.0 112.769 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.22 0.11 45.17 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 124.011 0.819 . . . . 0.0 110.833 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.53 40.57 2.02 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.48 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 12.6 mmm -127.15 -165.5 1.48 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -112.96 -65.51 1.18 Allowed 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.982 0.801 . . . . 0.0 109.16 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -123.83 -179.77 4.51 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.662 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.48 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -134.54 152.39 20.65 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-N 113.246 -1.797 . . . . 0.0 114.377 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -148.47 140.26 23.76 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -99.62 142.19 31.44 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 105.15 -2.166 . . . . 0.0 105.15 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.1 mm -115.11 -78.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.27 35.27 3.49 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.45 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.53 -24.51 29.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.223 -2.351 . . . . 0.0 107.223 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -99.95 167.92 10.19 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 124.761 0.918 . . . . 0.0 109.294 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 32.0 t -89.69 151.09 22.04 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.475 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 26.7 t70 -136.75 124.87 22.97 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' HG23 ' A' ' 3' ' ' ILE . 23.8 m -99.8 164.9 11.83 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 118.981 0.81 . . . . 0.0 112.367 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.7 m -120.93 61.85 9.92 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.075 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 58.9 Cg_endo -68.75 176.64 5.73 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 123.103 2.535 . . . . 0.0 111.663 -168.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -29.76 167.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 119.515 3.154 . . . . 0.0 119.515 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.34 0 O-C-N 118.799 -2.438 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.727 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 44.15 -173.39 0.01 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.609 HG13 ' H ' ' A' ' 4' ' ' ASN . 12.3 pt -122.54 -106.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.609 ' H ' HG13 ' A' ' 3' ' ' ILE . 49.5 t30 -177.24 34.6 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 125.509 1.524 . . . . 0.0 108.375 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' H ' HG13 ' A' ' 3' ' ' ILE . 42.6 t -124.57 164.54 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -99.74 137.94 37.51 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 124.583 1.177 . . . . 0.0 110.432 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 p -121.7 167.88 12.44 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 112.387 -2.188 . . . . 0.0 111.778 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -120.18 -40.35 2.72 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 110.387 -3.097 . . . . 0.0 105.643 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.421 ' H ' ' HB2' ' A' ' 12' ' ' GLN . 20.3 m80 -128.89 177.9 6.77 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.946 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.5 t -85.8 21.99 1.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 113.24 -1.8 . . . . 0.0 108.758 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -120.91 -49.07 0.29 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 103.571 -3.812 . . . . 0.0 103.571 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.421 ' HB2' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -52.13 -21.99 3.8 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 113.004 -1.598 . . . . 0.0 110.067 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 32.8 t -99.95 -38.9 8.41 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 112.98 -1.918 . . . . 0.0 110.939 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.484 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.9 tt -58.98 -38.42 79.1 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.776 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.97 -56.67 22.91 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.997 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.14 -31.8 35.51 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.137 1.891 . . . . 0.0 110.824 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.5 m -62.26 -58.22 8.55 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HZ2' ' HB3' ' A' ' 18' ' ' LYS . 2.3 mmmp? -48.89 -57.51 6.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.617 1.198 . . . . 0.0 108.171 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -55.62 -27.17 48.11 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 128.186 3.429 . . . . 0.0 112.455 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.98 1.97 48.45 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 124.264 0.978 . . . . 0.0 111.458 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.86 43.72 2.05 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 115.241 0.856 . . . . 0.0 115.241 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.494 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 27.0 mmt -124.85 -166.57 1.54 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 116.972 0.386 . . . . 0.0 109.974 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -113.87 -62.94 1.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.19 177.27 6.79 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.971 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -132.01 150.91 19.68 Favored Glycine 0 C--O 1.216 -0.986 0 CA-C-N 112.504 -2.135 . . . . 0.0 112.98 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -146.98 140.93 25.94 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.64 141.08 32.91 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.96 -81.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -110.32 34.41 3.93 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.226 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.56 -24.15 29.48 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.401 -2.279 . . . . 0.0 107.401 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -100.7 165.65 11.28 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.694 0.879 . . . . 0.0 109.157 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 25.7 t -89.48 149.6 22.85 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.44 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.6 t70 -133.11 134.75 44.66 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.727 ' H ' ' H ' ' A' ' 2' ' ' GLY . 33.4 m -110.46 163.82 13.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 119.079 0.854 . . . . 0.0 111.489 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.1 m -122.06 58.78 10.03 Favored Pre-proline 0 N--CA 1.49 1.541 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.639 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.494 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 37.1 Cg_endo -73.33 169.87 21.24 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 122.948 2.432 . . . . 0.0 111.832 -169.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -29.69 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 126.147 2.154 . . . . 0.0 114.987 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.36 0 O-C-N 118.839 -2.413 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.647 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 53.77 -175.91 0.33 Allowed Glycine 0 N--CA 1.485 1.928 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.545 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.593 HG13 ' H ' ' A' ' 4' ' ' ASN . 15.4 pt -122.5 -107.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.593 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.4 t30 -175.63 35.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 125.474 1.51 . . . . 0.0 108.339 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' H ' HG13 ' A' ' 3' ' ' ILE . 42.8 t -126.21 166.06 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -100.47 140.71 34.33 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 124.906 1.379 . . . . 0.0 108.638 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.3 p -125.27 166.83 15.81 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 113.266 -1.788 . . . . 0.0 112.532 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -120.97 -40.95 2.57 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 110.635 -2.984 . . . . 0.0 104.973 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -124.11 175.02 7.26 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.546 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.1 p -94.67 34.14 1.37 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.552 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 13' ' ' CYS . . . -126.7 -44.69 0.24 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -73.17 7.51 2.12 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.95 1.3 . . . . 0.0 110.604 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 37.6 t -114.19 -41.04 3.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.117 -1.856 . . . . 0.0 106.204 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.493 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 7.6 tt -61.94 -35.45 78.47 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.794 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -66.82 -56.23 14.87 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.815 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.13 -31.96 44.15 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.047 1.831 . . . . 0.0 111.327 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.6 m -63.51 -56.3 17.14 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -48.67 -58.69 4.37 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -56.09 -25.84 47.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 128.245 3.466 . . . . 0.0 113.241 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.12 1.67 47.79 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 124.522 1.139 . . . . 0.0 111.133 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.96 43.08 2.3 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 115.166 0.826 . . . . 0.0 115.166 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.403 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 21.5 mmm -128.57 -167.32 1.75 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HE ' ' C ' ' A' ' 36' ' ' PRO . 45.8 mtm180 -112.85 -66.46 1.08 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.066 0.854 . . . . 0.0 109.442 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -121.27 179.26 4.47 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.987 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.493 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -137.59 148.12 19.64 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-N 112.81 -1.995 . . . . 0.0 114.676 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.405 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -147.36 148.79 31.72 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -99.58 140.12 34.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.22 -77.65 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.37 33.72 4.33 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.656 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.57 -21.88 40.87 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -102.62 165.41 11.09 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.504 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 15.6 t -90.16 148.36 23.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.511 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 29.0 t70 -131.18 146.41 52.32 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 103.366 -2.828 . . . . 0.0 103.366 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.647 ' H ' ' H ' ' A' ' 2' ' ' GLY . 58.5 m -111.6 173.75 6.2 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.685 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.8 m -121.03 64.88 13.07 Favored Pre-proline 0 N--CA 1.486 1.331 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.465 ' C ' ' HE ' ' A' ' 23' ' ' ARG . 59.6 Cg_endo -57.5 174.8 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 123.286 2.657 . . . . 0.0 113.397 -173.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -29.26 -60.38 0.14 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 112.995 -1.911 . . . . 0.0 113.667 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.333 0 O-C-N 119.412 -2.055 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.413 ' C ' ' H ' ' A' ' 34' ' ' CYS . 35.7 m . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.773 0.321 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -21.12 149.78 0.0 OUTLIER Glycine 0 N--CA 1.503 3.133 0 N-CA-C 119.541 2.576 . . . . 0.0 119.541 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.632 HG13 ' H ' ' A' ' 4' ' ' ASN . 13.3 pt -114.25 -103.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.632 ' H ' HG13 ' A' ' 3' ' ' ILE . 14.0 t-20 -173.81 31.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.459 ' H ' HG13 ' A' ' 3' ' ' ILE . 46.3 t -131.52 165.71 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' N ' HG12 ' A' ' 5' ' ' VAL . 38.3 mtpt -103.6 140.86 36.98 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 125.016 1.448 . . . . 0.0 108.956 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 p -122.98 166.4 15.14 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.485 -1.689 . . . . 0.0 112.511 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -40.5 2.91 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 110.764 -2.925 . . . . 0.0 105.775 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -131.87 179.59 5.99 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.67 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.0 t -86.69 28.91 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.188 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.87 -51.16 0.19 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 103.294 -3.922 . . . . 0.0 103.294 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -22.6 2.03 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.506 -1.847 . . . . 0.0 110.077 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 44.3 t -99.24 -43.23 6.69 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.937 -1.938 . . . . 0.0 111.478 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.508 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.3 tt -53.73 -43.97 69.5 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.859 0.863 . . . . 0.0 112.329 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -61.46 -56.51 32.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 124.189 0.931 . . . . 0.0 112.707 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -67.57 -31.3 33.75 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.837 1.691 . . . . 0.0 110.323 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 9.2 m -61.44 -63.52 1.25 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -56.52 -47.82 78.53 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -59.03 -23.77 62.25 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 126.126 2.142 . . . . 0.0 111.486 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.91 -1.19 43.49 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 123.703 0.627 . . . . 0.0 110.391 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.67 40.8 1.54 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 116.112 1.205 . . . . 0.0 116.112 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.409 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 14.8 mmm -128.22 -164.04 1.34 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.3 mtm180 -111.57 -66.53 1.07 Allowed 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.14 178.86 5.33 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.234 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -140.6 149.0 20.63 Favored Glycine 0 C--O 1.215 -1.087 0 CA-C-N 113.101 -1.863 . . . . 0.0 114.502 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 21.5 ptmt -144.73 152.15 39.96 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -99.61 143.38 29.92 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.122 -1.431 . . . . 0.0 107.359 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.8 mm -114.68 -81.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.45 33.6 4.41 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.453 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.76 -22.57 35.13 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.103 -2.399 . . . . 0.0 107.103 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -99.97 163.81 12.28 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 11.4 t -90.44 150.78 21.69 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.557 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 32.5 t70 -135.01 144.23 47.24 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.573 ' SG ' HG23 ' A' ' 3' ' ' ILE . 35.9 m -112.37 167.48 10.4 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 119.317 0.962 . . . . 0.0 113.34 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.2 m -122.21 58.85 10.51 Favored Pre-proline 0 N--CA 1.487 1.421 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.072 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -68.41 173.67 9.38 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 123.25 2.634 . . . . 0.0 111.501 -168.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -29.35 -59.2 0.15 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 125.848 1.967 . . . . 0.0 113.761 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.338 0 O-C-N 119.391 -2.068 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 122.087 0.946 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -125.78 -170.29 13.0 Favored Glycine 0 C--N 1.306 -1.094 0 CA-C-N 113.391 -1.731 . . . . 0.0 113.67 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.625 HG13 ' H ' ' A' ' 4' ' ' ASN . 14.7 pt -111.62 -105.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.625 ' H ' HG13 ' A' ' 3' ' ' ILE . 12.9 t-20 -173.8 36.81 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 124.415 1.072 . . . . 0.0 108.326 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.83 163.27 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.26 143.61 31.12 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 122.111 0.958 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.6 p -128.85 167.49 17.28 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 112.52 -2.127 . . . . 0.0 113.159 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -121.93 -42.64 2.38 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 110.216 -3.175 . . . . 0.0 105.272 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.0 m80 -127.13 177.37 6.7 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.293 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.2 m -88.64 28.16 1.18 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.902 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -121.22 -50.54 0.26 Allowed Glycine 0 N--CA 1.494 2.53 1 N-CA-C 102.504 -4.239 . . . . 0.0 102.504 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -24.96 2.05 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 113.053 -1.574 . . . . 0.0 109.523 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 35.6 t -97.58 -39.33 9.17 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 112.559 -2.109 . . . . 0.0 110.77 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.457 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 10.5 tt -56.17 -45.3 79.77 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.198 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -58.05 -58.96 14.96 Favored Pre-proline 0 C--N 1.308 -1.196 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.829 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -66.97 -31.62 37.12 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.335 2.023 . . . . 0.0 110.888 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.748 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 32.8 m -61.38 -62.3 1.93 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -50.47 -54.42 22.28 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 113.82 -1.537 . . . . 0.0 107.997 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.19 -26.6 60.91 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 127.196 2.81 . . . . 0.0 112.072 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.08 2.19 48.43 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 124.004 0.815 . . . . 0.0 111.529 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.98 39.65 2.11 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.493 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 26.6 mmt -125.15 -164.27 1.27 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.42 ' HE ' ' C ' ' A' ' 36' ' ' PRO . 52.2 mtm180 -117.43 -62.04 1.62 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.19 178.82 5.36 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.167 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.457 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -131.9 150.74 19.63 Favored Glycine 0 C--O 1.216 -1.023 0 CA-C-N 113.15 -1.841 . . . . 0.0 113.792 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -145.15 140.72 28.17 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t -99.89 139.38 35.64 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 mt -116.91 -78.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 117.171 2.285 . . . . 0.0 117.171 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.38 35.36 3.47 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.353 1.033 . . . . 0.0 111.945 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.05 -21.38 41.97 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -105.11 166.37 10.44 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.748 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 37.9 t -84.97 149.54 25.54 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.877 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 26.6 t70 -134.71 120.91 20.06 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.593 ' SG ' HG23 ' A' ' 3' ' ' ILE . 21.8 m -99.66 166.06 11.3 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.646 1.112 . . . . 0.0 113.044 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.6 m -120.8 67.36 14.64 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.495 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.493 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 13.4 Cg_endo -80.92 176.37 9.02 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 123.175 2.583 . . . . 0.0 111.863 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -110.26 -58.72 2.03 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.278 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.381 0 O-C-N 119.456 -2.028 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -144.56 -170.94 14.11 Favored Glycine 0 C--O 1.216 -0.979 0 O-C-N 124.15 0.906 . . . . 0.0 111.124 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.648 HG23 ' SG ' ' A' ' 34' ' ' CYS . 12.9 pt -111.82 -104.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.622 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.7 t30 -176.01 33.76 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 124.714 1.259 . . . . 0.0 108.79 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' H ' HG13 ' A' ' 3' ' ' ILE . 46.6 t -125.65 164.0 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.471 ' C ' ' HD2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -99.96 139.38 35.71 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 124.732 1.27 . . . . 0.0 109.059 -179.723 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 p -123.36 166.75 14.8 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 112.616 -2.084 . . . . 0.0 111.525 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -42.79 2.21 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 110.513 -3.04 . . . . 0.0 103.953 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.405 ' C ' ' H ' ' A' ' 11' ' ' GLY . 18.7 m80 -124.32 179.0 5.08 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.081 0.944 . . . . 0.0 111.745 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.4 t -89.04 28.62 1.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.211 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 9' ' ' HIS . . . -124.63 -50.59 0.2 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 103.301 -3.92 . . . . 0.0 103.301 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.95 -22.84 1.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.718 -1.741 . . . . 0.0 109.788 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 43.0 t -99.4 -43.89 6.39 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.493 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.5 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 8.4 tt -54.8 -44.09 73.49 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.616 0.766 . . . . 0.0 112.499 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -60.85 -56.44 35.02 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.877 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.53 -32.93 23.75 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.336 2.024 . . . . 0.0 111.287 178.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.728 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 18.1 m -61.07 -61.07 2.84 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -52.72 -52.79 54.77 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.888 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.82 -24.66 62.29 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 126.431 2.332 . . . . 0.0 111.817 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.28 1.71 47.45 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.077 0.861 . . . . 0.0 111.073 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.69 38.31 2.07 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 116.592 1.397 . . . . 0.0 116.592 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.441 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 25.7 mmt -125.64 -164.85 1.34 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -113.27 -63.78 1.4 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.75 178.37 5.73 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 123.954 0.784 . . . . 0.0 111.036 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.5 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -143.91 150.93 22.94 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-N 113.154 -1.839 . . . . 0.0 114.145 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.72 153.14 41.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.84 141.96 31.96 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.08 -78.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 116.509 2.041 . . . . 0.0 116.509 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -110.28 34.84 3.68 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 124.526 1.141 . . . . 0.0 111.223 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.6 -24.2 31.59 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -103.58 163.07 12.54 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.443 0.731 . . . . 0.0 109.138 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.728 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 12.7 t -84.13 146.97 27.59 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.474 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 9.9 t70 -129.8 130.48 45.38 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.648 ' SG ' HG23 ' A' ' 3' ' ' ILE . 15.4 m -103.8 161.22 14.13 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 119.745 1.157 . . . . 0.0 112.439 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.2 m -123.37 63.09 23.85 Favored Pre-proline 0 N--CA 1.488 1.442 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.831 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.441 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 32.8 Cg_endo -74.6 171.96 17.13 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.955 2.437 . . . . 0.0 111.377 -172.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -29.58 81.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 126.219 2.199 . . . . 0.0 116.128 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.379 0 O-C-N 118.79 -2.444 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.769 0.795 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -129.77 -170.98 12.84 Favored Glycine 0 C--O 1.216 -1.012 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.184 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.64 HG23 ' SG ' ' A' ' 34' ' ' CYS . 14.2 pt -112.06 -104.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.629 ' H ' HG13 ' A' ' 3' ' ' ILE . 48.7 t30 -173.01 33.4 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 O-C-N 124.64 1.213 . . . . 0.0 108.932 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' H ' HG13 ' A' ' 3' ' ' ILE . 61.3 t -126.25 155.01 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -99.96 133.22 44.66 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 125.06 1.475 . . . . 0.0 111.226 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -123.61 167.13 14.35 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 112.458 -2.156 . . . . 0.0 111.959 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.466 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 6.9 mmpt? -117.79 -38.26 3.29 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 111.081 -2.781 . . . . 0.0 105.206 179.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -126.31 174.22 8.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.604 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -88.59 35.54 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.758 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.46 -50.63 0.21 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 104.531 -3.428 . . . . 0.0 104.531 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -56.15 -16.59 5.44 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 113.593 -1.304 . . . . 0.0 110.526 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 39.4 t -100.83 -41.31 6.91 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.255 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.428 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.9 tt -55.91 -46.13 78.51 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.023 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -57.93 -60.19 10.79 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.651 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -66.43 -32.75 39.65 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.102 1.868 . . . . 0.0 110.314 -177.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 33.5 m -59.84 -58.96 6.32 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -52.09 -56.0 17.19 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 124.888 1.367 . . . . 0.0 108.417 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -20.18 61.07 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 126.891 2.619 . . . . 0.0 113.268 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.3 -1.96 40.57 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 124.037 0.836 . . . . 0.0 109.841 179.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.93 38.19 2.06 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 115.735 1.054 . . . . 0.0 115.735 179.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.467 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 22.1 mmt -125.15 -165.71 1.44 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.21 -61.37 1.76 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.82 -178.21 4.2 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.195 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -131.05 154.17 20.68 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 112.267 -2.242 . . . . 0.0 113.361 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -151.83 136.13 16.75 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 t -99.74 143.06 30.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.6 -82.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -110.34 34.61 3.82 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.409 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.66 -20.99 40.09 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.082 -2.407 . . . . 0.0 107.082 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -100.02 166.61 10.96 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 36.4 t -91.6 150.95 20.93 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.488 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 25.1 t70 -137.01 124.04 21.54 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.64 ' SG ' HG23 ' A' ' 3' ' ' ILE . 28.5 m -99.75 176.5 5.43 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.466 1.03 . . . . 0.0 112.444 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.7 m -116.76 66.28 3.64 Favored Pre-proline 0 N--CA 1.486 1.327 0 CA-C-N 112.917 -1.947 . . . . 0.0 106.877 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.467 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 97.5 Cg_endo -63.04 179.05 0.86 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 123.962 3.108 . . . . 0.0 113.076 -176.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.75 179.28 4.31 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 112.844 -1.98 . . . . 0.0 111.671 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.3 0 O-C-N 119.208 -2.182 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 122.096 0.951 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . -130.78 -170.38 12.67 Favored Glycine 0 C--N 1.308 -1.026 0 CA-C-N 113.513 -1.676 . . . . 0.0 113.022 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.63 HG23 ' SG ' ' A' ' 34' ' ' CYS . 13.7 pt -110.47 -104.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.617 ' H ' HG13 ' A' ' 3' ' ' ILE . 12.7 t-20 -173.95 33.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 O-C-N 124.416 1.073 . . . . 0.0 108.585 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' H ' HG13 ' A' ' 3' ' ' ILE . 59.1 t -125.48 158.53 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -100.82 138.47 37.83 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.305 1.003 . . . . 0.0 111.131 -179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 p -126.85 167.28 16.02 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.595 -2.093 . . . . 0.0 112.328 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -118.35 -39.0 3.08 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 110.955 -2.839 . . . . 0.0 105.645 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -126.32 175.09 8.08 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.956 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.4 m -89.5 34.16 0.82 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.511 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.9 -48.38 0.25 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 104.959 -3.256 . . . . 0.0 104.959 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.86 -11.88 6.38 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 113.536 -1.332 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 38.7 t -103.24 -41.6 6.01 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.775 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.501 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.4 tt -57.31 -43.04 82.92 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.353 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -60.85 -57.23 27.97 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.203 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.29 -32.22 26.91 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.531 2.154 . . . . 0.0 111.065 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 22.4 m -61.54 -60.92 2.97 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.36 -54.51 30.91 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -57.75 -23.81 53.93 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 126.577 2.423 . . . . 0.0 112.601 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.25 0.76 46.32 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 124.098 0.874 . . . . 0.0 111.013 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.7 39.07 2.26 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.526 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 25.7 mmt -124.82 -165.95 1.46 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -112.36 -64.93 1.23 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -124.87 179.08 5.16 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.692 0.758 . . . . 0.0 110.62 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.501 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -132.92 149.56 19.6 Favored Glycine 0 C--O 1.216 -0.992 0 CA-C-N 112.802 -1.999 . . . . 0.0 113.252 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -144.25 141.63 29.96 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 104.47 -2.418 . . . . 0.0 104.47 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.3 t -99.65 141.03 32.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.6 mt -117.13 -78.45 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -110.26 35.58 3.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.57 1.169 . . . . 0.0 111.465 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.23 -23.35 34.69 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -101.93 167.82 9.81 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.75 0.912 . . . . 0.0 109.055 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.1 t -88.38 148.84 24.04 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.667 -1.151 . . . . 0.0 113.946 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.518 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 13.5 t70 -132.97 124.14 27.2 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.63 ' SG ' HG23 ' A' ' 3' ' ' ILE . 22.0 m -99.83 162.45 12.99 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 119.605 1.093 . . . . 0.0 111.946 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.3 m -121.79 61.12 12.27 Favored Pre-proline 0 N--CA 1.489 1.496 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.536 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 66.7 Cg_endo -68.2 175.24 6.94 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 C-N-CA 123.172 2.581 . . . . 0.0 111.659 -172.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -29.38 -59.21 0.15 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 125.775 1.922 . . . . 0.0 113.894 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.337 0 O-C-N 119.425 -2.047 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.504 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . -32.53 171.01 0.0 OUTLIER Glycine 0 N--CA 1.5 2.948 0 N-CA-C 120.304 2.882 . . . . 0.0 120.304 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.633 HG13 ' H ' ' A' ' 4' ' ' ASN . 13.5 pt -114.55 -105.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 112.434 -1.883 . . . . 0.0 106.705 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.633 ' H ' HG13 ' A' ' 3' ' ' ILE . 49.2 t30 -175.15 33.58 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 124.71 1.257 . . . . 0.0 108.951 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.457 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.3 t -124.25 163.22 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -99.98 136.87 39.23 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 124.457 1.098 . . . . 0.0 111.609 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 p -122.0 167.12 13.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.73 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -118.8 -41.12 2.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 110.598 -3.001 . . . . 0.0 105.405 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -126.21 177.22 6.53 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.607 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.5 p -87.33 21.05 2.56 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.904 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.58 -48.93 0.4 Allowed Glycine 0 N--CA 1.495 2.567 1 N-CA-C 103.088 -4.005 . . . . 0.0 103.088 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -23.91 4.37 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 113.071 -1.565 . . . . 0.0 109.522 179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 23.1 t -98.42 -36.01 10.1 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.827 -1.988 . . . . 0.0 111.035 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.428 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.0 tt -59.14 -42.3 90.34 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.288 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -60.17 -55.84 41.34 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-O 117.796 -1.097 . . . . 0.0 112.538 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -68.49 -36.81 14.36 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.289 1.992 . . . . 0.0 111.374 178.156 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 15.6 m -58.45 -59.43 5.36 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -52.85 -54.77 29.66 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.37 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.47 -24.74 57.53 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 126.764 2.54 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.41 -0.72 43.07 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 124.167 0.917 . . . . 0.0 111.541 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.38 38.78 1.58 Allowed Glycine 0 N--CA 1.483 1.809 0 N-CA-C 116.831 1.493 . . . . 0.0 116.831 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.445 ' HB2' ' C ' ' A' ' 17' ' ' CYS . 29.8 mmt -124.18 -165.62 1.39 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -114.09 -62.41 1.6 Allowed 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -126.28 179.59 5.2 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.048 0.842 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -126.57 158.1 20.54 Favored Glycine 0 C--O 1.217 -0.913 0 CA-C-N 113.001 -1.909 . . . . 0.0 113.247 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.38 137.03 15.17 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 102.138 -3.282 . . . . 0.0 102.138 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t -99.62 142.39 31.17 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 117.928 -1.509 . . . . 0.0 107.601 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 33' ' ' ASP . 33.0 mt -109.63 -85.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -179.361 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 28' ' ' ILE . 22.9 p30 -110.38 35.35 3.48 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.272 0.982 . . . . 0.0 111.329 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.22 -22.06 33.94 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 106.382 -2.687 . . . . 0.0 106.382 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -99.68 166.4 11.13 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 39.1 t -89.9 146.3 24.51 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -179.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.504 ' HA ' ' CA ' ' A' ' 2' ' ' GLY . 37.6 t70 -129.64 137.35 50.62 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.573 ' SG ' HG23 ' A' ' 3' ' ' ILE . 17.1 m -110.66 160.17 16.93 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.276 -0.969 . . . . 0.0 112.39 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.5 m -122.42 62.65 16.92 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.409 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 66.6 Cg_endo -68.33 176.36 5.72 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 123.525 2.817 . . . . 0.0 111.665 -173.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 38' ' ' NH2 . 0.0 OUTLIER -29.43 -37.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.929 2.196 . . . . 0.0 116.929 179.993 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . 0.53 ' N ' ' HD3' ' A' ' 37' ' ' LYS . . . . . . . . 0 C--N 1.304 -1.38 0 O-C-N 118.555 -2.591 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.746 0.784 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.655 ' H ' ' H ' ' A' ' 34' ' ' CYS . . . 74.63 177.24 38.1 Favored Glycine 0 C--N 1.307 -1.075 0 CA-C-N 113.853 -1.522 . . . . 0.0 113.927 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.615 HG13 ' H ' ' A' ' 4' ' ' ASN . 12.4 pt -120.92 -106.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.615 ' H ' HG13 ' A' ' 3' ' ' ILE . 13.2 t-20 -175.76 35.43 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 124.979 1.312 . . . . 0.0 108.022 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.468 ' H ' HG13 ' A' ' 3' ' ' ILE . 47.3 t -123.92 161.27 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 8.7 mtpm? -99.98 139.0 36.28 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 122.213 1.006 . . . . 0.0 111.244 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.0 p -125.44 167.37 15.08 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.709 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -117.51 -38.76 3.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 110.884 -2.871 . . . . 0.0 105.342 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -129.61 175.48 8.77 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.653 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.5 t -85.46 34.52 0.58 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.08 -48.47 0.19 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 106.598 -2.601 . . . . 0.0 106.598 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -62.65 -7.59 5.07 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.753 -1.224 . . . . 0.0 110.864 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 33' ' ' ASP . 35.4 t -105.85 -40.6 5.66 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.301 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.448 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 9.0 tt -57.46 -45.11 85.13 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.341 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -60.36 -56.15 38.18 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-O 117.995 -1.002 . . . . 0.0 112.846 -179.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -67.23 -34.7 26.91 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.694 1.596 . . . . 0.0 110.928 178.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 11.9 m -60.39 -63.97 1.11 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -56.3 -45.08 80.37 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.122 0.889 . . . . 0.0 109.347 -179.73 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 10.7 t70 -61.3 -25.19 66.95 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 125.832 1.958 . . . . 0.0 111.091 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.99 0.57 46.59 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 123.929 0.768 . . . . 0.0 110.858 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.35 39.43 1.36 Allowed Glycine 0 N--CA 1.483 1.81 0 N-CA-C 117.008 1.563 . . . . 0.0 117.008 179.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.501 ' SD ' ' HB3' ' A' ' 36' ' ' PRO . 26.1 mmt -126.14 -164.56 1.33 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.9 mtm180 -114.01 -64.59 1.29 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -126.07 179.95 4.99 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.384 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.448 ' HA3' ' N ' ' A' ' 14' ' ' LEU . . . -128.27 153.47 19.51 Favored Glycine 0 C--O 1.216 -1.013 0 CA-C-N 113.05 -1.886 . . . . 0.0 113.576 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -145.52 137.69 25.59 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -99.31 138.83 35.86 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 179.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.3 mt -116.45 -79.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 117.667 2.469 . . . . 0.0 117.667 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -110.31 35.29 3.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.468 1.105 . . . . 0.0 111.36 -179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.36 -22.82 36.33 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 106.922 -2.471 . . . . 0.0 106.922 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -102.46 168.26 9.42 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.815 0.95 . . . . 0.0 109.064 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.694 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 35.2 t -90.43 147.57 23.34 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 12.1 t70 -131.04 141.55 50.22 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.655 ' H ' ' H ' ' A' ' 2' ' ' GLY . 29.8 m -112.33 164.24 13.47 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 119.088 0.858 . . . . 0.0 112.315 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.3 m -121.5 58.12 7.94 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.781 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.501 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 36.7 Cg_endo -73.61 168.67 24.2 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.927 2.418 . . . . 0.0 111.51 -169.256 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -29.39 81.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 126.33 2.269 . . . . 0.0 115.69 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.401 0 O-C-N 118.711 -2.493 . . . . 1.0 . . . . . . . . . . 0 0 . 1 stop_ save_